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 ABSTRACT 
Mesenchymal stem cells are valuable for regenerative dental research.  However, the use 
of adipose-derived cells (ADCs) within regenerative dentistry remains relatively 
unexplored.  This project aimed to determine an optimal method for the isolation of rat 
ADCs, to evaluate the influence of cell selection and cryo-storage on MSC phenotype, and 
compare the relative stemness and dentinogenic capacity of ADCs with bone marrow 
(BMDCs) and dental pulp-derived cells (DPDCs).  Digestion with type-I collagenase for 
30 minutes at 37ºC released the greatest number of viable and proliferative ADCs from 
inguinal adipose tissue.  FACS and sqRT-PCR profiling indicated that ADCs shared 
similar levels of MSC markers (e.g. CD73, CD90, CD105) with BMDCS and DPDCs.  
The expression of MSC markers was also increased following cryo-storage for all cell 
types. Alizarin red staining, SEM and micro-CT analyses indicated that the osteogenic 
differentiation capacity of ADCs appeared lower than that of BMDCs and DPDCs.  The 
FACS procedure reduced cell viability and CD29/CD90 cells had limited osteogenic 
differentiation capacity when compared to unsorted cell populations.  Dentine matrix 
component (DMCs) supplementation (1 µg/mL) increased the volume of mineralised 
deposits in ADC, BMDC and DPDC cultures, as well as the expression of odontogenic 
markers (DMP1 and DSPP) in ADC and BMDC cultures.  In conclusion ADCs have an 
odontogenic capacity, although this may be limited when compared with BMDCs and 
DPDCs.  These findings indicate that when compared with BMDCs or DPDCs, ADCs may 
have a comparatively limited applicability for dental tissue engineering.  However, ADCs 
can be isolated in comparatively large numbers with relatively little patient discomfort 
when compared with BMDCs and DPDCs, and these and previous studies have indicated 
that ADCs can be induced towards a dentinogenic phenotype. 
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1.0 INTRODUCTION 
 
1.1 Dentine-Pulp Complex 
The dentine-pulp complex (Figure 1.1) comprises of two tissues that although 
compositionally and structurally distinct are embryologically similar, dentine and dental 
pulp (Linde and Goldberg, 1993).  These two tissues function together in the maintenance 
of homeostasis and have interlinked roles in the pathological and reparative responses of 
the tooth.  The dental pulp is a gelatinous innervated connective tissue containing a rich 
source of vasculature and is located centrally within the tooth.  The pulp is surrounded by a 
rigid calcified tissue called dentine, which represents the major constituent of teeth.  
Dentine matrix is produced by post-mitotic cells called odontoblasts that line the border of 
the dental pulp.  In reaction to tooth damage, these odontoblasts are able to up-regulate 
their activity and rapidly deposit a protective layer of dentine to prevent the invasion of 
pathogens.  More severe damage is reliant on the proliferation, migration and 
differentiation of multipotent cells located within the pulp.  The role of the dentine-pulp 
complex during tooth damage and the ways in which this can be exploited for tissue 
engineering research will be discussed in the following chapters. 
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Figure 1.1 Histological section displaying the organisation of the dentine-pulp complex in 
a human third molar with haematoxylin and eosin staining (H&E) (Image was captured at 
x10 magnification).  Image reproduced courtesy of Dr P. Tomson and Miss S. Finney 
(School of Dentistry, University of Birmingham). 
 
1.2 Dentine and its Matrix 
Dentine is a porous calcified tissue that represents the major constituent of teeth.  This 
tissue is perforated by dentinal tubules that are 1-3 μm in diameter that traverse the 
dentinal layer, radiating out from the dentine-enamel junction (DEJ) or cemento-enamel 
junction (CEJ) to the pulp in mantle or apical dentine respectively (Maniatopoulos and 
Smith, 1983; Sigal et al, 1985).  As dentinal tubules extend through the dentinal layer they 
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branch in areas of low tubule density producing a system of canaliculi similar to that found 
in bone (Mjor and Nordahl, 1996).  Dentine comprises of an inorganic mineral phase        
(70 % by wt), an organic collagenous matrix (20 % by wt) and water (10 % wt).  The 
organic matrix is predominantly made up of collagen (90 % wt), with the remainder 
comprising mainly of non-collagenous proteins (NCPs), glycosaminoglycans (GAGs) and 
proteoglycans (Veis, 1993; Butler and Ritchie, 1995; Butler, 1998).  The mineral phase of 
dentine is composed of a carbonate-substituted hydroxyapatite (HA), which is deposited as 
crystallites that become nucleated through the action of NCPs present in the organic 
dentine matrix such as phosphoryn (Linde and Lundgren, 1995; Goldberg et al, 1995; Xu 
and Wang, 2012).  The high mineral content of dentine (80 % by wt) makes it a harder 
tissue than bone and cementum (65 % by wt) and enables it to provide structural support to 
enamel (Hariri et al, 2013). 
Dentine can be subdivided into several different types: primary, secondary and tertiary 
(Kuttler, 1959).  Primary dentine represents the most abundant form within the tooth and is 
deposited before the tooth root is fully developed.  Primary dentine can be further 
subdivided into mantle, circumpulpal, peritubular and intertubular dentines depending on 
its location and composition (see figure 1.2) (Goldberg et al, 2011).  Mantle dentine is the 
first layer of dentine to be laid down and is located adjacent to the dentino-enamel junction 
(Goldberg et al, 2002).  It is produced by developing odontoblasts, is approximately 5 -    
30 μm wide, and is composed of loosely packed collagen fibrils and thicker Von Korff 
fibres (Bishop et al, 1991; Linde and Goldberg, 1993).  Circumpulpal dentine is deposited 
following the formation of mantle dentine and accounts for the bulk of dentine within the 
tooth.  This dentinal layer is located beneath the mantle dentine and is deposited at a rate 
of approximately 4 µm per day until crown and root development is complete (Vital et al, 
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2012). Circumpulpal dentine can be defined as inter-tubular dentine or intra-
tubular/peritubular dentine.  Intra-tubular dentine is secreted from odontoblast processes 
and can be observed as a lining around the dental tubules, potentially causing tubular 
occlusion as patients’ age (Gotliv et al, 2006; Goldberg et al, 2011).  Intra-tubular dentine 
is hyper-mineralised when compared with inter-tubular dentine and contains a relatively 
high proportion of glycosaminoglycans (GAGs), but comparatively few collagen fibrils 
(Linde and Goldberg, 1993).  Inter-tubular dentine is secreted from the terminal web of the 
odontoblast and is located between the zones of intra-tubular dentine (Linde and Goldberg, 
1993).  It is composed of a densely packed type-I collagen matrix associated with larger 
mineralised crystalline plates than those found within intra-tubular dentine (Xu and Wang, 
2012).  Collagen fibrils are also coated with NCPs that have roles in the nucleation and 
expansion of mineral.  The action of these proteins will be considered in section 1.2.1.  
Secondary dentine is formed after root formation has been completed and the tooth has 
become functional.  This type of dentine is structurally similar to primary dentine, but is 
intermittently deposited throughout life at a rate of approximately 0.4 µm per day 
(Wennberg et al, 1982).  The boundary between primary and secondary dentine can be 
observed as a subtle calciotraumatic line, although the continuity of odontoblast processes 
between these two dentines is not disturbed.  Secondary dentine exists as a layer 
surrounding the pulp chamber and contains tubules that are typically more curved in 
appearance when compared with primary dentine (Linde and Goldberg, 1993).  This 
increased curvature is thought to result from odontoblast crowding as a result of continued 
matrix deposition.  The deposition of secondary dentine does not occur uniformly but 
instead tends to be greater in areas subject to more stimuli, such as the crown.  This 
asymmetric pattern of deposition subsequently leads to reduction and distortion of the 
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central pulp chamber.  A third type of dentine may be deposited in response to chemical, 
physical or bacterial injury to the primary tissue.  This is termed tertiary dentine and it can 
either be categorised as reactionary or reparative (Tziafas, 2004; Smith, 2012).  The 
structure of tertiary dentine may differ somewhat from primary dentine since it is 
deposited rapidly in response to disease or trauma and may resultantly lack the regular 
tubular pattern of this tissue (Smith et al, 2005).  The deposition of tertiary dentine in 
response to irritation shall be discussed in section 1.5. 
 
Figure 1.2 Images depicting the organisation and structure of dentine.  (a) Unstained 
ground section depicting the location of primary mantle and circumpulpal dentines; (b) 
Scanning electron photomicrograph displaying the tubular arrangement of circumpulpal 
dentine with annotation indicating the location of inter- and intra-tubular dentines.  Image 
a modified from Hayashi et al. (2008) and image b reproduced with the kind permission of 
E. Comar (School of Dentistry, University of Birmingham). 
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1.2.1 Dentine Extracellular Matrix 
The dentine extracellular matrix shares many similarities with bone since both are 
predominantly composed of a type-I collagen network and contain proteoglycans, 
glycosaminoglycans and other non-collagenous proteins (NCPs) (Butler et al, 2003; Orsini 
et al, 2009).  Collagen fibrils present in the organic dentine matrix overlap with one 
another creating intermittent gaps where GAGs are localised, and provide a structural 
template for mineralisation (Wisemann et al, 2005).  The organic matrix is deposited by 
odontoblasts and concomitantly becomes mineralised by the subsequent formation and 
growth of carbonate-substituted apatite (this is described in more detail in section 1.4.2).  
Associated with the collagenous matrix are NCPs that are understood to play roles in tissue 
repair and homeostasis, as well as in the expansion, coordination and regulation of 
mineralisation (Boskey et al, 1991; Wu et al, 2008; Fujisawa and Tamura, 2012).  NCPs 
are synthesised and secreted into the developing dentine matrix by odontoblasts where 
they bind to collagen fibres and initiate the nucleation of mineral.  Interestingly, the types 
of NCP located within bone and dentine are similar and no unique marker has yet been 
identified to effectively differentiate the two tissues (Qin et al, 2001).  However, 
quantitative differences in the expression of NCPs between the two tissues are known to 
exist and shall be discussed presently (Fujisawa et al, 1993; Goldberg and Smith, 2004). 
NCPs account for approximately 10 % of all organic dentine matrix components and have 
been shown to have roles in adhesion and signalling as well as in mineralisation (Linde et 
al, 1989).  A major family of NCPs, the Small integrin-binding ligand N-linked 
glycoproteins (SIBLING), represent a well characterised family of calcium-binding 
proteins that have roles in the nucleation of mineral and the coordination and regulation of 
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hydroxyapatite (HA) crystal formation when pre-dentine or osteoid are converted to 
dentine and bone, respectively (Hunter et al, 1996; Hao et al, 2009).  This family currently 
comprises of five proteins, which contain phosphorylation, glycosylation and cell-binding 
(RGD) sites and include: dentine matrix protein 1 (DMP1), dentine sialophosphoprotein 
(DSPP), osteopontin (OP), bone sialophosphoprotein (BSP) and matrix extracellular 
phosphoglycoprotein (MEPE), and all are located on human chromosome 4q21 (Fisher et 
al, 2001).   Both DSPP and DMP1 are present in dentinal tubules at the site of peritubular 
dentine and pre-dentine (Hao et al, 2009).  DSPP is immediately cleaved into dentine 
phosphoprotein (DPP) and dentine sialoprotein (DSP) subunits, which account for 8 % and 
50 % respectively of the total NCPs present in dentine (Zhu et al, 2012).  Both DPP and 
DSP are expressed by differentiating and mature (see section 1.4) odontoblasts and 
participate in the binding of calcium for the conversion of pre-dentine to dentine (Butler, 
1998; Begue-Kirn et al, 1998; Simon et al, 2009).  These SIBLING proteins were once 
thought to be dentine-specific, but have since been observed in bone (Baba et al, 2004; 
Goldberg and Smith, 2004; Hao et al, 2009).  However, the level of DSP in bone is 1/400 
of that found in dentine and as a result a high concentration of this marker is often used to 
distinguish between these two hard tissues (Goldberg et al, 1995; Qin et al, 2001, 2002).  
DMP1 is located in the nucleus of differentiating odontoblasts where it becomes 
phosphorylated and is subsequently transported into the extracellular matrix (ECM) 
(Narayanan et al, 2006).  This protein is proteolytically processed into N- and C-terminal 
fragments resulting from the cleavage of X-Asp bonds, with the full length form only 
being detected in dentine and not bone (Lu et al, 2011).  The active N-terminal fragment of 
this protein has been implicated in the regulation of odontoblast maturation since blocking 
the action of this protein has demonstrated reductions in the expression of terminal 
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odontoblast markers such as DSP and DMP2 (Narayanan et al, 2001) (see section 1.4) 
Moreover, the presence of DMP1 is required as a downstream effector of DSPP, with the 
absence of this protein leading to dentine hypomineralisation (Ye et al, 2004; Qin et al, 
2007; Chaussain et al, 2009; Gibson et al, 2013).   
BSP and OP represent two well characterised NCPs that were initially identified in bone 
(Williams and Peacocke, 1965; Franzen and Heinegard, 1985).  These two SIBLINGs have 
since been identified in dentine, but at significantly lower concentrations (Fujisawa et al, 
1993). These proteins are also present in cementum (OP and BSP) and mineralising 
cartilage (BSP) (Fujisawa et al, 1993; Zhao et al, 2007).  In fact, the comparatively 
reduced level of these SIBLINGs in dentine has led to them being compared with dentinal 
proteins such as DMP1 and DSPP for the characterisation of dentine and bone (Fujisawa et 
al, 1993).  OP is a highly phosphorylated protein associated with the mediation of cell-
matrix and matrix-matrix/mineral adhesion during the formation of mineralised tissues, as 
well as in the regulation of mineral crystal formation (McKee and Nanci, 1996; Sodek et 
al, 2000).  BSP is a highly sulphated and glycosylated protein that binds to HA and cell 
surface integrins to promote nucleation and formation of apatite crystals in both dentine 
and bone (Ganss et al, 1999; Malaval et al, 2008).  Both proteins are important for bone 
and dentine mineralisation and are up-regulated in response to mechanical wear indicating 
a potential role in tissue maintenance (Kubota et al, 1993; Carvalho et al, 2002).   
A second family of glycoproteins found in both dentine and bone is the secretory calcium-
binding phosphoprotein (SCPP) family, which contains the proteins osteocalcin (OC) and 
osteonectin (ON).  OC is commonly used as a marker to identify the post-proliferative 
phase of mineralisation and has been implicated in regulating the maturation of pre-dentine 
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and osteoid matrix as well as in calcium ion homeostasis (Owen et al, 1990).  The 
presence of this protein in dentine was demonstrated in the early 1980’s, although it was 
detected in significantly lower concentrations than in bone (Linde et al, 1982).  The role of 
this protein in the dentine ECM is not entirely understood, although several studies have 
demonstrated a potential function in the regulation of the mineral phase (Bleicher et al, 
1999; Papagerakis et al, 2002).  The SCPP ON functions in the regulation of collagen 
deposition within the ECM, the remodelling of mineralised tissues, as well as in the 
regulation of cell proliferation and the production of matrix metalloproteinases (MMPs) 
(Gundberg et al, 1984; Kawasaki et al, 2006; Martinek et al, 2007; Delany and 
Hankenson, 2009).  The temporal expression of this protein in bone and dentine is known 
to vary with high levels being present within mineralised bone matrix, whereas in dentine 
it is typically found within un-mineralised pre-dentine layer (Mundlos et al, 1992; Reichert 
et al, 1992).   
The NCP component of the dentine matrix also contains a diverse range of proteoglycans, 
enzymes such as MMPs, serum proteins and growth factors.  Proteoglycans can be sub-
divided into small leucine-rich proteoglycans (SLRP) and large aggregating proteoglycans.  
SLRPs present in dentine can be further sub-divided into two classes with class I 
containing decorin and biglycan and class II containing fibromodulin, lumican and 
osteoadherin.  Members of the SLRP family of proteins function in the formation of ECM, 
and bind to and stabilise collagen fibrils within the organic matrix to direct and regulate 
both HA crystal growth and collagen fibrillogenesis (Hall et al, 1997).  Many of the large 
aggregating proteoglycans are absent from the organic dentine matrix with only versican 
being detectable (Ruggeri et al, 2009.  The presence of this protein in the dentine matrix 
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has been shown to be associated with the maintenance of ECM hydration and organisation 
(Sone et al, 2005).  
MMPs constitute a family of calcium and zinc-dependent enzymes involved in the 
degradation of ECM components such as collagen during organisation of the dentine 
matrix.  These enzymes have been shown to be released from the dentine matrix following 
treatment with EDTA and have been implicated many dentinogenic events, such as the 
formation of intra-tubular dentine, the proteolytic cleavage of DSPP into its two 
constituents and the splitting of DMP1 into N- and C-terminal domains (Tay et al, 2006; 
Chaussain et al, 2009). It is also likely that MMPs play roles in the release and activation 
of dental growth factors such as TGF-β1 (Tatti et al, 2008; Boukpessi et al, 2008), IGFs 
and adrenomedullin (ADM), and may themselves be activated within the dentine matrix by 
various members of the SIBLING family such as BSP (MMP-2) and OP (MMP-3) (Koli et 
al, 2001).  Other less well characterised NCPs located within the dentine matrix include 
ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs), cathepsins, 
various serum proteins such as albumin and immunoglobulins, as well as a variety of 
growth factors (Orsini et al, 2009; Tersariol et al; 2010).   
 
1.2.2 Growth Factors Present in the Dentine Matrix 
The mineralised dentine matrix contains a large number of growth factors that become 
released through the demineralising action of bacterial acids, trauma, or the action of 
restorative materials such as EDTA.  The release of growth factors from the dentine matrix 
reportedly promotes local cellular proliferation and differentiation mimicking the process 
of embryonic tooth development (Butler et al, 2003; Goldberg and Smith, 2004).  Growth 
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factors present within the dentine matrix are synthesised and secreted by odontoblasts in 
the form of precursors or bound to specific binding proteins (Butler et al, 1995; 
Clemmons, 1997; Valcarce et al, 1999; Huang et al, 2008). In the ECM these factors 
interact with other components of the matrix such as proteoglycans - an interaction which 
modifies the bioactivity of these factors and prolongs their life and function (Smith et al, 
2012).  For instance, TGF-β-1 is associated with proteoglycans present in the dentine 
matrix such as biglycan, decorin as well as an N-terminal fragment of the TGF-β transcript 
called latency-associated protein (LAP) (Baker et al, 2009).  Heparan sulphate 
proteoglycans located within the ECM are also able to bind these bioactive factors, such as 
fibroblast growth factors (FGFs), hepatocyte growth factor (HGF), vascular endothelial 
growth factor (VEGF), platelet-derived growth factor (PDGF), bone morphogenetic 
proteins (BMPs), tumour necrosis factor-α (TNF-α) and a number of interleukins (ILs) 
(Smith et al, 2001; Dreyfuss et al, 2009).   
Active growth factors have been successfully released from the dentine matrix using dental 
restorative agents such as EDTA or pulp capping materials such as calcium hydroxide and 
mineral tri-oxide aggregates (MTA) (Smith and Smith, 1998; Ferracane et al, 2013).  In 
terms of yield, EDTA-extraction appears to be far superior in its ability to solubilise larger 
amounts of glycosaminoglycans (GAGs), non-collagenous proteins (NCPs) and 
transforming growth factor-β (TGF-β) than MTA or calcium hydroxide solutions (Graham 
et al, 2006; Tomson et al, 2007). The addition of these dental materials in vivo has been 
shown to release growth factors present within the dentine matrix that promote the 
proliferation and differentiation of odontoblast-like cells in a dose-dependent manner, with 
the accompanying formation of tertiary dentine matrix (Smith and Leaver, 1981; Zhao et 
al, 2000; Smith et al, 2001; Deque et al, 2006).  EDTA, MTA and calcium hydroxide 
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solubilisation can also be used as a means of isolating the active growth factors and 
bioactive components from mechanically pulverised dentine to produce a putative 
dentinogenic supplement, as shall be discussed in the following paragraphs.  
Given the structural and functional similarities of dentine and bone it is not surprising that 
these tissues contain a similar profile of growth factors.  Growth factors common to both 
tissues include: TGF-β superfamily members such as TGF-β1, 2 and 3; insulin-like growth 
factors 1 and 2 (IGF-1 and 2); fibroblast growth factor 2 (FGF2); platelet-derived growth 
factor (PDGF) and epidermal growth factor (EGF) (Begue-Kirn et al, 1994; Ruch et al, 
1995; Cassidy et al, 1997; Veis et al, 2000; Silva et al, 2004).  Members of the bone 
morphogenetic protein family have been identified during the developmental stages of 
dentinogenesis but the identification of these factors in mature dentine extracts is 
inconsistent (Thomadakis et al, 1999; Casagrande et al, 2010; Jagr et al, 2012).  BMP 
family members are consistently present in demineralised bone extracts and are involved 
in the induction, maintenance and repair of this tissue (Hanamura et al, 1980; Takahashi et 
al, 1987).  Other growth factors such as IGF-1 and 2 have also been detected in dentine 
and bone although their dentinal concentrations remain comparatively low (Finkelman et 
al, 1990).  One of the most characterised growth factors present in the dentine matrix is 
TGF-β1.  This growth factor or cytokine is an inducer of odontoblast differentiation and 
reparative dentine formation as well as an immunosuppressant involved in maintaining 
dentine-pulp homeostasis following tooth injury (Begue-Kirn et al, 1994; D’Souza et al, 
1998; Dobie et al, 2002; Li et al, 2011).   
The application of growth factors present in the dentine matrix to cell cultures either 
independently or in combination with crude dentine matrix extracts has been shown to 
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promote odontogenic differentiation in multipotent cell types such as dental pulp stem 
cells (DPSCs) (Nie et al, 2004; Deng et al, 2005; Liu et al, 2005).  The in vivo application 
of dentine matrix components (DMCs) into dental cavities has been shown promote 
odontogenic differentiation, as defined by the presence of polarised, columnar cells 
containing widened cisternae and long filamentous processes, as well as the formation of 
tertiary dentine (Smith et al., 1990; Smith et al, 1994; Tziafas et al, 1995; Smith and 
Lesot, 2001).  Studies applying EDTA-extracted DMCs to adult stem cells in vitro have 
indicated that these NCPs had a cell-specific effect, promoting the odontoblast-like 
differentiation of DPSCs, but only having a comparably limited effect on the 
mineralisation of stem cells isolated from adipose or bone marrow tissues (Chun et al, 
2011).  The action of TGF-β1 appears to be highly important to the odontogenic properties 
of DMCs with the blocking of TGF-β1 activity in EDTA-soluble DMCs diminishing the 
odontogenic activity of these bioactive extracts (Begue-Kirn et al, 1992).  The purification 
of DMCs using heparin-affinity chromatography, which has been shown to be able to 
select for growth factors such as TGF-β1, has also been shown to further enhance the 
odontogenic effects of these extracts indicating that the cellular response to DMCs may 
primarily be reliant on the activity of a few key factors (Begue-Kirn et al, 1992).   
Cells formed in the aforementioned studies are defined as odontoblast-like.  Such cells are 
typically defined as cells that possess odontoblast characteristics that differentiate them 
from other similar cell types such as osteoblasts.  These cells can be identified using 
morphological observation to assess whether the cells are elongated, polarised and 
secreting a tubular dentine matrix (Tziafas et al, 1993; Tziafas et al, 1995; Janebodin et al, 
2011).  Therefore, odontoblast-like cells are morphologically similar to primary 
odontoblasts.  However, unlike primary odontoblasts, their formation does not result from 
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signals originating from the oral epithelium (Goldberg and Smith, 2004).  Odontoblast-like 
cells commonly express dentine-related proteins, such as DMP1 and DSPP, and may 
feature comparative reductions in the expression of BSP and OP when compared with 
osteoblasts (Narayanan et al, 2001; Lei et al, 2013). The tertiary dentine matrix produced 
by odontoblast-like cells can either have a tubular and organised pattern characteristic of 
primary dentine or feature a more disorganised scar-like calcified fibro-dentine 
arrangement (Tziafas and Kodonas, 2010).  Comparative microarray studies contrasting 
the mRNA profiles of odontoblast-like cells formed by the induced differentiation of 
progenitor cells with that of primary odontoblasts derived from human third molars have 
displayed only minor differences between the two cell types (Paakkonen et al, 2007).  The 
differences observed between these cells related to the expression of genes involved with 
cell growth and cell cycle, and could be accounted for by the post-mitotic state of primary 
odontoblasts (Paakkonen et al, 2009).  Other differences related to genes involved in the 
recognition of stimuli that are likely to be linked to the sensory function of primary 
odontoblasts during tertiary dentinogenesis (Paakkonen et al, 2009).  Such observations 
indicate that odontoblast-like cells are morphologically and transcriptionally similar to 
primary odontoblasts.   
 
1.3 Dental Pulp 
Dental pulp is a gelatinous mesenchymal tissue that has nutritional, sensory, formative, 
defensive and protective roles in the maintenance of the tooth.  The cells of the pulp derive 
from ecto-mesenchymal cells that condense and form the dental papilla, which further 
differentiate to form the mature pulp (Linde, 1985).  The pulp has two distinct regions: the 
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coronal pulp, which represents the centrally located region within the tooth crown and the 
radicular pulp, which is situated within the apical portion of the tooth.  Surrounding the 
pulp is an odontoblast layer that intermittently secretes secondary dentine matrix during an 
individual’s lifespan and consequently reduces the size of the pulp chamber as the tooth 
ages (Paewinsky et al, 2005).  Dendritic cells and free nerve endings are associated with 
the odontoblast layer and provide a means of sensing injurious stimuli for the protection of 
the underlying pulp (Couve et al, 2013).  Subjacent to the odontoblasts layer is the central 
pulp chamber containing the cell-free (zone of Weil) and cell-rich zones as well as a pulpal 
core, which contains a rich vascular network, a neural supply and a large number of cells 
(see figure 1.3) (Provenza, 1958; Zhang et al, 1998).  The cell-free zone is located 
immediately beneath the odontoblast layer and represents a 40 μm wide richly innervated 
area of the pulp containing fibroblast processes and a capillary network (Linde and 
Goldberg, 1993).  The pulp contains a heterogeneous mixture of cells including fibroblasts, 
odontoblasts, white blood cells, macrophages, as well as a multipotent progenitor 
population (Goldberg and Smith, 2004).  This collection of cells is predominantly localised 
to the cell-rich zone of the pulp.  However, the exact location of the progenitor population 
is at present not fully understood (see section 1.6.1).  The heterogeneous collection of cells 
within the pulp is surrounded by a fibrous extracellular matrix that is rich in type-I and 
type-III collagen fibres, providing pulp architecture and elasticity, as well as a mixture of 
GAGs and PGs (Goldberg and Smith, 2004).  Cells located within the pulp have been 
shown to express members of the transforming growth factor-β (TGF-β) superfamily, as 
well as VEGF, FGF-2 and PDGF.  These factors are associated with the maintenance of 
tissue homeostasis, as well as progenitor cell proliferation, migration and differentiation 
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following dental injury (see section 1.2.1 and 1.2.2) (Toyono et al, 1997; Sloan et al, 1999; 
Matsushita et al, 2000; Kim et al, 2010). 
The pulp is a well innervated tissue containing both sensory and autonomic nerves that 
enable it to perform vasomotor and defensive functions (Okamura et al, 1995; Rodd and 
Boissonade, 2001).  Sensory nerves within the pulp are principally located below the cell 
rich zone and form the plexus of Raschkow (Linde and Goldberg, 1993).  As sensory 
neurons of the plexus migrate into the cell-rich zone of the pulp and beyond reaching the 
surrounding odontoblast layer they lose their myelin coating and function as pain receptors 
involved in the initiation of tertiary dentinogenesis (Magloire et al, 2010).  The pulp is also 
richly vascularised with arterioles running centrally and branching off to form capillary 
networks at the periphery of the tissue.  These capillaries are most evident during active 
dentinogenic phases and are closely related to the secretory activity of odontoblasts 
(Yoshida and Ohshima, 1996).  The capillary network provides the circumpulpal 
odontoblasts with a source of nutrients and oxygen, as well as disposing of metabolites 
(Provenza, 1958).  The network is also responsible for supplying a systemic source of raw 
materials required for the mineralisation of pre-dentine at the calcification front (Yoshida 
and Ohshima, 1996).  Increases in blood pressure resulting from pulpal inflammation 
activate neurons that transduce the pain stimulus into action potentials that are received by 
the brain.  The presence of shunt vessels that are able to open in response to increased 
blood flow are considered to be important for controlling increases in intrapulpal pressure 
resulting from inflammation due to the action of dental caries (Kim et al, 1992).  Such 
direct control over blood pressure is particularly important within the pulp due to its 
confinement within a structurally rigid wall of dentine and enamel.   
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Figure 1.3 Illustration depicting the cell-rich and cell-free zones of the dental pulp along 
with the surrounding odontoblast layer and accompanying pre-dentine matrix.  The cell-
rich zone contains a rich network of blood vessels that supply the pulp with oxygen and 
nutrients, as well as a collection of neurons that are able to transduce stimuli resulting from 
injury.  Modified from Ten Cate, Oral Histology. (2007) 
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1.4 Odontoblasts 
Odontoblasts are large columnar cells that line the periphery of the dental pulp.  These 
cells function in the intracellular accumulation of calcium and the secretion of a dentine 
ECM, as well as in the maintenance of tissue homeostasis (Linde and Goldberg, 1993).  
The morphology of these cells is known to differ depending on their level of maturity (see 
figure 1.4) and the location of these cells in the odontogenic layer, since odontoblasts 
located near the crown are larger than those located near the root (Simon et al, 2009).  
Immature odontoblasts are also relatively small cells containing limited cytoplasm and an 
under-developed RER and Golgi complex.  As these cells begin to mature and become 
secretory they develop an extensive rough endoplasmic reticulum (RER), Golgi apparatus, 
multiple mitochondria, lysosomes and secretory vesicles (Sasaki and Garant, 1996; Simon 
et al, 2009).  These intracellular organelles are required for the formation and secretion of 
an organic collagenous matrix that forms pre-dentine followed by the deposition of 
calcium phosphate required for dentine maturation.  Odontoblasts lie on the formative 
surface of dentine and as the thickness of this matrix increases it forces the odontoblasts to 
move pulpally (Larmas, 2008).  As the tissue mineralises, the remaining odontoblast 
processes become surrounded by a mineralised matrix forming the characteristic tubules 
associated with dentine (Nino-Barrera et al, 2013).   As these cells become less active they 
become more cuboidal with less cytoplasm and decreased numbers of RER complexes 
(Couve, 1986; Simon et al, 2009).  As odontoblasts mature the secretory apparatus 
becomes reduced through the action of autophagic activity, the remaining cellular 
organelles become relocated to the base of the cell and the odontoblast becomes quiescent 
(Couve, 1986; Couve et al, 2013) (see figure 1.4). 
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Odontoblasts are partly characterised by an elongated cytoplasmic process that extends 
from the cell body into dentinal tubules.  The exact depth of the process is a highly debated 
topic with some studies claiming that the process extends to reach the dentinal surface 
(Maniatopoulos and Smith, 1983; Aubin, 1985; Sigal, 1985), while others claim that 
processes are limited to the inner pulpal third of dentine (Brannstrom and Garberoglio, 
1972; Holland and Rogers, 1975).  It is thought that the exact length of the odontoblast 
process is related to age with evidence indicating that the process only reaches the dentinal 
surface at early developmental stages (Byers and Sugaya, 1995).  These processes contain 
no organelles but comprise of a large collection of structural proteins such as actin, 
vimentin and tubulin as well as secretory vesicles (Sigal et al, 1985).  Lateral branches 
extend from the main process and are thought to provide routes for the diffusion of 
nutrients and matrix molecules as well as facilitating cell-cell and cell-matrix interactions 
and communication (Arana-Chavez and Massa, 2004).  During dentinogenesis, these 
processes function in the transport of secretory vesicles containing pro-collagen, which is 
deposited in the developing ECM (Garces-Ortiz et al, 2013).  Odontoblast processes also 
facilitate the movement of calcium into pre-dentine during the formation of mature dentine 
(Linde, 1995).  Furthermore the odontoblast process also acts as sensory receptor, either 
directly or hydrodynamically, that is able to detect environmental alterations (Holland, 
1985).  Developing dentine matrix forms around these elongated cellular processes, 
eventually mineralising to form a dentinal tubule (see section 1.4.2). 
Odontoblasts also have a defensive role and are involved in the initiation of inflammatory 
responses following pathogenic invasion of the dentinal tubules (Couve et al, 2013).  Due 
to the fact that odontoblasts extend their long cellular processes through the dentinal layer 
they represent the first cells to be encountered by microorganisms that successfully 
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penetrate through the protective enamel and dentine layers of the tooth (Cooper et al, 
2010).  Adjacent odontoblasts are connected by inter-cellular junctions that provide an 
impervious barrier, which is the first line of defence against pathogenic pulpal invasion 
(Holland, 1975).  The odontoblast layer is closely associated with dendritic cells and 
lymphocytes that are thought to sense and react to the infiltration of exposed dentinal 
tubules (Ohshima et al, 1995).  Odontoblasts have also been shown to express bacteria-
recognising Toll-like receptors (TLRs) and NOD-like receptors (NLR) on their cell 
surfaces that can recognise bacterial components and respond by producing cytokines that 
initiate an inflammatory response (Keller et al, 2010; Farges et al, 2011).  This has been 
corroborated by studies in vitro demonstrating that odontoblasts respond to the presence of 
bacterial components such as lipoteichoic acid (LTA) that are common to gram positive 
bacteria primarily found in dentinal caries (Carrouel et al, 2013; Farges et al, 2011).   
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Figure 1.4 Illustration of the morphological and intra-cellular changes associated with 
odontoblast maturation.  Secretory odontoblasts form the primary dentine matrix and 
contain an extensive RER and Golgi complex required for the transportation of organic 
and inorganic matrix constituents.  As the tooth ages odontoblasts reduce their secretory 
activity and become mature.  Mature odontoblasts are characterised by the presence of 
autophagic vesicles and mediate the deposition of secondary dentine.  GC, Golgi complex; 
JC, junctional complexes; Ly, lysosome; M, mitochondria; N, nucleus; OP, odontoblastic 
process; PC, primary cilium; RER, rough endoplasmic reticulum; SG, secretory granules; 
AV, autophagic vesicles (modified from Couve and Schmachtenberg, 2011). 
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1.4.1 Odontoblast Development 
Understanding the signalling processes involved in physiological odontoblast induction 
and differentiation is important if we are to develop biological mechanisms for dental 
repair.  The generation of dentine-producing odontoblasts represents a major research 
challenge in regenerative dentistry and could provide a biological basis for regenerative 
strategies.  Odontoblasts are derived from migrating cranial neural crest cells that form a 
layer of oral ecto-mesenchyme that condenses around the epithelial bud.  The odontogenic 
mesenchyme forms cells of the dental papilla during the cap stage of tooth morphogenesis, 
during which reciprocal interactions that occur between the early oral epithelium and 
underlying mesenchyme results in the formation of the developing epithelial tooth bud 
(Ruch et al, 1995; Sharpe, 2001; Lisi et al, 2003).  Signals derived from the dental 
epithelium are sequestered and immobilised within the basement membrane and presented 
to peripheral dental papilla cells during the induction of odontoblast differentiation, 
leading to the polarization of odontoblasts (Ruch et al, 1995).  The differentiation of these 
cells is characterised by withdrawal from the cell cycle, cytological polarisation and the 
secretion of pre-dentine/dentine matrix (Lesot et al, 2001).  Currently, knowledge of the 
mechanisms leading to odontoblast differentiation is far from complete.  However, studies 
have indicated that members of the transforming growth factor-β family, such as TGF-β1, 
2 and 3, as well as BMP-2, -4 and -6 are capable of inducing odontoblast differentiation in 
vitro (Smith and Lesot, 2001; Begue-Kirn et al, 1992; Li et al, 2011; Kawai et al, 2013).  
It is likely that combinations of these factors are likely to originate from the oral 
epithelium, basement membrane and primary enamel knot during tooth morphogenesis 
(Ruch et al, 1995; Lesot et al, 2001).  In particular, the action of BMP-2 and TGF-β1 have 
been demonstrated to promote the expression of transcription factors involved in the 
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differentiation of odontoblasts, such as core-binding factor 1 (Cbfa1) and DSPP 
respectively (Ducy et al, 1997; He et al, 2004).  Odontoblast differentiation has also been 
shown to be accompanied by the coordinated expression of unique sets of genes like FGF-
1 and -2, and nuclear factor I-C (NFI-C), indicating that a complex network of factors may 
be immobilised and presented by the basement membrane to induce odontoblast 
differentiation in vivo (Ruch et al, 1995; Unda et al, 2001; Lisi et al, 2003; Lee et al, 
2009).  Other factors involved in the differentiation process include systemically derived 
molecules such as IGF-1, which has been shown to stimulate cytological differentiation, 
such as the re-organisation of microfilaments and fibronectin during odontoblast 
polarisation, but not functional differentiation of these cells (Lesot et al, 2001).   
Odontoblast differentiation is also accompanied by cytoskeletal reorganisation.  Alteration 
in the cytoskeletal arrangement of differentiating odontoblasts results in the polarisation of 
these cells and has an influence on their function, as does the compartmentalisation of 
intracellular organelles through the formation of a terminal web, which separates the 
odontoblastic process from the cell body (Linde, 1985; Lesot et al, 1985; Linde and 
Goldberg, 1993).  Interaction between odontoblasts and molecules located in the pre-
dentine and dentine matrix, such as the high molecular weight glycoprotein fibronectin, 
may also be instrumental in determining cytoskeletal organisation during odontoblast 
terminal differentiation (Thesleff et al, 1979; Ruch et al, 1995; Yoshiba et al, 1996).  For 
instance, fibronectin has been observed to interact with three high molecular weight 
odontoblast membrane proteins and influence the organisation of microfilaments in these 
cells (Lesot et al, 1992; Yoshiba et al, 1996).   Inter-cellular interactions in the odontoblast 
layer resulting from junctions present between odontoblasts are also considered important 
for the cytological (cytoskeletal reorganisation) and functional activity of these cells, with 
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alterations in odontoblast activity resulting from an increase in the number and size of 
junctional complexes formed during odontoblast maturation (Couve, 1986; Ushiyama, 
1989; Simon et al, 2009). 
Terminal odontoblast differentiation is characterised by the transcription of NCPs such as 
DMP1, DMP2 and DSPP with the accompanying formation of a mineralised dentine 
matrix.  The pattern of NCP expression by odontoblasts varies as these cells differentiate, 
with each NCP expressed in odontoblasts at specific and overlapping time points (Hao et 
al, 2004).  For instance DMP1 levels are decreased in secretory odontoblasts following the 
mineralisation of pre-dentine, while DSPP and DMP2 levels are sustained in mature 
odontoblasts (D‘Souza et al, 1997; Hao et al, 2004; Simon et al, 2009).  Differences in the 
expression patterns of these three proteins may be explained by the fact that DMP1 has 
been shown to be important in regulating the transcription of many odontoblast-associated 
genes such as DSPP and DMP2 (Narayanan et al, 2001).  The expression of DSPP has also 
been linked with BMP2, a growth factor expressed during the early stages of tooth 
morphogenesis (see section 1.2.2).  Pathologies relating to the absence of DSPP include 
dentinogenesis imperfecta type II and III and indicate that this NCP is also likely to have a 
role in the initiation of odontogenesis (Chen et al, 2009).  DSPP is further regulated during 
in odontoblasts by interactions with transcription factors involved in the early stages of 
dentine mineralisation, such as Cbfa1 and Osterix (Chen et al, 2005).   
Cbfa1 (also called Runx2) and Osterix represent two important transcription factors 
required for odontoblast differentiation and the synthesis of many SIBLINGs involved in 
the progression of dentine mineralisation.  Many of the key factors involved in the 
mineralisation of pre-dentine are also common to bone and are important for the 
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calcification of osteoid matrix (Staines et al, 2012).  Cbfa1 is a member of the runt/Cbfa 
transcription factor family and has a master regulatory role in the development of 
osteoblasts, and consequently bone; while Osterix is activated downstream of Cbfa1 
(Ducy, 2000; Huang et al, 2004).  These transcription factors have been proposed to play a 
similar role in the differentiation of odontoblasts, although their temporal expression and 
relative concentrations may differ from those in bone (Chen et al, 2009).  Absence of 
Cbfa1 and Osterix has been linked with severe skeletal abnormalities as a result of arrested 
osteoblast differentiation, along with dental abnormalities such as osteogenesis imperfecta 
(Mundlos et al, 1997; Lapunzina et al, 2010).  Studies analysing the effects of Cbfa1 and 
Osterix expression on odontogenic genes have demonstrated correlations between the 
expression of these genes and key odontoblast markers such as DSPP and DMP1, linking 
these two transcription factors with odontoblast-associated gene transcription (Kobayashi 
et al, 2005; Chen et al, 2009).  The expression of Cbfa1 and Osterix overlap within the 
developing dental and osteogenic mesenchyme, although only Osterix is strongly 
expressed in mature odontoblasts (E12 to E16), whereas both are strongly expressed in the 
mature osteoblasts indicating that Cbfa1 may be primarily required for the initiation of 
dentine mineralisation (Ducy, 2000; (Chen et al, 2009).  This is further confirmed by the 
temporal role of Cbfa1 in the determination of odontoblast lineage commitment in 
progenitor cell populations located in the dental papilla (Gaikwad et al, 2001).  Indeed, the 
involvement of these factors during tooth development is thought to be distinct from their 
roles during bone morphogenesis, functioning as potential regulators during epithelium-
mesenchymal signalling for the progression of tooth morphogenesis (D’Souza et al, 1999).   
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1.4.2 The Role of the Odontoblast in Dentine Maturation 
Odontoblasts synthesise pro-collagen, which is packaged in transport vesicles that migrate 
to the Golgi complex where the collagen pre-cursor becomes glycosylated (Weinstock and 
Leblond, 1974).  Following post-translational modification in the Golgi complex pro-
collagen is transported in secretory vesicles to the secretory pole of the odontoblast where 
these vesicles fuse with the cell membrane and the pro-collagen is exocytosed proximally 
into the surrounding ECM (Sato et al, 2009).  Once deposited in the ECM the pro-collagen 
becomes activated, losing its amino acid and carboxy-terminal fragments, and forms the 
collagen fibrils of pre-dentine (Weinstock and Leblond, 1974; Frank, 1979).  NCPs of the 
developing dentine matrix such as proteoglycans, phosphoproteins, SCPPs such as 
osteocalcin, and SIBLINGs such as DMP1, BSP and ON, are secreted along a similar 
pathway but their exocytosis occurs at the distal end of the odontoblast near the 
mineralisation front (Linde and Lundgren, 1995).  The rate of NCP synthesis, transport and 
secretion is also much faster than that of collagen requiring minutes rather than days for 
these NCPs to reach the ECM.  Following secretion NCPs localise within the dentine 
matrix and play extensive roles in the nucleation, expansion and regulation of 
hydroxyapatite deposition within the dental matrix (Huang et al, 2008; Hao et al, 2009).   
The maturation of dentine is characterised by the mineralisation of pre-dentine and 
requires the deposition of calcium and phosphate into the organic matrix.  Once exported 
into the pre-dentine matrix the calcium and phosphate ions nucleate and expand forming 
the calcified dentine matrix (Linde and Lundgren, 1995).  The process of mineralisation in 
mantle dentine initiates with the formation of mineral crystals from matrix-bound vesicles 
that have been synthesised and exported by primary odontoblasts (see figure 1.4.2) 
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(Eisenmann and Glick, 1972; Sisca and Provenza, 1972).  It is thought that matrix vesicles 
provide an environment within which the solubility product for calcium phosphate is 
exceeded to enable crystallisation (Boskey et al, 1978; Boskey et al, 1997).  Recent studies 
have indicated that matrix vesicles found within the odontoblast processes may also have 
an accompanying role in the mineralisation of the circumpulpal dentine matrix with these 
vesicles shown to bud from the odontoblast and attach to the wall of the dentinal tubules 
(Garces-Ortiz et al, 2013).  However, the mineralisation of circumpulpal dentine is 
primarily considered to lack the involvement of matrix vesicles, with the deposited mineral 
instead being associated with collagen fibrils and having a more globular appearance 
(Stratmann et al, 1997; Takano et al, 2000).  This is thought to occur by movement of 
calcium and phosphate ions from the vascular network of the subodontoblastic area, across 
the odontoblast cell layer and towards the mineralisation front.  In order to achieve this 
high level of calcium transport odontoblasts require a means of facilitating the movement 
of intracellular and extracellular calcium.  At present the exact mechanism of calcium 
transport within odontoblasts and the surrounding ECM is not fully understood but is most 
likely achieved though the presence of calcium channels and Na
+
/Ca
2+
 exchangers 
(Lundgren and Linde, 1988, 1992).  Furthermore, a high Ca
2+
-activated ATPase activity 
has been recognised in the membranes of vesicles localised in the distal portion of the 
odontoblast cell body, as well as in the odontoblast plasma membrane, which may be 
responsible for coordinating the movement of ions (Granstrom et al., 1978; Lundgren and 
Linde, 1988).  The regulation of odontoblast calcium transport has also been linked with 
the presence of calcium binding proteins of the cytoskeleton and cell membrane such as 
dentine matrix protein 4 and calbindin (Magloire et al, 1988; Linde, 1985; Hao et al, 
2007).  Many NCPs (e.g. DPP, BSP, OP, ON, OC) (see section 1.2.1) present within the 
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dentine matrix have been shown to have similar roles in collagen mineralisation as found 
in bone, acting as both mineral nucleators and inhibitors of crystal growth (Wallwork et al, 
2002).  A study investigating the effect of eliminating the NCPs on bone mineralisation 
has indicated that the remaining collagenous structure was no longer able to support the 
deposition of HA, which is also likely to be the case for dentine due to the structural and 
functional similarities of these tissues (Termine et al, 1981).    
 
Figure 1.4.2 Diagrammatic representation of the mechanisms of intra-cellular and extra-
cellular transport during dentine maturation.  The diagram illustrates the presence of 
matrix vesicles produced by secretory odontoblasts and highlights their role during the 
initial stages of mantle dentine mineralisation.  The diagram also shows the binding of 
hydroxyapatite to collagen fibrils of the organic dentine matrix, which is primary mode of 
mineralisation in circumpulpal dentine.  Image reproduced from Boonrungsiman et al. 
(2012). 
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1.5 Tertiary Dentinogenesis 
The action of irritants, dentinal caries or physical trauma on the tooth can facilitate the 
invasion of micro-organisms within the pulp where the harmful toxins they produce can 
cause damage.  In response to this damage the pulp deposits a layer of tertiary dentine at 
the pulp-dentine interface.  Tertiary dentine is a rapidly deposited matrix that can vary 
from an ordered tubular arrangement that is structurally similar to primary dentine to a 
more disordered, atubular matrix containing cellular inclusions (osteodentine) (Linde and 
Goldberg, 1993).  Tertiary dentinogenesis can be sub-divided into two classes depending 
on the severity of stimulus and the cells that respond to that stimulus.  The cells that 
increase their biological activity in response to the stimulus are either local primary 
odontoblasts located within the vicinity of the damage or a population of multipotent 
progenitor cells likely to reside in the dental pulp that proliferate, migrate to the site of 
damage and differentiate to form odontoblast-like cells (Linde and Goldberg, 1993; Smith 
et al, 2001; Sangwan et al, 2013). 
  
1.5.1 Reactionary Dentinogenesis 
Reactionary dentinogenesis is defined by the capacity of odontoblasts to up-regulate their 
biological and secretory activity in response to caries or trauma (Smith et al, 1995).  The 
biological mechanisms underlying reactionary dentinogenesis are thought to result from 
the action of endogenous growth factors and bioactive molecules released from the dentine 
matrix following tooth damage (see figure 1.5). The bioactive molecules released possess a 
similar inductive potential to those produced by the enamel epithelium and basement 
membrane during tooth morphogenesis (Smith et al, 1995).  Tertiary dentine deposited as a 
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result of reactionary dentinogenesis typically has tubular continuity with secondary 
dentine, although the exact structure of tertiary dentine depends on the degree of irritation, 
with more severe damage resulting in a less organised matrix containing a higher number 
of cellular inclusions (Tziafas, 2010). 
 
1.5.2 Reparative Dentinogenesis 
The exposure of dentine by caries, operative procedures or treatment with therapeutic 
dental materials such as EDTA results in the death of odontoblasts and requires a 
population of progenitor cells located within the pulp to differentiate to form odontoblast-
like cells (see figure 1.5) (Magloire et al, 2001).  These cells deposit a reparative dentine 
matrix at the site of injury in a process termed reparative dentinogenesis (Lesot et al, 1993; 
Harichane et al, 2011).  Similar to reactionary dentinogenesis an injurious stimulus leads 
to the release of endogenous growth factors and bioactive molecules from the dentine 
matrix.  These dissociated factors initiate cell recruitment, proliferation and differentiation 
within the dentine-pulp complex and the deposition of tertiary dentine, which provides a 
protective barrier between the pulp and the external environment (Simon et al, 2010).  
  
Reparative dentinogenesis is characterised by the formation of new odontoblast-like cells 
from local stem/progenitor cells located within the pulp.  However, the identity of the 
stem/progenitor population(s) associated with reparative dentinogenesis remains elusive.  
Multiple progenitor cell niches have been identified within the dental pulp (Sloan and 
Smith, 2007; Sloan and Waddington, 2009).  The cell-rich layer of Hohl, which lies 
adjacent to the odontoblast layer, is one example of a niche that contains a population of 
31 
 
undifferentiated mesenchymal cells (Cotton, 1967).  These cells are embryologically 
similar to pre-odontoblasts but lack the final signals leading to odontoblast terminal 
differentiation (Tziafas, 1995).  In continually erupting rodent incisors, progenitor cells 
can also be found within the dental papilla situated below the inner enamel epithelium and 
the mesenchymal region of the cervical loop, with these cells demonstrating the potential 
for odontogenic differentiation both in vitro and in vivo (Balic and Mina, 2010).  Pericytes 
also represent a population of multipotent cells that have been localised within the 
vasculature of the dental pulp (Carlile et al, 2000; Janebodin et al, 2013).  There is 
however much debate relating to the derivation of pericytes with some reports claiming 
they represent a stage in the differentiation of mesenchymal stem cells (MSCs), while 
other reports claim that MSCs are in fact of vascular origin (Caplan, 2008; Crisan et al, 
2008).  Further evidence corroborating the role of pericytes during reparative 
dentinogenesis was derived from lineage tracing experiments demonstrating that 
vasculature-derived cells were capable of acting as an MSC-like population for the 
generation of odontoblasts-like cells following dental trauma (Feng et al, 2011).  The 
mature pulp also contains a multipotent stem cell population referred to as dental pulp 
stem cells (DPSCs) that are derived from the oral ecto-mesenchyme during tooth 
morphogenesis (Gronthos et al, 2000; Wang et al, 2013).  DPSCs represent a potential 
source of odontoblast precursors with many studies documenting the odontogenic potential 
of these cells both in vivo and in vitro (Huang et al, 2006; Huang et al, 2010; Gronthos et 
al, 2011).   
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Corroboration of the role of DPSCs during reparative dentinogenesis has been provided by 
the evaluation of DPSC signalling pathways following dental injury.  Studies have 
confirmed that Notch receptors associated with MSC differentiation become activated on 
DPSCs following dental injury (Lovschall et al, 2005; Zhang et al, 2008).  Further proof of 
the involvement of DPSCs in reparative dentinogenesis was obtained from comparative 
analysis of the gene expression profiles of pulp cells derived from healthy teeth with those 
from mildly carious teeth (Paakkonen et al, 2005).  This comparison identified two notch 
ligands (Jagged2 and JaG2 and mitogen-activated protein kinase) implicated in the 
differentiation of progenitor cells towards replacement odontoblasts following tooth 
damage.  These ligands were expressed by cells derived from carious pulp tissue, but 
absent from healthy tissue and prove that DPSCs are involved at some level in 
dentinogenic response to tooth injury (Paakkonen et al, 2005; Mitsiadis et al, 1999).   
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Figure 1.5 Diagrammatic representation of a cross section of a tooth illustrating the key 
events required for the deposition of tertiary dentine.  The figure demonstrates the up-
regulation of odontoblasts during reactionary dentinogenesis, as well as the proliferation 
and recruitment of pulpally located stem/progenitor cells required for the production of 
reparative dentine in response to growth factors and signalling molecules released 
following tooth damage.  Modified from Smith et al. (1995). 
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1.6 Stem Cells 
Stem cells are undifferentiated cells with an unlimited self-renewal capacity that are 
capable of differentiating towards specialised cell types in response to specific molecular 
cues.  These cells are capable of symmetric divisions, creating two daughter cells both 
endowed with stem cell properties, or asymmetric divisions in which one stem cell and one 
tissue progenitor cell is produced.  Stem cells can be subdivided based on their 
differentiation potentials into totipotent, pluripotent and multipotent types.  These cells are 
highly valuable for the progression of regenerative clinical therapies, pharmaceutical 
testing, and the development of bioprosthetics (Egusa et al, 2012).  The following chapters 
will define stem cell subsets and outline the role of these cells in regenerative dentistry. 
1.6.1 Embryonic Stem Cells 
Embryonic stem cells (ESCs) are pluripotent cells derived from the inner cell mass of the 
blastocyst and give rise to all the somatic cells types present in an embryo.  Stable ESC 
lines were first developed in 1981 and are characterised by an indefinite self-renewal 
capacity and the potential to form cells of all three embryonic germ layers (Evans and 
Kaufman, 1981; Martin, 1981; Thomson et al, 1998).  The potential of ESCs for 
regenerative medicine is great with clinical trials currently underway for the treatment of 
degenerative eye conditions, Stargardt’s macular dystrophy and age-related macular 
degeneration (Schwartz et al, 2012).  The study of ESC signalling pathways that regulate 
self-renewal and differentiation is also providing insights into early embryonic 
development, cancer and the potential of these cells for regenerative medicine (Evans, 
2011).   
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1.6.2 Post-Natal Stem Cells 
1.6.2.1 Mesenchymal Stem Cells 
The term mesenchymal stem cell did not originate until 1991, two decades after the initial 
discovery of colony-forming multipotent cells within the bone marrow (Friedenstein et al, 
1970; Caplan, 1991). These cells have since been isolated from almost every bodily tissue 
and have proved useful for the advancement of many regenerative therapies, such as bone, 
cardiac and neuronal regeneration (Zavan et al, 2010; Loughran et al, 2013; Lopez and 
Daigle, 2013).  MSCs are currently defined by three criteria established by the 
Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular 
Therapy (ISCT).  The definition states that to be defined as an MSC a cell must: be able to 
adhere to tissue culture polystyrene; be CD73, CD90, and CD105 positive and CD45, 
CD34, CD14, CD11b, CD79, CD19 and HLA-DR negative; and have the ability to 
differentiate into osteoblasts, chondroblasts and adipocytes in vitro (Dominici et al, 2006).  
Further collation of positive markers used for the characterisation of MSCs has indicated 
that CD29 and CD44 also represent valuable markers that are highly conserved between 
species (see table 1.6.2.1) (Harting et al, 2008; Mafi et al, 2011).  A more recent 
development has seen the identification of several markers of stem cell renewal and 
maintenance once thought to be exclusive to embryonic stem cells (see section 1.6.1) in 
adult MSCs, specifically Oct4, Nanog and SOX2 (Riekstina et al, 2009; Tsai and Hung, 
2012).  These markers function in the maintenance of embryonic stem cell self-renewal 
and regulate the expression of loci involved in pluripotency and differentiation.  Studies 
characterising the roles of these factors in post-natal stem cells are as yet limited, although 
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it has been proposed that they are likely to function in MSC maintenance of cell plasticity 
(Kashyap et al, 2009; Varlakhanova et al, 2010; Shyh-Chang, 2013).   
Bone marrow stem cells are perhaps the best characterised of all the post-natal stem cells.  
Since the bone marrow contains minimal ECM, these cells can be isolated without the use 
of digestive enzymes typically employed during the isolation of MSCs from other tissues, 
such as adipose-derived stem cells (ADSCs) and dental pulp-derived stem cells (DPSCs) 
(Bianco et al, 2001).  The estimated proportion of stem cells within the bone marrow is 
approximately 0.001-0.1 %, which is lower than the proportion of MSCs found in adipose 
tissue (approximately 10 %) (Wexler et al, 2003; Zuk, 2010).  MSCs isolated from bone 
marrow were first identified as a population of stromal osteogenic progenitor cells that 
could be distinguished from the haematopoietic population based on their ability to adhere 
to tissue culture polystyrene and their fibroblast-like morphology (Friedenstein et al, 
1970).  Additionally, transplantation of these cells in vivo demonstrated they had a multi-
differentiation capacity (Friedenstein et al, 1987).  Subsequently BMSCs have become the 
most widely used MSCs for regenerative research with studies demonstrating the ability of 
these cells to differentiate to neurogenic and myogenic lineages (Woodbury et al, 2000; 
Gojo et al, 2003).  Furthermore, the number of clinical trials involving BMSCs far exceeds 
those of other MSC (Chen et al, 2006; Segers and Lee, 2008; Nery et al, 2013). 
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Marker Functional Details 
CD29 
An integrin transmembrane receptor involved in the assembly of 
ECM components (collagen, laminin and fibronectin) (Cybulsky et 
al, 1992) 
CD44 
Cell membrane glycoprotein that tethers to the ECM and monitors 
changes that influence cell survival, proliferation and differentiation 
(Aruffo et al, 1990; Ponta et al, 2003) 
CD73 
Plasma membrane located nucleotidase involved in cell adhesion as 
well as immunity, inflammation and the regulation of apoptosis (Ohta 
et al, 2013; Mikhailov et al, 2008; Antonioli et al, 2013) 
CD90 
GPI-anchored glycoprotein involved in cell-cell and cell-matrix 
interactions and the regulation of inflammation (Rege and Hagood, 
2006; Wandel et al, 2012) 
CD105 
Membrane glycoprotein component of the TGF-β receptor complex 
that has associations with the vascular system (Li et al, 2003; Rius et 
al, 1998) 
 
Table 1.6.2.1 Table illustrating the five most common markers used for the 
characterisation and isolation of human, mouse and rat-derived MSCs and their related 
biological functions.  Markers were selected based on the frequency of their use in MSC 
isolation studies throughout the literature. 
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1.6.2.1.1 Adipose-Derived Stem Cells 
Adipose tissue can be macroscopically divided into at least five types with each serving its 
own specific function: white, brown, mammary, bone marrow-specific and mechanical 
(Gimble et al, 2007).   White adipose tissue is the most prevalent throughout the body and 
represents the most abundant source of ADSCs (Algire et al, 2013).  Adipose tissue is a 
loose connective tissue largely composed of mature adipocytes but also containing stromal 
vascular cells such as fibroblasts, smooth muscle cells, pericytes, endothelial cells and 
adipogenic progenitor cells (Niemela et al, 2007).  Adipose tissue primarily functions as a 
store of energy in the form of lipids but also acts as a major endocrine organ and provides 
bodily insulation (Kershaw and Flier, 2004).   
Knowledge of progenitor cell types within adipose tissue dates back to the late 1980’s 
when cells capable of adipogenic differentiation were first isolated (Deslex, 1987; Hauner, 
1989).  These cells were termed pre-adipocytes and it took over ten years for the 
multipotent capacity of these cells to be recognised (Zuk et al, 2001, Gimble and Guilak, 
2003).  The anatomical location from which ADSCs are harvested has no observable 
influence on morphology, proliferation or immunophenotype (Jurgens et al, 2008; 
Kaewkhaw et al, 2011).  However, recent evidence has indicated that the anatomical site 
of derivation in human donors may influence the differentiation capacity of these cells 
(Requicha et al, 2012).  Subcutaneous and perinephric adipose tissue have also been 
shown to contain multipotent cells that possess an increased neurogenic capacity 
(Kaewkhaw et al, 2011).  Furthermore, the differentiation potential of ADSCs may be 
inversely related to the depth of adipose tissue from which they are obtained, with ADSCs 
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isolated from superficial fat possessing an improved differentiation potential when 
compared with those isolated from deeper adipose layers (Aksu et al, 2008).   
A variety of terms have been employed to define the tissue culture polystyrene adherent 
population of multipotent cells isolated from adipose tissue (Gimble et al, 2007).  To 
eliminate any discrepancies in nomenclature, the International Fat Applied Technology 
Society (IFATS) reached a consensus to adopt the term “adipose-derived stromal/stem 
cells” (Mitchell et al, 2006; Gimble et al, 2007).  ADSCs are most often described as cells 
obtainable from the cultured stromal vascular fraction (SVF) of an adipose digest that 
adhere to tissue culture polystyrene and give rise to the colony forming unit fibroblast 
(CFU-F) (Zuk et al, 2001; Gimble et al, 2007). These cells like other MSCs should express 
markers defined by the ISCT (see section 1.6.2.1) and demonstrate the ability to 
differentiate toward several specific lineages including adipogenic, osteogenic or 
chondrogenic, if cultured under suitable conditions (Gimble et al, 2007).  A recent 
definition by IFATS characterised ADSCs as a CD45-CD235a-CD31-CD34+ cell type that 
can be distinguished from BMSCs by the presence of CD36 and absence of CD106 
(Bourin et al, 2013).   
Over the last two decades various studies have shown that ADSCs can be differentiated 
into a variety of cell types such as oligodendrocytes and Schwann cells, epidermal cells, 
hepatocytes, and pancreatic islets (Seo et al, 2005; Timper et al, 2006; Kingham et al, 
2007; Banas et al, 2007; Chandra et al, 2009; Mitzuno and Nambu, 2011).  Freshly 
isolated lipoaspirates contain relatively low levels of contaminating pericytes, endothelial 
cells, or smooth muscle cells (Zuk et al, 2001), while stem and progenitor cells within 
freshly isolated adipose tissue represent up to 10 % of the total cell population with 
40 
 
approximately 0.05 - 2 × 10
5
 stem cells isolated per gram of adipose tissue, a much larger 
proportion than present in bone marrow (see section 1.6.2.1) (Oedayrajsingh-Varma et al, 
2006; Zuk, 2007; Fraser et al, 2008).  At present the precise localisation of ADSCs remain 
unclear with proposals suggesting they are a subpopulation of stem cells located within the 
vasculature that exit the circulation and become lodged within adipose tissue (see section 
1.6.3) (Crisan et al, 2008; Lin et al, 2010; Zimmerlin et al, 2010).   
If MSCs are to be potentially useful in regenerative medicine, they should be abundant, 
easily isolated and harvested using minimally invasive procedures, differentiate towards 
multiple lineages in a reproducible manner and be safely and effectively transplanted into 
an autogenic or allogenic host (Gimble et al, 2007).  ADSCs therefore potentially represent 
a model source of MSCs, since these cells can be isolated in large quantities under local 
anaesthesia with little patient discomfort in contrast to bone marrow isolations, which 
often result in pain as well as high donor-site morbidity (Zuk et al, 2001; Schaffler and 
Buchler, 2007).  ADSCs have also been shown to be less prone to reductions in 
differentiation capacity and the expression of MSC markers associated with increased 
donor age or prolonged in vitro expansion than other MSCs.  In fact, ADSCs have been 
shown to retain a stable differentiation capacity and MSC marker profile for ≥70 
population doublings, almost double that of BMSC populations (Bruder et al, 1997; 
Bianco et al, 2001; De Ugarte et al, 2003; Wu et al, 2013).   
 
1.6.2.1.2 Dental Stem Cells  
The cells responsible for forming tertiary dentine following exposure of the pulp with 
subsequent differentiation into odontoblast-like cells were initially identified as fibroblasts 
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and endothelial cells based on local proliferation of these cells after tooth damage 
(Fitzgerald, 1979).  It took another two decades for these odontoblast-forming cells to be 
recognised as a resident stem cell population existing within the pulp tissue (Gronthos et 
al, 2000).  These cells were of neural crest origin and ontological analysis demonstrated 
that they continued to express genes related to blood vessel and neuron formation when 
cultured in vitro (Kim et al, 2011).  DPSCs have since been shown to be a highly 
proliferative when compared with MSCs derived from bone marrow, potentially due to a 
comparatively increased expression of cell cycling mediators such as IGF-1 and cyclin-
dependant kinase 6 (Shi et al, 2005).  DPSCs have also been shown to possess a multi-
differentiation potential and have demonstrated the capacity to form dentine-like tissue 
both in vitro and in vivo (Gronthos et al, 2002; Yu et al, 2006; Huang et al, 2010; 
Casagrande et al, 2011).  These cells have express MSC markers defined by the ISCT and 
are commonly identified by the presence of the cell surface protein, Stro1 (Yang et al, 
2007; Yang et al, 2009). 
Characterisation of DPSCs led to the discovery of further multipotent populations of cells 
within the oral environment.  Stem cells from human exfoliated deciduous teeth (SHED) 
were documented three years after DPSCs and have since been shown to possess a higher 
rate of proliferation and the capacity to differentiate towards odontogenic and osteogenic 
lineages (Miura et al, 2003).  Soon after the discovery of SHED cells, a population of stem 
cells were isolated from the periodontal ligament of human third molar roots (Seo et al, 
2004). Periodontal ligament stem cells (PDLSC) demonstrated the ability to form 
cementum-like tissue in vivo and have since been isolated from the alveolar bone surface 
(Seo et al, 2004; Wang et al, 2011).  Stem cells from the apical papilla (SCAP) were the 
next population of multipotent dental stem cells to be reported (Sonoyama et al, 2006).  
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These cells demonstrated a similar proliferative capacity and multi-differentiation potential 
to SHEDs (Sonoyama et al, 2008).  The most recently identified population of MSCs are 
the gingiva-derived stem cells (Tomar et al, 2010).  Studies have indicated that stem cells 
derived from dental tissues typically have a greater proliferative potential when compared 
with BMSCs (Gronthos et al, 2000; Alge et al, 2010; Tamaki et al, 2013).  However, due 
to the comparatively low volume of tissue obtainable from dental sources and the loss of 
MSC phenotype with increased passage (typically reported at around passage 10), the 
future clinical applicability of these cells remains debatable (Jing et al, 2007; Patel et al, 
2009). 
 
1.6.2.1.3 The Accuracy of MSC Phenotyping 
No individual marker outlined by the ISCT (see section 1.6.2.1) is unique to MSCs.  
Conflicting results have also emerged throughout the literature regarding the expression of 
ISCT negative markers, as well as other commonly used MSC markers such as CD10, 
CD34, CD36, CD44, CD49d, CD49f, CD106 and CD146 (Mafi et al, 2011; Pachon et al, 
2011).  For instance, in many studies MSCs isolated from adipose tissue are described as 
having a CD34+ CD31- immuno-phenotype, while remaining positive for other MSC 
markers such as CD105, CD90, and CD73 (Dominici et al, 2006; Lin et al, 2010).  ADCs 
are also unique in the sense that their expression of Stro1, one of the most common adult 
stems cell markers, is routinely disputed (Gronthos et al, 2001; Lin et al, 2008, 2010, 
2011).  Indeed, ambiguities relating to differences in the expression of cell surface markers 
are widespread throughout the literature and may be due to the semi-quantitative nature of 
certain profiling methods (e.g. sqRT-PCR).  Differences may also be related to the fact that 
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immunophenotypic studies are often performed using different species even though 
information regarding the transferability of MSC marker characteristics among these 
species is limited (see section 1.6.3).  Furthermore, the use of non-standardised isolation 
protocols for the dissociation of MSCs (particularly ADSCs and DPSCs) may also 
contribute to variations in the immunophenotype of these cells (Horn et al, 2011; Baer and 
Geiger, 2012; Hilkens et al, 2013). 
Differences have also been documented in the ability of MSCs sourced from different 
tissues to differentiate towards osteogenic, adipogenic and chondrogenic lineages equally 
(Al-Nbaheen et al, 2013).  Indeed, many studies have indicated that ADSCs may have a 
comparatively reduced osteogenic potential in comparison with BMSCs or DPSCs (De 
Ugarte et al, 2003; Zaminy et al, 2008; Hayashi et al, 2008).  However, in contrast the 
adipogenic, myogenic and cardiomyogenic potentials of ADSCs appear relatvely increased 
increased when compared with BMSCs or DPSCs (Im et al, 2005; Huang et al, 2005; 
Pachon-Pena et al, 2011).  Gronthos et al. (2000) have further indicated differences in the 
rate of proliferation and colony-forming unit capacity of BMSCs and DPSCs, as well as 
differences in the appearance of mineral deposited by these MSCs following osteogenic 
culture (Gronthos et al, 2000).  Moreover, variations have also been documented relating 
to the secretion of various paracrine factors by MSCs isolated from different tissues with 
ADSCs demonstrating a comparatively high expression of IGF-1, VEGF-D and IL-8 when 
compared with BMSCs (Hsiao et al, 2012).   
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1.6.2.1.4 Inter- and Intra-Species Differences between MSCs 
As mentioned in Section 1.6.2.1, a profile of markers has been specified by the ISCT for 
the selection of MSCs from heterogeneous populations.  However the majority of studies 
defining stem cell surface markers are often conducted using human or murine MSCs with 
less data available for rat-derived MSCs.  Such a gap in knowledge makes the 
identification of MSCs within rats difficult and relies on the cross-transferability of 
information obtained using human or mouse-derived MSCs. The immunophenotyping of 
rat-derived MSCs has demonstrated positivity for ISCT defined markers, such as CD73, 
CD90 and CD105 (Karaoz et al, 2009; Harting et al, 2008; Barzilay et al, 2009).  
However, such profiles have been primarily constructed using MSCs derived from rat bone 
marrow and no reports have been published comparing rat BMSCs with MSCs sourced 
from other tissues such as adipose or dental pulp.  A lack of commercially available 
antibodies is likely to be a contributing factor in the limited immunophenotyping of rat-
derived MSCs.  Ambiguities relating to the expression of defined MSC markers may result 
from studies using antibodies targeted against humans or mice in other related species, 
even though there may only be limited cross-reactivity (Boxall and Jones, 2012).  A 
comprehensive evaluation of markers used for the selection of MSCs among different 
species has indicated that CD29 and CD44 represent the most widely expressed surface 
antigens, while certain ISCT recommended markers are frequently absent from MSCs 
isolated from pig, goat, sheep and horse (Boxall and Jones, 2012).  Evidently the need for 
in-depth and comparative profiling of MSCs sourced from different anatomical locations 
in a wide number of species is important for the progression of tissue engineering research. 
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1.6.3 Stem Cell Niche 
The concept of a stem cell niche was originally proposed in the late seventies when 
scientists noted that haematopoietic stem cells were regulated by their association with 
discrete cellular microenvironments (Dexter et al, 1977; Schofield, 1978; Allen, 1978).  
The stem cell niche has since been shown to play a pivotal role in controlling the 
participation of its cells in tissue maintenance, repair and regeneration through the action 
of endocrine and paracrine factors involved in Notch, Wnt and hedgehog (hh) signalling 
pathways (Mitsiadis et al, 2007, 2011).  The niche may comprise of a wide network of 
various cell types that function in the maintenance of MSCs, or simply be refined to 
signals derived from the basement membrane of the ECM and other non-cellular 
components such as NCPs, inorganic ions and metabolic products (Scadden et al, 2006; 
Hynes, 2009).  It has been proposed that the regulation of asymmetric divisions by the 
basement membrane may be crucial for stem cell polarity and the prevention of 
uncontrolled cell divisions that may lead to the development of cancers (Singh, 2012). 
Recently a model of a non-specialised stem cell niche has been proposed (Ema and Suda, 
2012).  The non-specialised niche is thought to comprise of a wide range of cells such as 
MSCs, fibroblasts, adipocytes, vascular endothelial cells, neurons and blood cells.  The 
signals involved in MSC maintenance in this instance are far more complex since they 
originate from multiple cell types and may affect MSCs both directly and indirectly.  
Hence, the concept of the stem cell niche is a complex topic that needs to be further 
studied in order to provide a basis for manipulation of MSCs for regenerative medicine. 
Many MSCs routinely used in tissue engineering research are understood to reside in a 
perivascular niche (Zannettino et al, 2008).  Both DPSCs and BMSCs have been identified 
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within perivascular regions using Stro1 and CD146 localisation (Shi and Gronthos, 2003; 
Kolf et al, 2007). CD146 represents a cell surface glycoprotein that has been identified as a 
pericyte marker and its co-localisation with Stro1 raised many questions as to the potential 
perivasular microenvironment of MSCs, or whether pericytes are in fact MSCs (Caplan, 
2008).   Moreover, the expression of α-smooth muscle actin, a protein primarily associated 
with blood vessels, and CD106, a vascular cell adhesion molecule associated with 
endothelial cells of the blood vessel wall, by DPSCs and ADSCs has further strengthened 
this hypothesis (da Silva Meirelles, 2006; Kolf et al, 2007).  Furthermore, the localisation 
pattern of MSC markers within the capillaries, arteries, smooth muscle and endothelium of 
adipose tissue has indicated that this stem cell population may in fact reflect a group of 
vascular precursor stem cells at multiple stages of differentiation (Lin et al, 2008).  This 
hypothesis has been developed by studies demonstrating the capacity of cells within the 
adipose SVF to form endothelial cells and aid the formation of blood vessels (Miranville et 
al, 2004; Park et al, 2013; Sahar et al, 2012).  The origin of these vascular cells and their 
association with MSCs at present remains uncertain and further studies are required to 
elucidate whether MSCs originate from the local mesenchyme and migrate to these 
perivascular locations, or if these stem cells are actually derived from the vasculature and 
acquire their tissue specificity through the action of local signals (Orbay et al, 2012).  
However, it has been implied that the perivascular location of stem cells would facilitate 
their dispersal throughout the post-natal organism (Feng et al, 2010).  
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1.6.4 ADSCs for Dental Tissue Engineering 
Current dental treatments are restorative and provide no biological basis for tooth 
regeneration.  Cellular therapies may eliminate the need for dental implants that can lead to 
tooth crowding and potential periodontal bone defects caused by direct integration with the 
maxilla or mandible.  Post-natal stem cells represent the ideal cell choice for dental 
regeneration since these cells have the capacity to differentiate towards odontoblasts, 
ameloblasts and cementoblasts under the appropriate culture conditions (Wen et al, 2011; 
Jiang et al, 2014).  Of these post-natal stem cells DPSCs are the most thoroughly 
characterised for dental regeneration.  However, ADSCs represent a more abundant and 
easily harvested population of stem cells that have shown dentinogenic potential in several 
studies (Wu et al, 2008; Jiang et al, 2008; Zuk, 2010).   
Mineralisation of adipose tissue to produce ectopic calcified bone is a feature of several 
diseases, such as Paget’s disease, Lupus profundus or subcutaneous fat necrosis (Clarke 
and Williams, 1975; Shakelford et al, 1975).  This is indicative of an inherent capacity of 
cells within the adipose tissue to differentiate towards a mineral-producing cell type.  
However, as yet, the potential for ADSCs in dental tissue engineering remains relatively 
unexplored.  A small number of investigations into the odontogenic capacity of these cells 
have yielded some encouraging results (Jing et al, 2008; Wu et al, 2008).  For instance, the 
over-expression DSPP using a transfected epigenetic adenovirus (Ad-DSPP) vector in 
ADSCs has been shown to induce odontoblast-like cell differentiation (Wu et al, 2008).  
Over-expression of DSPP was found to enhance the expression of genes associated with 
mineralisation and odontogenesis (Cbfa1, BSP, OCN and DMP1) as well as increasing the 
expression of alkaline phosphatase and the formation of mineralised nodules, thus 
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suggesting an odontogenic potential (Wu et al, 2008).  Additionally, three-dimensional 
culture of ADSCs in a growth factor-rich medium has been shown to promote the 
formation of dental bud structures expressing markers associated with dental 
morphogenesis (Ferro et al, 2011).  Moreover, a recent study demonstrated that ADSCs 
could differentiate to produce innervated and vascularised tooth-like structures when 
implanted into extraction sockets of the rabbit dental alveolus (Hung et al, 2011).  
Together, these studies indicate that ADSCs represent a promising, albeit relatively 
unexplored, stem cell source for dental regenerative therapies. 
1.7 Project Aims 
It is hypothesised that ADCs represent an abundant and easily accessible source of stem 
cells that can be utilised for dental tissue engineering.  This project aims to investigate the 
odontogenic capacity of adipose-derived cells (ADCs) and examine how this compares 
with multipotent cells obtained from bone marrow (BMDCs) and dental pulp (DPDCs) 
tissue.  To meet this aim, the following research objectives were addressed: 
1. Developing an optimal method for the dissociation and isolation of ADCs from 
adipose tissue 
The effect of several digestive enzymes and incubation periods were compared to analyse 
the release of ADCs from rat inguinal adipose tissue.  The growth kinetics of ADCs was 
determined together with the ability of these cells to form viable colonies. 
2. Comparison of the stem cell profiles of multipotent cells isolated from three 
distinct tissue sources 
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The present study directly aimed to compare the "stemness" of ADCs, BMDCs and 
DPDCs isolated from donor-matched animals using standardised protocols to provide an 
accurate profile of MSCs isolated from these different tissues.  Growth kinetics and 
differentiation potentials were compared, while FACS and sqRT-PCR were used to 
generate comparative MSC marker profiles. 
 
3. Determination of the influence of FACS on primary cell populations 
The study aimed to evaluate the effectiveness of FACS as a method of MSC selection.  
CD29/CD90 positive ADCs, BMDCs and DPDCs were FACS selected and their 
viabilities, MSC marker profiles and differentiation potentials compared with relevant 
unsorted primary cells derived from the same tissues. 
4. Determination of the effect of cryo-storage on multipotent cells 
This study aimed to determine whether the process of cryo-storage affected the viability 
and stem cell properties of MSC-like cells.  ADCs, BMDCs and DPDCs were subjected to 
cryo-storage, revived and their viability and MSC marker profiles compared with primary 
cells (which had not undergone cryo-storage) from the same tissues. 
5. The ability of dentine matrix components to promote odontogenic 
differentiation 
This study investigated the ability of dentine matrix components (DMCs) to act as a 
putative dentinogenic supplement to promote the odontogenic differentiation of ADCs, 
BMDCs and DPDCs. Odontogenic differentiation was evaluated by comparing the effects 
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of DMCs on the expression of odontoblast associated transcripts and the formation of 
mineral in vitro. 
Investigating the in vitro odontogenic capacity of ADSCs and comparing these results with 
those of BMSCs and DPSCs should provide a better understanding to enable the 
application of adult stem cells for regenerative dentistry.   
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2.0 MATERIALS AND METHODS 
 
2.1 Cell Culture 
For each experiment ADCs, BMDCs and DPDCs were isolated from three independent 
rats (three biological repeats).  Cells derived from each rat were assayed three times 
(technical repeats) and combined to calculate a mean.  
2.1.1 Cell Culture Media and Reagents 
2.1.1.1 Primary cell culture medium 
Growth medium consisted of alpha-modified minimum essential medium (α-MEM) 
(Biosera, UK), containing 2 mM L-glutamine (Sigma-Aldrich, UK) supplemented with         
1 % penicillin/streptomycin/amphotericin (100 units/mL penicillin with 100 µg/mL 
streptomycin and 2.5 μg/mL amphotericin) (Sigma-Aldrich, UK), and 10 % (v/v) foetal 
bovine serum (FBS) (Biosera, UK).   
2.1.1.2 Phosphate buffered saline (PBS) 
PBS comprised of 7.8 g NaCl (Sigma-Aldrich, UK), 1.5 g K2HPO4 (Sigma-Aldrich, UK) 
and 0.2 g KH2PO4 (Sigma-Aldrich, UK) in 1 L of distilled water and adjusted to a pH of 
7.5.  The solution was autoclaved at 121 °C to sterilise prior to use.   
2.1.2 Tissue and Cell Isolation 
Adipose tissue, bone marrow and dental pulp tissue were isolated from 100-120 g, 6 week 
old male Wistar-Hann rats that had been killed by cervical dislocation (Aston University, 
Pharmaceutical Sciences Animal House, Birmingham, UK).   
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2.1.2.1 Adipose Tissue 
2.1.2.2 Isolating the Rodent Inguinal Fat Pad 
Inguinal fat pads were removed by making incisions at the right and left hand sides of the 
abdomen using a scalpel and the adipose tissue separated from the dermis using toothed 
forceps.  Adipose tissue was placed in a universal tube containing α-MEM (Biosera, UK) 
supplemented with 10% (v/v) FBS (Biosera, UK) and 1 % 
penicillin/streptomycin/amphotericin (100 units/mL penicillin with 100 µg/mL 
streptomycin and 2.5 μg/mL amphotericin) (Sigma-Aldrich, UK).  The tissue was washed 
three times in sterile PBS (Section 2.1.1.2), placed onto a glass slide (Fisher Scientific, 
UK) within a 90 x 16 mm petri dish (Sarstedt, UK) and minced to give pieces of 
approximately 1mm
3
 in size.  α-MEM + 10 % (v/v) FBS was added to the extracted 
adipose tissue to prevent desiccation. 
2.1.2.3 Establishing a Method for Adipose Tissue Digestion 
Several digestive enzymes were compared for the dissociation of cells from adipose tissue.  
Minced adipose tissue was placed into 15 mL Falcon
® 
tubes (VWR, UK), incubated at           
37 ºC and subjected to one of the digestive treatments outlined in Table 2.1.2.3  The 
method yielding the highest number of cells was adopted within the protocol for adipose 
cell isolation (see Section 2.1.2.4). 
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Digestive Enzyme(s) Concentration/Volume 
AApp 
Digestion Period (mins) 
Type I Collagenase (C0130, 
Sigma-Aldrich, UK) 
1 g/L 
15 
30 
45 
Trypsin/EDTA (25200-072, 
Gibco, UK) 
2.5 g/L trypsin in 0.38 
g/L EDTA 
30 
45 
Type I Collagenase + 
Trypsin/EDTA 
1 g/L Collagenase + 2.5 
g/L trypsin in 0.38 g/L 
EDTA 
15 
30 
45 
Accutase (A1110501, Gibco, UK) 
10 mL per 75 cm
2
 culture 
area 
15 
30 
45 
 
Table 2.1.2.3 Table comparing several digestive methods for the dissociation of a 
heterogeneous population of cells from freshly isolated adipose tissue.  All concentrations 
were based on supplier’s guidelines. 
 
2.1.2.4 Adipose Cell Isolation 
Minced adipose tissue (15 g) was placed into 15 mL Falcon
®
 tubes (VWR, UK) containing 
Collagenase type I isolated from Clostridium histolyticum (1 g/L) (C0130, Sigma-Aldrich, 
UK), 1 % (w/v) BSA (Sigma-Aldrich, UK) in sterile PBS (see Table 2.1.1.2).  Tissue was 
digested with collagenase for 30 minutes at 37 °C in a rotary hybridisation oven (SI20H, 
Stuart Scientific, UK).  After incubation, collagenase activity was neutralised with an 
equal volume of α-MEM (Biosera, UK) supplemented with 10 % (v/v) FBS (primary 
54 
 
culture medium) (Gibco, UK) and the cell suspension was passed through a 70 μm sieve 
(Millipore, UK) to enable single cell isolation.  The resulting cell suspension was 
centrifuged at 1600 g (Eppendorf 5804R, Eppendorf, UK) for 5 minutes, after which the 
supernatant was aspirated and the remaining pellet re-suspended in 1 mL primary culture 
medium (see section 2.1.1.1).  Adipose derived cells were seeded in 75 cm
2
 culture flasks 
(Nunc, UK) containing primary culture medium, and incubated at 37 ºC in a 5 % CO2 
atmosphere.  Culture medium was replaced every three days until the cells became                 
80 – 90 % confluent. 
 
2.1.3 Bone Marrow 
2.1.3.1 Dissection of Rodent Femora 
Femora were isolated using scalpel, scissors and tweezers to tease away surrounding 
muscle and ligaments.  This was achieved by making a longitudinal incision down the 
thigh and peeling back the skin to expose the femur and surrounding soft tissue.  Soft 
tissue was stripped away from the femoral bones using a scalpel and tweezers.  Femora 
were then dislocated from the pelvic girdle and placed in universal tubes containing 10 mL 
sterile α-MEM (Gibco, UK).   
2.1.3.2 Bone Marrow Cell Isolation 
Each femur was lightly sprayed with 70 % (v/v) ethanol and the epiphyses removed using 
scissors.  A 20 mL syringe (BD Bioscience, UK) containing primary culture medium (see 
section 2.1.1.1) was attached to a 22 gauge needle (Appleton Woods, UK), which was 
inserted into the femoral cavity.  Medium was then passed through the cavity to dislodge 
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the bone marrow and enable its collection in universal tubes.  Flushed bone marrow was 
then passed through a 70 μm cell strainer (Millipore, UK) and collected in a 50 mL 
Falcon
®
 tube (VWR, UK).  Cells were pelletted by centrifugation using an Eppendorf 
5804R centrifuge (Eppendorf, UK) at 900 g for a period of 5 minutes and re-suspended in 
primary culture medium (see section 2.1.1.1).  Cell suspensions were seeded into 75 cm
2
 
culture flasks (Nunc, UK) containing α-MEM (Biosera, UK) supplemented with 10 % 
(v/v) FBS.  Medium was changed every three days until cultures became approximately  
80 % confluent. 
 
2.1.4 Dental Pulp 
2.1.4.1 Dissection of Rodent Incisors 
Maxillary and mandibular incisors were dissected by removing the surrounding hard and 
soft tissues with scissors and scalpel to carefully remove the surrounding jaw bone.  
Incisors were placed in universal tubes containing sterile primary culture medium (see 
section 2.1.1.1) and stored for no longer than 1 hour prior to use. 
2.1.4.2 Dental Pulp Isolation 
Incisors were lightly sprayed with 70 % (v/v) ethanol and the inner pulp exposed by 
cutting along the longitudinal axis.  Each incisor was placed onto a glass slide (Fisher 
Scientific, UK) within a petri dish (Sarstedt, UK), teased open and the dental pulp removed 
from the pulp chamber using a scalpel and forceps.  Medium was added to the extracted 
pulp to prevent desiccation, the tissue minced into pieces of approximately 1 mm
3
 and 
digested for 30 minutes at 37 °C in a rotary hybridisation oven (SI20H, Stuart Scientific, 
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UK) using 0.25 % (w/v) trypsin, 1 mM EDTA
.
4Na [2.5 g/L trypsin in 0.38 g/L EDTA 
(25200-072, Gibco, UK)].  After incubation, an equal volume of primary culture medium 
(see section 2.1.1.1) was added to neutralise trypsin activity.  The resulting cell suspension 
was passed through a 70 μm cell strainer (Millipore, UK) and centrifuged (Eppendorf 
5804R, Eppendorf, UK) for 5 minutes at 900 g.  The supernatant was aspirated and the 
pellet re-suspended in 1 mL α-MEM (Gibco, UK).  Cells were seeded in 25 cm2 culture 
flasks (Nunc, UK) overnight at 37 °C, 5 % CO2 to enable cell attachment to the tissue 
culture polystyrene.  The following day, a further 4 mL α-MEM supplemented with 20 % 
FBS (v/v) was added to each culture (Gale et al, 2011).  Culture medium was changed 
every three days until cultures became approximately 80 – 90 % confluent. 
 
2.1.5 Cell Culture Assays 
2.1.5.1 Cell Counting 
10 μL of a cell suspension was added to an equal volume of 0.4 % (w/v) Trypan blue cell 
stain (Sigma-Aldrich, UK).  The suspension was mixed thoroughly using a Gilson pipette, 
transferred to a Neubauer haemocytometer (Hawksley, UK) and viable cells counted 
manually under a variable relief contrast (VAREL) microscope (Zeiss Axiovert 25) (Zeiss, 
UK).  Five counts per sample were recorded and an average calculated. Suspensions were 
then diluted according to the required seeding density and cultured at 37 ° in 5 % CO2 in 
an RS Galaxy S+ incubator (RS Biotech). 
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2.1.5.2 Growth Kinetics and Population Doubling Time Analysis 
Freshly isolated adipose tissue, bone marrow and dental pulp were incubated with 160 mM 
NH4Cl (BDH Laboratory Supplies, UK) at room temperature for 5 minutes to lyse any 
erythrocytes present (Stroo et al, 2009).  Each extraction was then centrifuged at 1200 g 
using an Eppendorf 5804R centrifuge (Eppendorf, UK) for 5 minutes and the resulting 
pellet re-suspended in 1 mL primary culture medium (see section 2.1.1.1).  Cells were 
seeded at a density of 3.5 x 10
4
 cells per 25 cm
2
 flask (Nunc, UK) and cultured for 2, 4, 6, 
8, 10, 12 and 14 days in osteogenic (see section 2.6.1.1), odontogenic (see section 2.6.1.2), 
or primary culture medium (see section 2.1.1.1) – with and without the addition of                      
1 µg/mL human dentine matrix components (see section 2.3).  Culture flasks were 
removed from the RS Galaxy S+ incubator (RS Biotech) on days 2, 4, 6, 8, 10, 12 and 14 
and the adherent cells treated with 0.25 % (w/v) trypsin, 1 mM EDTA (25200-072, Gibco, 
UK) to promote cellular detachment.  Subsequently, cells were counted using an improved 
Neubauer haemocytometer (Hawksley, UK) (see section 2.1.5.1).  The time taken for a 
population of cells to double in number was calculated for freshly isolated, and passage 1 
and 2 cells, using the following formula (Lawson and Pederson, 1987):  
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2.1.6 Storage of Tissue Cell Isolates 
Adipose-derived (ADCs), bone marrow-derived (BMDCs) and dental pulp-derived 
(DPDCs) cells were stored in liquid nitrogen (BOC Gases) prior to future use.  To prepare 
the cells for storage, detached monolayers were centrifuged (Eppendorf 5804R, Eppendorf, 
UK) at 900 g for a period of 5 minutes, the supernatant aspirated, and the pellet re-
suspended in 10 % (v/v) FBS (Gibco, UK) containing 10 % (v/v) dimethyl sulfoxide 
(DMSO) (Sigma-Aldrich, UK).  The cell suspension was transferred to cryogenic vials 
(Corning, UK) that were prepared for liquid nitrogen storage by incubation at 4 ºC for         
1 hour, then at -20 ºC for 2 hours and finally -80 ºC overnight.  Frozen cell suspensions 
were then transferred to vats of liquid nitrogen where they were stored until required.  
When required, vials of cells were recovered from storage by thawing in a 37 ºC RS 
Galaxy S+ incubator (RS Biotech) for approximately 5 minutes.  To remove residual 
DMSO prior to culture, the contents of each vial were transferred to 15 mL Falcon
®
 tubes 
containing 5 mL α-MEM + 10 % (v/v) FBS (Biosera, UK) and centrifuged (Eppendorf 
5804R, Eppendorf, UK) at 900 g for 5 minutes.  The supernatant was aspirated and the 
pellet re-suspended and seeded in a 25 cm
2
 culture flask (Nunc, UK). 
To determine cell viability following storage, cells were cultured until approximately 80 % 
confluent.  The cell monolayer was then detached using 0.25 % (w/v) trypsin, 1 mM 
EDTA
.
4Na [2.5 g/L trypsin in 0.38 g/L EDTA (25200-072, Gibco, UK)], centrifuged 
(Eppendorf 5804R, Eppendorf, UK) at 900 g for 5 minutes, neutralised with α-MEM +     
10 % (v/v) FBS and the resulting suspensions transferred to 15 mL Falcon
®
 tubes (VWR, 
UK).  Cell suspensions were incubated at 4 ºC for a total period of 5 hours using a Denley 
orbital mixer (Appiely Quality Services, Ltd, UK) to provide constant agitation.  The 
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number of viable cells was counted every 30 minutes during this incubation period by 
adding 0.4 % (v/v) Trypan blue solution (Sigma-Aldrich, UK) to an equal volume of cell 
suspension and manually counting the cells using an improved Neubauer haemocytometer 
(Hawksley, UK) (see section 2.1.5.1).   
 
2.2 Fluorescence Activated Cell Sorting (FACS)  
2.2.1 Cell Preparation and Analysis 
FACS was employed to assess the relative expression of the surface proteins CD29 and 
CD90, which are reportedly common to mesenchymal stem cells (Dominici et al, 2006; 
Mafi et al, 2011).  Confluent cultures had their media aspirated and were washed with 
sterile PBS (see section 2.1.1.2) prior to addition of 5 mL of 0.2 % (w/v) EDTA (Gibco, 
UK).  Each culture was then incubated at 37 ° to promote cell detachment.  An equal 
volume of primary culture medium (see section 2.1.1.1) was added to neutralise the 
reaction and 10 μL of the cell suspension removed for use in cell counting (see section 
2.1.5.1).  The cell suspension was centrifuged (Eppendorf 5804R, Eppendorf, UK) at 400 g 
for 5 minutes and the pellet re-suspended in sufficient sterile PBS to provide a final cell 
concentration of 10 x 10
6
 cells/mL.  Non-specific binding sites were blocked by incubating 
the cell suspension with 1 μg/mL of anti-rat Fc block (BD Pharmingen, UK) in sterile PBS 
for 10 minutes at room temperature.  Cells were then washed using sterile PBS, 
centrifuged (Eppendorf 5804R, Eppendorf, UK) at 400 g, and re-suspended in FACS 
buffer (ice cold sterile PBS supplemented with 1% (v/v) FBS).  1 mL of FACS buffer 
containing approximately 10
6
 cells was transferred to sterile 1.5 mL Eppendorf tubes 
(Eppendorf, UK) and primary conjugated antibodies (Table 2.2.1) were added at a 
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concentration of 0.5 μg/mL in sterile PBS supplemented with 3 % (w/v) BSA.  The cell 
suspensions were then incubated in the dark at room temperature for 30 minutes to 
promote antibody binding.  Cell suspensions were then washed using sterile PBS and 
centrifuged (Eppendorf 5804R, Eppendorf, UK) at 400 g for 5 minutes - this process was 
repeated three times, after which the pellet was re-suspended in 1 mL FACS buffer.  The 
cells were stored on ice and transported to the FACS Facility at the Functional Genomics, 
Proteomics and Metabolomics Facility, University of Birmingham.  Cells were sorted 
using a FACSAria™ II cell sorter (BD Pharmingen, UK) and results analysed using 
CellQuest Pro software (BD Pharmingen, UK). Sorted cells were placed on ice and 
transported to the School of Dentistry, University of Birmingham, where cell viability was 
immediately assessed using the method described in Section 2.1.5.1. 
After determining cell viability, FACS cell suspensions were centrifuged (Eppendorf 
5804R, Eppendorf, UK) at 900 g to pellet cells, and the supernatant aspirated.  Sorted 
populations were then either used directly for differentiation assays or expanded to 
increase cell numbers (indirect use).  For expansion, cells were cultured in 25 cm
3
 culture 
flasks containing 20 % (v/v) FBS supplemented growth medium and grown until 
approximately 80 % confluent.  Cells were detached using 0.25 % (v/v) trypsin, 1 mM 
EDTA
.
4Na [2.5 g/L trypsin in 0.38 g/L EDTA (25200-072, Gibco, UK)], centrifuged 
(Eppendorf 5804R, Eppendorf, UK) at 900 g for 5 minutes and the resulting pellets re-
suspended in growth medium or re-profiled using FACS as previously described (Section 
2.2.1).  To assess multilineage differentiation, FACS cell suspensions or re-suspended 
pellets obtained following expansion were seeded at 1 x 10
5
 cells per well in 35 mm
2
 
culture dishes (Sarstedt, UK) containing α-MEM supplemented with 20 % (v/v) FBS 
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(Biosera, UK) for 24 hours.  Following expansion, growth medium was aspirated and 
replaced with osteogenic (Section 2.6.1.1) or adipogenic media (Section 2.6.2.1). 
 
Target Antigen 
Conjugated 
Fluorophore 
Excitation/Emission 
Wavelength (nm) 
Manufacturer/Catalogue 
Number 
CD29 (Integrin 
β1) 
APC 650; 755/767 eBiosciences/17-0291 
CD90 (Thy-1) FITC 495/519 eBiosciences/11-0900 
 
Table 2.2.1 Details of antibodies used for the FACS profiling of MSC-associated markers 
for cells isolated from adipose, bone marrow and dental pulp tissue.   
 
2.2.2 Live/Dead Assay 
Live/dead assay using ethidium bromide/acridine fluorescent markers was used to 
discriminate between living and dead cells (Mironova et al, 2007).  Acridine orange (AO) 
(Sigma-Aldrich, UK) is able to cross membranes of viable cells and intercalate with the 
DNA resulting in the emission of a green fluorescence, while ethidium bromide (EtBr) 
(Helena Bioscience, UK) is only able to intercalate with the DNA of cells with damaged 
cell membranes, emitting an orange fluorescence.  Therefore, live cells appear green while 
the up-take of EthBr by damaged/dead cells effectively overrides the fluorescent signal 
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emitted by AO, thereby causing dead cells to appear orange.  The live/dead reagent was 
prepared by dissolving 50 mg EtBr in 1 mL 95 % (v/v) ethanol, adding 15 mg of AO and 
diluted with 49 mL dH2O (Gale et al, 2011).  The stock solution was thoroughly mixed 
using a vortex mixer, 1 mL aliquots distributed in opaque-walled Eppendorf tubes 
(Eppendorf, UK) and stored at -20 ºC.  500 μL of a 1 % (v/v) working solution was diluted 
in d.H2O and placed in 15 mL Falcon
®
 tubes (VWR, UK) containing FACS analysed cells 
and incubated at room temperature in the dark for 5 minutes with constant agitation. 10 μL 
of each cell suspension was added to an improved Neubauer haemocytometer, where 
live/dead cells were visualised and counted (N=5) using a TE300 Nikon Eclipse 
fluorescent microscope (Nikon, UK) with a 480-520 nm filter.   
 
2.3 Preparation of Dentine Matrix Components  
2.3.1 Dentine Extraction 
Ethical approval was obtained for the collection of non-carious human teeth from patients 
attending the Birmingham Dental Hospital (ethical approval reference: 
BCHDent286.1471.TB).  Freshly extracted teeth were placed in PBS containing 15 mM of 
the bacteriostatic agent sodium azide (BDH Laboratory Supplies, UK), washed under 
running water for several hours to remove debris and stored at -20 °C.  Teeth were further 
cleaned using a prophylaxis paste to remove contaminants (BDH Laboratory Supplies, 
UK), then cut longitudinally into approximately 1 mm thick sections using a low speed 
diamond saw (Isomet Buehler, USA) with an MK303 102 mm diamond blade to allow for 
easy extraction of the pulp and enamel removal.  A scalpel was used to remove central 
pulp tissue from the tooth slices, while remaining enamel was removed using bone 
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clippers.  Isolated dentine slices were weighed using an Ohaus high precision analytical 
balance (Ohaus, UK) and pulverised using a Glen Creston percussion mill (Spex 6700 
Freezer/Mill) under constant liquid nitrogen cooling.  The resulting dentine powder was 
passed through a 60 mesh sieve (Millipore, UK) and the weight recorded.   
2.3.2 Solubilisation of Dentine Matrix Components  
A 10 % (w/v) EDTA extraction solution (pH 7.2) was prepared containing 10 mM N-
ethylmaleimide (NEM) (Sigma-Aldrich, UK) and 5 mM phenylmethylsulphonyl fluoride 
(Sigma-Aldrich, UK) to inhibit the action of proteases.   
To dissolve the inorganic mineralised component of the dentine and solubilise the non-
collagenous organic matrix, 5 g of powdered dentine was placed in 20 mL EDTA-
extraction solution (described above) at 4 ºC with constant agitation.  On a daily basis, the 
mixture was centrifuged at 3600 g using an Eppendorf 5804R centrifuge (Eppendorf, UK) 
for 20 minutes, the EDTA-soluble fraction was pooled in 1 litre collection vessels (BDH 
Laboratory Supplies, UK) and stored at -20 ºC prior to further use.  Each EDTA-soluble 
fraction had its absorbance measured at 280 nm using a Philips UV/VIS spectrophotometer 
(Philips, UK) to provide a daily indication of organic content present within the extract.  
The dentine pellet was then re-suspended in 20 mL of fresh EDTA-extraction solution and 
incubated at 4 ºC for a further 24 hours.  This cycle of incubation, centrifugation, removal 
and pooling of the EDTA-soluble fraction, and re-suspension of the dentine pellet was 
repeated daily for a total period of 14 days. 
Dialysis was performed to remove and replace the EDTA-extraction solution with dH2O.  
Pooled EDTA-soluble extracts were transferred to 19 mm dialysis tubing (14000 MWCO) 
(Fisher Scientific, UK) and exhaustively dialysed against dH2O for a period of 14 days at      
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4 ºC, with daily water changes.  Following dialysis, extracts were transferred to round-
bottomed flasks and shell frozen under liquid nitrogen.  Extracts were lyophilised for                
24 hours using an Edwards 4K Modulyo freeze dryer (Edwards High Vacuum Int, UK).  
The resultant lyophilised extracts were stored at -20 ºC until required. 
 
2.4 Characterisation of Dentine Matrix Components 
2.4.1 Dye-Binding Assay for the Quantification of Non-Collagenous Proteins 
A method developed by Bradford (1976) was employed to analyse the total non-
collagenous protein content of EDTA-extracted dentine matrix components (DMCs).  
Bradford reagent was prepared by dissolving 20 mg Coomassie Brilliant Blue G-250 
(Sigma-Aldrich, UK) in 10 mL of 95% (v/v) methanol, added to 20 mL of 85 % (v/v) 
phosphoric acid and made up to 200 mL with dH2O.  The final reagent was filtered using 
number 1 Whatman filter paper (Whatman Int, UK) to remove any insoluble material prior 
to use. 
100 µL of Bradford reagent was added to a micro-cuvette, diluted with 900 µL of dH2O 
and the absorbance measured at 595 nm using a Philips UV/VIS spectrometer (Philips, 
UK) to provide a reference blank.  A standard curve was produced by adding 100 μL of 
bovine serum albumin (BSA) (Sigma-Aldrich, UK) and using this to produce serial 
dilutions ranging from 0-10 μg/mL (see figure 2.4.1).  Test samples were generated by 
dissolving 1 mg of EDTA-extracted dentine matrix components in 1 mL dH2O and the 
total NCP content evaluated by adding 100 μL of Bradford reagent.  Each sample was 
mixed thoroughly and allowed to stand for 5 minutes to ensure thorough binding of the 
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Bradford reagent.  Absorbance values were then measured at 595 nm using a Philips 
UV/VIS spectrometer (Philips, UK).  Values obtained for test samples were plotted and 
extrapolated to provide a measurement of total NCP concentration. 
 
Figure 2.4.1 Standard curve displaying a series of absorbance values obtained at 595 nm 
for known non-collagenous protein concentrations ranging from 0-10 μg/mL.  Both the 
equation for the line and R
2 
value are displayed.  The R
2
 value obtained indicates a low 
lineage variance with a value > 0.99. 
2.4.2 Dye-Binding Assay for Glycosaminoglycan Quantification 
A method developed by Farndale et al. (1986) was used to quantify total 
glycosaminoglycan (GAG) content based on staining with dimethyl methylene blue dye.  
Farndale reagent was prepared by dissolving 4 mg dimethyl methylene blue (Hopkin & 
Williams Ltd, UK), 0.75 g glycine (BDH Laboratory Supplies, UK) and 0.584 g sodium 
chloride (Sigma-Aldrich, UK) in 250 mL dH2O.  The working solution was then passed 
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through number 1 Whatman filter paper (Whatman International Ltd, UK) to remove any 
insoluble material prior to use. 
1 mL of the Farndale reagent was added to 100 μL dH2O in a micro-cuvette and the 
absorbance measured at 525 nm using a Philips UV/VIS spectrometer (Philips, UK) to 
provide a reference blank.  100 μL of GAG-chain standard, chondroitin sulphate (Sigma-
Aldrich, UK) was added to 0.5 M acetic acid and used to produce serial dilutions ranging 
from 0 to 5 μg/mL (see figure 2.4.2).  Test samples were prepared by dissolving 1 mg of 
EDTA-extracted dentine matrix components in 1 mL dH2O.  Total GAG content was 
evaluated by adding 100 μL of sample to 1 mL Farndale reagent in a micro-cuvette.  Each 
sample was mixed thoroughly and the absorbance immediately measured at 525 nm using 
a UV/VIS spectrometer (Philips, UK).  Values obtained for test samples were plotted and 
extrapolated to provide a measurement of total GAG concentration. 
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Figure 2.4.2 Standard curve displaying a series of absorbance values obtained at 525 nm 
for known GAG concentrations ranging from 0-5 μg/mL.  Both the equation for the line 
and R
2 
value are included.  The R
2
 value obtained indicates a low lineage variance with a 
value > 0.97. 
 
2.5 Using Dentine Matrix Components (DMCs) for Odontogenic Induction 
2.5.1 Colony forming unit fibroblast (CFU-F) 
Passage 2 ADCs, BMDCs and DPDCs were seeded in 35 mm
2
 culture dishes (Sarstedt, 
UK) at a density of 500 cells per dish and cultured in α-MEM supplemented with 10 % 
(v/v) FBS (Gibco, UK), with or without the addition of 1 μg/mL DMCs.  1 µg/mL DMCs 
was selected from preliminary experiments that indicated that this concentration promoted 
the most significant increases in the mineral content and odontogenic gene expression of 
cell cultures.  After 6 days, cultures were immediately fixed using 10 % (v/v) formalin and 
68 
 
stained with 0.1 % (w/v) toluidine blue (Sigma-Aldrich, UK).  Cultures were then washed 
three times with PBS to remove any unbound dye, and CFU-F visualised and counted 
manually under a Nikon TE-DH100w camera attached to a Nikon Eclipse TE300 
microscope (Nikon, UK). 
2.5.2 Metabolic Activity Analysis 
The colorimetric 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay provides a measure of cellular metabolic activity through the action of mitochondrial 
NADPH-dependent oxido-reductase enzymes.  The reduction of this dye leads to the 
formation of an insoluble purple formazan product that can be quantified 
spectrophotometrically to provide a measure of metabolic activity.  10 µL of 5 mg/mL 
MTT solution was added to ADC, BMDC and DPDC cultures grown in 6.86 mm
3
 wells 
containing 2 mL α-MEM + 10 % (v/v) FBS (Corning, UK) and left to incubate for 4 hours 
at 37 ºC.  After incubation, culture plates were removed, 50 µL DMSO (Sigma-Aldrich, 
UK) added and the absorbance determined at 570 nm using an ELx800 plate reader 
(Biotek, UK).  To provide a measure of metabolic activity per cell, counts were performed 
as previously described (see section 2.1.5.1).   
 
2.6 Multi-Lineage Differentiation 
To assess the differentiation potential of passage two ADCs, BMDCs and DPDCs, these 
cells were seeded on 35 mm
2
 polystyrene culture surfaces (Sarstedt, UK) containing 
primary growth medium (see section 2.1.1.1) at a density of 1x10
5
 cells/well.  Cells were 
cultured for a period of 24 hours after which the medium was aspirated and replaced with 
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osteogenic (see section 2.6.1.1), adipogenic (see section 2.6.2.1) or odontogenic media 
(see section 2.6.1.2).  
2.6.1 Osteogenic/Odontogenic Induction 
2.6.1.1 Osteogenic Medium 
Basic growth medium was supplemented with factors necessary for osteogenic induction:    
50 μg/mL ascorbic acid (Sigma-Aldrich, UK) and 10 mM β-glycerophosphate (Sigma-
Aldrich, UK) (Castano-Izquierdo et al, 2007; Kyllonen et al, 2013).   
The influence of dexamethasone on mineralisation was assessed by culturing passage 2 
ADCs in osteogenic medium containing varying concentrations of dexamethasone (Sigma-
Aldrich, UK).  Dexamethasone was added to osteogenic medium at concentrations of 10
-7
, 
10
-8
, and 10
-9
 M, and medium was replaced every three days for a period of three weeks.  
Images of cellular morphologies were obtained using a Nikon TE-DH100w camera 
attached to a Nikon Eclipse TE300 microscope (Nikon, UK) every seven days and each 
culture stained with alizarin red after three weeks incubation to evaluate the amount of 
mineral present (Section 2.6.1.3). 
2.6.1.2 Odontogenic Medium 
Odontogenic culture medium consisted of osteogenic medium (see section 2.6.1.1) 
supplemented with dentine matrix components (DMCs) (see section 2.3) (Deng et al, 
2005; Liu et al, 2005; Smith et al, 2001).  DMCs were added and cellular responses 
assessed at concentrations of 0.1, 1, and 10 µg/mL.   
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2.6.1.3 Alizarin Red Staining and Quantification 
Alizarin red stain (ARS) (Sigma-Aldrich, UK) was used to visualise calcium deposition in 
mineralising cultures.  The stain used comprised of 2 mg/mL 40 mM ARS in 0.5 M acetic 
acid (BDH Laboratory Supplies, UK) and its pH adjusted to 4.2 using 1 % (v/v) 
ammonium hydroxide (BDH Laboratory Supplies, UK) (Gregory et al, 2004).  Prior to 
staining, the number of cells present in each well was manually counted in different fields 
(N = 5) of view using a graticule mounted on a Nikon Eclipse TE300 microscope (Nikon, 
UK).  Each well was washed using PBS and fixed with 10 % (v/v) formaldehyde (VWR, 
UK) at 4 °C for 20 minutes. ARS was added to each well and incubated at room 
temperature for 20 minutes to allow ARS binding of calcium deposits.  Cells were washed 
five times with PBS to remove any unbound stain, and visualised and photographed using 
a Nikon TE-DH100w camera attached to a Nikon Eclipse TE300 microscope (Nikon, UK). 
ARS bound within osteogenic cultures was solubilised from the cultures by incubation 
with 300 µL 10 % (v/v) acetic acid (VWR, UK) at room temperature for 30 minutes.  A 
cell scraper (Corning, UK) was used to remove the loosely attached monolayer and cells 
transferred to a 1.5 mL Eppendorf tube (Eppendorf, UK).  The detached monolayer and 
alizarin red mixture was vortexed for 30 seconds to disaggregate the monolayer and placed 
on a block heater at 85 °C for 10 minutes. The resultant cell slurry was placed on ice for          
5 minutes and then centrifuged (Eppendorf 5804R, Eppendorf, UK) at 20,000 g for          
15 minutes.  Supernatant containing the extracted ARS was removed and 200 µL 10 % 
(v/v) ammonium hydroxide (BDH Laboratory Supplies, UK) was added.  The supernatant 
was transferred to 6.35 mm
2
 wells of a flat bottomed opaque-walled assay plate (Corning, 
UK) and the absorbance measured at 405 nm using an ELx800 plate reader (Biotek, UK).  
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2.6.2 Adipogenic Induction 
2.6.2.1 Adipogenic Medium 
Basic growth medium was supplemented with factors necessary for adipogenic induction:  
0.5 mM 1-methyl-3-isobutylxantine (Sigma-Aldrich, UK), 60 μM indomethacin (Sigma-
Aldrich, UK), 0.5 μM hydrocortisone (Sigma-Aldrich, UK) (Gronthos et al, 2002; Zhang 
et al, 2008).   
2.6.2.2 Oil Red O Staining and Quantification 
Oil red O (ORO) stain is a lysochromic dye used to visualise lipid droplets in adipogenic 
cultures.  An ORO stock solution was prepared by dissolving 0.5 g of ORO stain (VWR, 
UK) in 200 mL 60 % (v/v) propan-2-ol (VWR, UK), which was heated at 56 °C for 1 hour 
and then left to cool at room temperature (Zhang et al, 2008).  A working solution was 
prepared by adding three parts ORO stock solution to two parts distilled water, which was 
filtered immediately to remove any un-dissolved stain.  Cultures were initially washed 
twice with PBS, and representative fields (N = 5) counted manually using a graticule 
mounted on a Zeiss Axiovert 25 microscope (Zeiss, UK).  ORO working solution was 
added to the cultures, which were incubated for 40 minutes at room temperature with 
constant agitation. Cultures were then washed once with 60 % (v/v) propan-2-ol (VWR, 
UK), followed by two consecutive washes in PBS to remove any unbound ORO.  Stained 
monolayers were visualised and photographed using a Nikon TE-DH100w camera 
attached to a Nikon Eclipse TE300 microscope (Nikon, UK). 
Bound ORO dye was eluted from cell monolayers by the addition of 200 μL of 60 % (v/v) 
propan-2-ol (VWR, UK) and incubated at room temperature for 20 minutes with constant 
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agitation.  60 μL volumes were transferred to an opaque-walled 96 well assay plate 
(Corning, UK) and the absorbance measured at 500 nm using an ELx800 plate reader 
(Biotek, UK). 
 
2.7 Gene Expression Analysis 
2.7.1 RNA Isolation 
RNA was isolated from cell cultures using the Qiagen RNeasy minikit according to the 
manufacturer’s instructions (Qiagen, UK).  Medium was aspirated from cultures and the 
cells washed with PBS. Cells were lysed by the addition of 600 μL RLT lysis buffer 
supplemented with 1 % (v/v) β-mercaptoethanol.  An equivalent volume of 70 % (v/v) 
ethanol was added to the cell lysate, which was briefly vortexed.  700 μL of the mixture 
was transferred to an RNeasy mini-column, which drained into a 2 mL collection tube.  
RNeasy mini-columns containing cell lysate were centrifuged (Eppendorf 5804R, 
Eppendorf, UK) for 15 seconds at 8,000 g and the elute discarded.  Successive washing 
steps were performed at 8,000 g (Eppendorf 5804R, Eppendorf, UK) using 700 μL of kit 
wash buffer for 15 seconds, 500 μL of ethanol kit buffer for 15 seconds, and 500 μL of 
ethanol kit buffer for 2 minutes.  Each RNeasy spin column was then transferred to a             
1.5 mL flat-bottomed collection tube (Appleton Woods, UK) and 30 μL molecular grade 
RNase-free water added to the column membrane.  The assembly was centrifuged 
(Eppendorf 5804R, Eppendorf, UK) at 8000 g for 1 minute to remove any RNA bound to 
the membrane. 
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2.7.2 RNA Analysis 
To determine the concentration of RNA isolated (see section 2.7.1) the absorbance of each 
sample at 260 nm was determined using a Biophotometer (Eppendorf, UK).  RNA content 
was further analysed by electrophoresis by running each lysate on a 1 % (w/v) agarose gel 
(WebScientific, UK) to determine RNA presence and integrity (see figure 2.7.2).  The 
agarose gel was produced by adding 1 % (w/v) agarose to 60 mL of 1x 
tris(hydroxymethyl)-aminomethane (TAE) buffer (Qiagen, UK) and boiling using a 
microwave until dissolved.  The gel was allowed to cool at room temperature to 
approximately 60 ºC and 3 μL of 10,000X SYBR gold nucleic acid stain staining solution 
(Invitrogen, UK) added.  The mixture was manually transferred to a gel tray, a well-
forming comb inserted, and left to cool at room temperature.  1 μL of the extracted RNA 
was added to 3 μL RNase-free water and 1 μL 10X loading buffer (Promega, UK).  This 
mixture was loaded into wells in the 1 % (w/v) agarose gel and electrophoresed at 120 V 
for ~40 minutes.  The gel was then transferred to a G:Box gel documentation and analysis 
unit (Syngene, UK) where the presence of 18S and 28S bands were visualised by UV 
illumination. 
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Figure 2.7.2 Representative image of electrophoresed RNA on a 1 % (w/v) agarose gel 
with 18S and 28S bands visible.  4 μL of PCR ranger 100 bp RNA ladder was used to 
provide a measure of RNA band size (Norgen, UK). 
2.7.3 Reverse Transcription of RNA  
RNA was reverse transcribed into cDNA using the QIAGEN Omniscript RT kit according 
to the manufacturer’s instructions (Qiagen, UK).  Approximately 2 μg of RNA was diluted 
in a total volume of 12 μL of sterile molecular grade water (BDH Laboratory Supplies, 
UK). 2 μL of 10 μM oligo-dT primer (Ambion, UK) was added to the RNA solution and 
the mixture incubated at 80 ºC for 10 minutes, and then quenched on ice for 5 minutes to 
stop the reaction.  A PCR master-mix was generated by combining 2 μL reverse 
transcriptase buffer, 2 μL deoxynucleoside triphosphates (dNTP), 1 μL RNase inhibitor 
(Promega, UK) and 1 μL omniscript reverse transcriptase; which was then added to the 
quenched RNA mixture.  The solution was mixed using a vortex mixer and incubated at    
37 ºC for 1 hour to allow the synthesis of double stranded cDNA.  Finally, the mixture was 
heated to 95 ºC for 5 minutes to halt the reaction. 
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2.7.4 Concentration and Purification of Synthesised cDNA 
20 μL of synthesised cDNA was added to Microcon YM-30 spin column (Millipore, UK) 
containing 460 μL molecular grade water (BDH Laboratory Supplies, UK).  The mixture 
was centrifuged (Eppendorf 5804R, Eppendorf, UK) at 10,000 g for 2 minutes and the 
elute discarded.  The volume of liquid remaining in the spin column was measured; if over         
50 μL was still present, the mixture was further centrifuged (Eppendorf 5804R, Eppendorf, 
UK) at 10,000 g for successive 1 minute periods.  When the volume of cDNA mixture 
remaining in the spin column was below 50 μL, the spin column was inverted, transferred 
to a sterile 1.5 mL collection tube and centrifuged (Eppendorf 5804R, Eppendorf, UK) at 
8000 g for 1 minute to collect the concentrated cDNA.  To gain an estimate of the 
concentration of cDNA, the absorbance was measured at 260 nm using a Biophotometer 
(Eppendorf, UK). 
2.7.5 Semi-Quantitative Reverse Transcriptase Polymerase Chain Reaction (sqRT-
PCR) Amplification 
A REDTaq mastermix was produced, comprising of 12.5 μL REDTaq ready mix (Sigma-
Aldrich, UK), 12.5 μL of molecular grade water (BDH Laboratory Supplies, UK), 1 μL of     
1 μM forward primer (Invitrogen, UK) and 1 μL  of 1 μM reverse primer (Invitrogen, UK).   
6 μL of PCR mastermix was added to individual 0.2 mL PCR tubes (Appleton Woods, 
UK) to which 50-100 ng of cDNA was added.  All components were mixed thoroughly 
using a vortex mixer and transferred to a GeneAmp 2700 PCR Thermocycler (Applied 
Biosystems, UK).  The amplification parameters were optimised for each gene, details of 
which are provided in Table 2.7.5.  Parameters common to all genes were: an initial 
denaturation temperature of 94 ºC for 5 minutes, followed by a 94 ºC treatment for                
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20 seconds, during which dsDNA was separated to give ssDNA.  This step would allow 
DNA to be bound by primers and accessed by the Taq polymerase enzyme.  The creation 
of ssDNA was followed by a 20 second cycle at 60/60.5 ºC for primer annealing to ssDNA 
and a period of primer extension at 68 ºC for 20 seconds.  After the final 68 °C cycle, the 
primers entered an extension phase at 72 ºC for 10 minutes. 
 
Primer 
Primer Sequence 
(5’      3’) 
Annealing 
Temperature (°C) 
Cycle 
Number 
Normalisation 
GAPDH 
F-CCCATCACCATCTTCCAGGAGC; 
R-CCAGTGAGCTTCCCGTTCAGC 
60.5 21-27 
Pluripotent Markers 
Klf4 
F-ATCATGGTCAAGTTCCCAGC; 
R-ACCAAGGACCATCGTTTAGG 
60.5 35 
C-myc 
F-CTTACTGAGGAAACGGCGAG; 
R-GCCCTATGTACACCGGAAGA 
60.5 35 
Nanog 
F-TATCGTTTTGAGGGGTGAGG; 
R-CAGCTGGCACTGGTTTATCA 
60.5 35 
Lin28 
F-TTTCTTGTTTCCCCCAAATG; 
R-AGAGGGGCTGGTTGTAAGGT 
60.5 35 
Sox-2 
F-ATACAAGGGAATTGGGAGGG; 
R-AAACCCAGCAAGAACCCTTT 
60.5 35 
Multipotent Markers 
CD44 
F-TGGGTTTACCCAGCTGAATC; 
R-CTTGCGAAAGCATCAACAAA 
60.5 33-37 
CD105 (Endoglin) 
F-TTCAGCTTTCTCCTCCGTGT; 
R-TGTGGTTGGTACTGCTGCTC 
60.5 41-45 
CD73 (5’-nucleotidase) 
F-GGACTGATTGATCCCCTCCT; 
R-TTGTCCCTGGATTTGAGAGG 
60.5 25 
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CD29 (Integrin β1) 
F-AATGGAGTGAATGGGACAGG; 
R-TCTGTGAAGCCCAGAGGTTT 
60.5 25 
CD90 (Thy1) 
F-AGCTCTTTGATCTGCCGTGT; 
R-CTGCAGGCAATCCAATTTTT 
60.5 26 
Osteogenic/Odontogenic Markers 
Core-Binding Factor Subunit 1 
(Cfbα1) 
F-GCCGGGAATGATGAGAACTA; 
R-GGACCGTCCACTGTCACTTT 
60.5 35 
Osterix 
F- CAGCCTGCAGCAAGTTTGG; 
R- TTT TCCCAGGGCTGTTGAGT 
60.5 35 
Collagen Type 1α1 (Col1α1) 
F-CACCCTCAAGAGCCTGAGTC; 
R-GCTTCTTTTCCTTGGGGTTC 
60.5 35 
Osteopontin (OP) 
F- AAGCCTGACCCATCTCAGAA; 
R- GCAACTGGGATGACCTTGAT 
60.5 25 
Osteonectin (ON) 
F-AAACATGGCAAGGTGTGTGA; 
R-AGGTGACCAGGACGTTTTTG 
60.5 22 
Bone Sialoprotein (BSP) 
F-ATGGAGATGGCGATAGTTCG; 
R-TCCACTTCTGCTTCTTCGTTC 
60.5 35 
Alkaline Phosphatase (ALP) 
F- CTCCGGATCCTGACAAAGAA; 
R- ACGTGGGGGATGTAGTTCTG 
60.5 30 
Dentine Sialophosphoprotein 
(DSPP) 
F-TGCATTTTGAAGTGTCTCGC; 
R-CCTCCTGTCTTGGTGTGGTT 
60.5 25 
Dentine Matrix Protein 1 
(DMP1) 
F-CGGCTGGTGGTCTCTCTAAG; 
R-CATCACTGTGG GGTCCTTG 
60.5 30 
Nestin 
F-CATTTAGATGCTCCCCAGGA; 
R-AATCCCCATCTACCCCACTC 
60.5 31 
Adipogenic Markers 
Adipocyte Protein 2 (aP2) 
F-TGGAAACTCGTCTCCAGTGA; 
R-GCTCATGCCCTTTGCTAAAC 
60.5 25 
Lipoprotein Lipase (LPL) 
F-GTCACCAGCATCCCCATTAT; 
R-TTCCGGATAAAACGTTCTCG 
60.5 25 
Proliferator-activated Receptor 
2 (PPAR2) 
F-CTGGCCTCCCTGATGAATAA; 
R-GCACGTGCTCTGTGACAATC 
60.5 25 
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2.7.6 Gel Electrophoresis of RT-PCR products 
A 1.5 % (w/v) agarose gel was produced as previously described (Section 2.7.2) and 3 μL 
of 0.5 µg/mL ethidium bromide (Helena Bioscience, UK) added to aid visualisation.  The 
solidified gel was transferred to an electrophoresis tank filled with 1 x tris-acetate-EDTA 
(TAE) running buffer (Qiagen, UK) and 5.5 μL of amplified cDNA was added to each 
well.  Samples were electrophoresed at 120 V for a period of 40 minutes.  The gel was 
then removed from the eletrophoresis tank and visualised by UV illumination using a 
G:Box gel documentation and analysis unit (Syngene, UK) and images captured using 
accompanying Genesnap software (Syngene, UK).  Semi-quantitative values of band 
intensities were extrapolated from these images using the GeneTools image analysis 
software (Syngene, UK).  
 
2.8 Mineral Analysis 
2.8.1 Micro-Computed Tomography 
A polychromatic SkyScan-1172 µCT scanner (SkyScan, Kontich, Belgium) was used to 
analyse mineral deposited in passage 2 ADC, BMDC and DPDC cultures after three weeks 
differentiation in 35 mm
2
 petri dishes (Sarstedt, UK) containing osteogenic medium 
(Section 2.6.1.1). Osteogenic medium was removed and the cultures fixed with 10 % (v/v) 
formalin (VWR, UK) and whole dishes analysed in air using an isotropic voxel size of         
10 μm, which was able to provide whole dish scans while maintaining high resolution 
images.  An electrical potential of 40 kV was applied, and a 0.5 mm aluminium filter 
installed to limit the number of low energy (softer) photons reaching the sample, thereby 
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reducing beam-hardening and attenuation artefacts that may cause dark bands or streaks 
and thereby lower image quality.  All samples were scanned under identical conditions, 
with each dish independently mounted on a revolving turntable with a programmed 
rotation step of 0.4 degrees, and scanned using a current of 120 mA and an exposure time 
of 1100 ms.  To produce a phantom for system calibration, di-potassium phosphate 
(K2HPO4) was solubilised at concentrations of 0, 250, 500, 750, 1000, 1250, and            
1500 mg/cm
3
. Following scanning, each cross-section was reconstructed with a 32-bit 
dynamic range and converted to an 8-bit bitmap (BMP) to allow visualisation and analysis 
using format conversion software (Skyscan, Kontich, Belgium), with each pixel having a 
representative grey value between 0 and 255 (black and white).  Grey values were 
extrapolated to provide corresponding mineral density measurements (mg/cm
3
), which 
were colour coded using Fiji software (National Institute of Health, USA) to represent 
increasing densities.   
2.8.2 Scanning Electron Microscopy (SEM) 
SEM was used to analyse mineral present following 21 days culture in osteogenic (see 
section 2.6.1.1) and control (α-MEM + 10 % (v/v) FBS) medium.  Samples were fixed 
with 2.5 % (v/v) glutaraldehyde (Agar Scientific, UK) in a 0.1 M sodium cacodylate buffer 
(Fisher Scientific, UK) for 30 minutes at room temperature.  Samples were dried using a 
progressive series of alcohol dehydration steps with increasing concentrations of (v/v) 
ethanol (Sigma-Aldrich, UK) (20 - 100 %), followed by overnight incubation with 
hexamethyldisilazane (HMDS) (Sigma-Aldrich, UK) in a fume hood for complete 
dehydration of each sample.  The tissue culture polystyrene surfaces on which cells were 
grown, fixed and dehydrated were cut into sections of approximately 3 cm
2
 using a pair of 
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wire cutters.  Cut sections were fixed to aluminium SEM stubs (Agar Scientific, UK) using 
conductive Acheson electrodag tape (Agar Scientific, UK).  Samples were sputter coated 
with gold under vacuum using an Emitech K550X coater for 2 minutes at 25 mA.  
Secondary (SE) and backscattered (BSE) electron micrographs were generated for each 
sample using an accelerating voltage of 10 kV using a Zeiss EVO MA10 scanning electron 
microscope (Zeiss, UK). 
Energy dispersive X-ray spectroscopy (EDS) was used to provide an elemental analysis of 
the mineral present in osteogenic cultures.  Ashed inorganic material (see section 2.8.3) 
was affixed to aluminium SEM stubs (Agar Scientific, UK) as described above.  Samples 
were sputter coated with gold under vacuum using an Emitech K550X coater for 2 minutes 
at 25 mA.  Secondary and backscattered electron micrographs were generated for each 
sample using an accelerating voltage of 15 kV in a Zeiss EVO MA10 scanning electron 
microscope (Zeiss, UK).  Elemental analysis of inorganic material was achieved via the 
analysis of X-rays emitted by atoms present within the material using an energy dispersive 
X-ray spectrometer (EDS-INCA, Oxford Instruments, UK). 
2.8.3 Quantification of Total Inorganic Content 
ADCs, BMDCs and DPDCs were cultured in osteogenic (see section 2.6.1.1) medium for 
21 days.  Medium was aspirated from culture dishes, the cells washed once with PBS, and 
fixed in 10 % (v/v) formalin (VWR, UK) for 20 minutes.  Following fixation, the cell layer 
containing synthesised mineral was manually dissociated from the culture dish using a cell 
scraper (Corning, UK), placed on a glass slide (Fisher Scientific, UK) and finely diced 
using a scalpel.  Glass slides were weighed using an Ohaus high precision analytical 
balance (Ohaus, UK) before and after the addition of dissociated culture contents and the 
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total weight of combined organic and inorganic matter quantified.  Glass slides were then 
transferred to an ashing furnace (Carbolite AAF 11/3, UK) and heated at 600 ºC for          
15 minutes to remove any organic material and reduce any inorganic mineral to ash, 
without altering the mineral phase (Holager, 1970; Lim and Liboff, 1972).  The total 
weight of the ashed inorganic content was then weighed and subtracted from the value 
obtained for total organic/inorganic content to provide a measure of the total mineralised 
portion of osteogenically cultured cells. 
To quantify levels of calcium and phosphate, the ashed inorganic material needed to be 
solubilised.  Inorganic material, as well as a hydroxyapatite standard (Sigma-Aldrich, UK), 
was solubilised in 10 % (v/v) hydrochloric acid (BDH Laboratory Supplies, UK).  
Following solubilisation, the acidic solutions were gradually neutralised using 0.1 % (w/v) 
ammonium hydrochloride (BDH Laboratory Supplies, UK) (Miles et al., 2001).   
 
2.8.4 Determination of Calcium and Phosphorus Content 
The concentration of calcium and phosphorus present in ashed osteogenic cultures (see 
section 2.8.3) was quantified using established methods (Chen et al, 1956; Robinson & 
Weatherall, 1968).  To determine calcium content, a calcein reagent was prepared by 
dissolving 5 mg calcein (Biotium Inc, UK) in 25 mL 3 M KOH (Sigma-Aldrich, UK)  and 
diluted with 100 mL with dH2O.  Calcium carbonate was dried at 105 ºC for one hour 
using a muffle furnace (Carbolite AAF 11/3, UK), followed by further dehydration at               
60 ºC for 1 hour.  To determine phosphorus content, a phosphorus reagent was prepared by 
making two solutions: solution A, containing 10 % (v/v) ascorbic acid (Sigma-Aldrich, 
UK) dissolved in 25 mL double distilled water (d.d.H2O), and solution B, containing        
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0.625 % (v/v) ammonium molybdate (Sigma-Aldrich, UK) dissolved in 1.5 N sulphuric 
acid (BDH Laboratory Supplies, UK) and made up to 100 mL with d.d.H2O.  A working 
phosphorus reagent was then prepared by adding one part solution A with four parts 
solution B.   
 
Calcium standards were prepared by drying calcium carbonate (Sigma-Aldrich, UK) at      
105 °C for 1 hour, followed by further dehydration at 60 °C for 1 hour.  12.5 mg of dried 
calcium carbonate was dissolved in 13.5 mL 2 M perchloric acid (VWR, UK), and made 
up to 1 litre with d.d.H2O.  This 5 μg/mL calcium stock solution was used to make serial 
dilutions with calcium concentrations ranging from 2-4 μg/mL.  Phosphorus standards 
ranging from 0.5-100 mg/L were produced by dissolving 0.22 g of potassium di-hydrogen 
orthophosphate (Sigma-Aldrich, UK) in 500 mL d.d.H2O and using this stock solution for 
serial dilutions.  Test samples were generated by culturing passage 2 ADCs, BMDCs and 
DPDCs in osteogenic medium (see section 2.6.1.1) for 21 days, ashing the resulting 
mineral phase, and solubilising the inorganic material (see section 2.8.3).  Total calcium 
content was evaluated by adding 1 mL of solubilised inorganic material to micro-cuvettes 
containing 1 mL of calcein reagent.  All samples were thoroughly mixed using a vortex 
mixer and the absorbance of each immediately read at 506 nm using a UV/VIS 
spectrometer (Philips, UK), with 2 mL of calcein reagent used to provide a reference 
blank.  The absorbance values for calcium carbonate standards were used to produce a 
standard curve (see figure 2.8.4a).  Values obtained for test samples were plotted and 
extrapolated to provide a measurement of total calcium content.   
Total phosphorus content was evaluated by adding 2 mL of solubilised inorganic material 
to tubes containing 2 mL of freshly made phosphorus reagent, mixing thoroughly and 
83 
 
incubating for 2 hours at 37 ºC in a water bath.  Samples were removed from the water 
bath and left to cool for 5 minutes before being transferred to micro-cuvettes and 
absorbance measured at 820 nm using a UV/VIS spectrometer (Philips, UK), with 2 mL of 
phosphorus reagent used to provide a reference blank.  The absorbance values for 
potassium di-hydrogen orthophosphate standards were used to produce a standard curve 
(see figure 2.8.4b).  Values obtained for test samples were plotted and extrapolated to 
provide a measurement of total phosphorus content. 
 
   
 
Figure 2.8.4a  Standard curve displaying a series of absorbance values obtained at 506 nm 
for known calcium concentrations ranging from 2-4 μg/mL.  Both the equation for the line 
and R
2
 value are displayed.  The R
2
 value obtained indicates a low lineage variance with a 
value >0.98. 
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Figure 2.8.4b  Standard curve displaying a series of absorbance values obtained at 820 nm 
for known phosphorus concentrations ranging from 0.5-10 mg/L.  Both the equation for 
the line and R
2
 value are displayed.  The R
2
 value obtained indicates a low lineage 
variance with a value >0.99. 
 
2.8.5 Fourier Transform Infra-red Spectroscopy (FTIR) 
FTIR was used to qualitatively compare phosphate and carbonate peaks of the inorganic 
mineral phase of odontogenic cultures with those obtained for powdered human dentine 
and reagent grade hydroxyapatite (289396-25G, Sigma-Aldrich, UK).  Dentine powder 
was obtained from human non-carious teeth (ethical approval reference: BCHDent 
286.1471.TB), which were cleaned, cut and pulverised as previously described (see section 
2.3.1).  100 mg of dentine and hydroxyapatite powders were compressed with 1800 N 
force applied by an Instron 5544 electromechanical testing system (Instron, UK) to create 
discs of 1.2 mm diameter.  Passage 2 ADCs, BMDCs and DPDCs were cultured in 
85 
 
osteogenic medium for 21 days (Section 2.6.1.1), the media aspirated and the remaining 
cultures heated at 600 °C to eliminate any organic content (Section 2.8.3).  Ashed samples 
were deposited in an FTIR sample cup (13 mm, 3 mm thickness), the surface levelled and 
analysed using an FTIR spectrometer (Nicolet 520, Nicolet Instrument Corp., Madison, 
WI) operating with 32 scans at a resolution of 4 cm
-1
 within a wavelength range of 585-
2000 cm
-1
. 
 
2.9 Statistical Analysis 
All data were expressed as mean ± standard deviation and analysed using Microsoft Excel 
(Microsoft Corporation, USA) and SPSS software (SPSS Inc, USA).  Basic statistical 
analyses were performed using the paired Students T-test, while the one way analysis of 
variance (ANOVA) with Bonferroni post hoc was used to determine significance between 
cell types and treatments.  P values < 0.05 were considered significantly significant. 
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3.0 RESULTS 
3.0 ISOLATION OF ADIPOSE-DERIVED CELLS 
Adipose tissue potentially represents an abundant and accessible source of mesenchymal 
stem cells that can be utilised for regenerative dentistry (Gimble et al, 2007).  However, 
methods of isolating adipose-derived cells (ADCs) have not yet been standardised.  
Variations in the methodology used for ADC isolation are thought to contribute to 
discrepancies in the immunophenotype and differentiation capacity of these cells (see 
section 1.6.2.1.3).  Therefore, to utilise MSCs from adipose tissue for regenerative 
purposes the identification and development of an efficient method of ADC dissociation is 
required.  This study compared the relative capacity of several enzymes for the 
dissociation of cells from inguinal adipose tissue, and evaluated the effect of each 
approach on the growth kinetics and colony forming capacity of the cells obtained. 
 
3.1 Enzymatic Dissociation of Cells 
Incubation with type I collagenase for 30 minutes released the largest number of cells 
(Table 3.1), with this method releasing approximately 24 % more cells than the next best 
method (30 minute treatment with type I collagenase/trypsin).  15 minute incubations with 
each of the enzymes released significantly (P<0.05) fewer cells when compared with 30 or 
60 minute incubations, with a 15 minute type I collagenase treatment releasing 73 % fewer 
cells than 30 minute treatment with the same enzyme.  Both Trypsin and accutase 
digestions were relatively ineffective at dissociating cells from adipose tissue, with 30 
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minute treatments with either of these enzymes releasing significantly (P<0.05) fewer cells 
than a 30 minute incubation using type I collagenase.  
 
Treatment 
Digestion Period 
(mins) 
Cells Released per Gram Adipose 
Tissue (± Percentage SD) 
 
Type I Collagenase 
(1 g/L) 
15 481,798 ± 25 % 
30 1,766,553 ± 40 %  * 
60 585,516 ± 35 % 
Trypsin 
(2.5 g/L trypsin in 0.38 g/L 
EDTA) 
30 286,180 ± 31 % 
60 258,302 ± 46 % 
 
Type I Collagenase + Trypsin 
(1 g/L Collagenase + 2.5 g/L 
trypsin in 0.38 g/L EDTA) 
15 692,041 ± 31 % 
30 1,335,669 ± 41% * 
 
Accutase 
(10 mL per 75 cm
2
 culture area) 
15 270,780 ± 27 % 
30 452,851 ± 34 % 
60 382,021 ± 29 % 
 
Table 3.1 Numbers of cells released per gram of inguinal adipose tissue following 
incubation at 37 °C with different digestive enzymes for periods of 15, 30 and 60 minutes 
(Mean ± SD, n=5, * = P<0.05). 
88 
 
3.1.1 The Influence of Digestion Time on Cell Growth 
Digestion periods of 30 and 60 minutes were most effective for the release of cells from 
adipose tissue.  Therefore, the effect of 30 and 60 minute digestion periods on the growth 
of dissociated cells was next compared.   
3.1.1.1 Type I Collagenase Digestion 
Following 3 days in culture, the number of cells declined by 44 % and 69 % for enzyme 
digestion periods of 30 and 60 minutes respectively ( see figure 3.1.1a) indicating that the                  
60 minute digestion caused a comparatively significant (P<0.05) reduction in cell viability 
when compared with the 30 minute treatment.  Cell numbers increased after the third day 
of culture for both 30 and 60 minute treatments with increases by day 6 of 97 % and 96 % 
respectively. After 6 days in culture, cell numbers stabilised for ADCs dissociated using 30 
and 60 minute type I collagenase treatments.  After 12 days culture, the 30 minute 
digestion resulted in a higher yield of cells with a significantly higher cell number than the 
60 minute digestion (1.8 fold higher). 
3.1.1.2 Trypsin/EDTA Digestion 
Following 3 days culture the number of cells declined by 87 % and 96 % for incubations of 
30 and 60 minutes, respectively (see figure 3.1.1b).  Cell numbers plateaued at the third 
day of culture with no further cell loss.  Cells derived using a 60 minute incubation period 
with trypsin demonstrated no substantial increase in numbers when compared with the 30 
minute treatment but maintained a constant number of cells until day 12.  Cells derived 
using 30 minute trypsin incubation also plateaued between days 3 and 6, but began to rise 
steadily between days 6 and 9 with a significant (P<0.05) increase of 92 %.  After 12 days 
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culture, a 30 minute digestion generated the highest yield of cells with a significantly 
(P<0.05) higher final cell number than a 60 minute digestion (60 fold higher).   
3.1.1.3 Accutase Digestion 
Following 3 days in culture the number of cells declined by 98 % and 99 % from the initial 
seeding density for both the 30 and 60 minute digestion periods respectively (see figure 
3.1.1c).  Cell numbers obtained using both 30 and 60 minute digestions plateaued at day 3.  
Following the plateau only a minor increase of 6 % was observed between days 3 and 12 
for both treatments.   
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Figure 3.1.1 Growth curves displaying the effect of incubation time on the dissociation of 
ADCs.  Adipose tissue was treated with (a) type I collagenase, (b) Trypsin or (c) Accutase 
and incubated for periods of 30 or 60 minutes.  Resulting cell isolates were cultured over a 
period of 12 days with cell counts performed at 3 day intervals (Mean ± SD, n=5,                
* = P<0.05). 
 
3.1.2 Influence of Digestive Treatment on Colony-Forming Frequency 
ADC cultures were stained with a 0.1 % Toluidine blue solution to visualise the number of 
colonies present in 25 cm
2
 culture dishes after 8 days culture (see figure 3.1.2).  Digestion 
for 30 minutes with type I collagenase or a combination of collagenase plus Trypsin 
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yielded significantly (P<0.05) higher numbers of cells (Figure 3.1.1) and significantly 
(P<0.05) more colonies per dish (44 and 40 colonies, respectively) than any other 
treatment.  Cells released using a 30 minute period of digestion formed significantly 
(P<0.05) more colonies per dish than following a 60 minute digestion.  Treatment with 
either Accutase or Trypsin generated significantly (P<0.05) fewer colonies per dish than 
any other treatment, with ≤3 colonies obtained for each. 
 
Figure 3.1.2 The number of colonies formed within ADC cultures derived using 
independent enzyme treatments and incubation periods.  Cells were cultured in 25 cm
2
 
flasks for a period of 8 days, stained with 0.1 % Toluidine blue and the number of colonies 
counted manually under a phase contrast microscope.  Colonies were defined as ≥50 cells 
and were counted per dish (Mean ± SD, n=5, * = P<0.05). 
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3.1.3 Comparison of 30 Minute Digestive Treatments on Cell Growth 
For all enzyme regimes tested a 30 minute digestion period dissociated higher numbers of 
cells than a 15 or 60 minute digestion (Section 3.1).  ADCs obtained using a 30 minute 
digestion period demonstrated increased growth rates (Section 3.1.1) and colony 
frequencies (Section 3.1.2) when compared with other treatments.  Therefore, comparative 
growth profiles of cells derived from adipose tissue following enzymatic digestion for 30 
minutes were compared.  Following 3 days culture the numbers of viable cells present 
were reduced for all digestive methods.  Cells obtained using type I collagenase or a 
combination of type I collagenase plus trypsin were least affected, with significantly 
(P<0.05) more viable cells present in these cultures after 3 days than in ADC cultures 
obtained using Accutase or Trypsin dissociation (Figure 3.1.3).  Cells derived using type I 
collagenase or a combination of collagenase and trypsin treatment demonstrated 
significant (P<0.05) increases in cell numbers following 3 days in culture.  In contrast, 
Trypsin digested adipose cultures showed no increase in cell numbers until day 6, after 
which the number of cells increased by > 90 % until day 12.  Cell obtained following 
accutase treatment plateaued at day 3 and only increased by 6 % by day 12.  Final cell 
numbers were significantly (P<0.05) higher for cultures derived using type I collagenase 
or combined collagenase plus trypsin treatment, with final cell counts of 18 x 10
6
 and 15 x 
10
6
, respectively. 
93 
 
 
Figure 3.1.3 Growth curves for primary cells derived from adipose tissue using 
independent 30 minute enzyme treatments.  Cells were dissociated from adipose tissue 
using type I collagenase, Trypsin: EDTA, Accutase, or a mixture of type I 
collagenase/trypsin: EDTA and their growth recorded over a period of 12 days (Mean ± 
SD, n=5, * = P<0.05). 
 
3.1.4 Influence of Digestive Treatment on Population Doubling Time 
The influence of the most effective dissociative treatments on population doubling times 
(PDTs) over a period of 12 days were next compared.  PDTs obtained using Accutase and 
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60 minute Trypsin digestions were discarded due to a reduction in cell number following 
digestion (see figures 3.1, 3.1.1b and 3.1.1c).  Cells derived using a 30 minute type I 
collagenase treatment had the lowest PDT and doubled on average every 44 hours.  Cells 
derived using a combination of type I collagenase and Trypsin digestion also displayed a 
PDT of just 48 hours.  A 60 minute incubation with type I collagenase increased the PDT 
by approximately 10 hours, while Trypsin digestion significantly (P<0.05) increased the 
PDT to 147 hours.  This information, along with that obtained in sections 3.1, 3.1.2 and 
3.1.3 indicated that 30 minutes digestion with type I collagenase was the most efficient and 
effective method for dissociating the highest number of viable cells from adipose tissue. 
 
Figure 3.1.4 Graph displaying the average time taken for cells obtained using different 
digestive treatments to double in number.  PDT was calculated over a period of 12 days 
using the formula displayed in section 2.1.5.2 (Mean ± SD, n=5, * = P<0.05). 
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4.0 COMPARATIVE ANALYSIS OF MESENCHYMAL STEM CELL SOURCES 
 
4.1 Comparison of MSC-Like Cells Derived from Different Anatomical Sources 
Mesenchymal stem cells (MSCs) can be isolated from a variety of different anatomical 
sites throughout the body, such as adipose tissue, bone marrow and dental pulp tissues.  
These cells are characterised by their ability to adhere to tissue culture polystyrene, 
express a profile of common surface markers and undergo multipotent differentiation 
(Dominici et al, 2006).  However, a number of differences between MSCs isolated from 
different tissues have been demonstrated with discrepancies in marker profiles and 
potentially distinctive differentiation capacities reported (Mafi et al, 2011; Al-Nbaheen et 
al, 2013).  Therefore, cells derived from adipose (ADCs), bone marrow (BMDCs) and 
dental pulp (DPDCs) tissues were examined using a number of stem cell characterisation 
assays to provide a direct comparison of their stem cell profiles. 
4.1.1 Morphological Comparison 
Photomicrographs taken of tissue culture polystyrene adherent cells at passage 1 and 2 
using phase contrast microscopy demonstrated that BMDCs and DPDCs appeared 
morphologically similar demonstrating fibroblast-like appearances with several thin 
processes extending from the cell bodies (see figure 4.1.1).  Cells appeared to become 
more homogenous at passage 2 with a loss of some larger cell types and a more uniform 
fibroblastic appearance.  ADCs typically had smaller cell bodies than BMDCs or DPDCs.  
ADCs also presented thinner, more elongated processes with a more spindle-like 
appearance.   
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Figure 4.1.1 Representative phase contrast photomicrographs displaying passage 1 (I) and 
2 (II) ADC, BMDC and DPDC cultures.  Cells demonstrated fibroblast morphologies with 
ADCs appearing slightly smaller with a more spindle-like appearance.  Scale bar 
represents 200 µm. 
 
4.1.2 Growth Rates  
4.1.2.1 Growth Rates for Passage 1 Cells 
Cell counts obtained using Trypan blue “exclusion” staining  every 3 days over a total 
period of 18 days showed that ADCs and BMDCs had significantly (P <0.05) increased 
cell numbers at all time points when compared with DPDCs (see figure 4.1.2.1).  ADCs 
and BMDCs showed 2.5 fold increases in cell numbers between days 0-3, whereas the 
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number of DPDCs did not increase until day 3.  ADCs, BMDCs and DPDCs displayed 
2.55, 2.88 and 2.5 fold increases in cell numbers between days 3-6.  ADC and BMDC 
cultures displayed significantly (P<0.05) short population doubling times (PDTs) when 
compared with DPDC cultures during the first 9 days of culture. However, this pattern was 
reversed between days 9-18 with DPDCs demonstrating significantly (P<0.05) shorter 
PDTs than both ADCs and BMDCs.  Cell counts at day 18 indicated that BMDC 
populations displayed the highest cell number with 5 % more cells than ADC cultures and 
significantly (P<0.05) more (35 %) cells than DPDC cultures.   
 
4.1.2.2 Growth Rates for Passage 2 Cells 
Passage 2 ADC, BMDC and DPDC cultures demonstrated similar growth patterns as 
passage 1 (Figure 4.1.2a) with ADCs and BMDCs demonstrating 4-fold increases in cell 
number at day 3, while DPDCs displayed a significantly (P<0.05) lower rate of cell growth 
until day 6 (Figure 4.1.2b).  DPDCs demonstrated 2.8- and 2.4-fold increases in cell 
numbers between days 3-6 and 6-9 respectively, while the rate of cell growth in ADC and 
BMDC cultures began to reach a relatively constant level.  Evaluation of population 
doubling times (PDTs) indicated that passage 2 ADC and BMDC populations displayed 
significantly (P<0.05) lower PDTs between days 0-9 than DPDCs, with this pattern being 
reversed after 9 days culture.  Cell counts at day 18 indicated that ADCs and BMDCs 
achieved significantly (P<0.05) higher numbers of cells than DPDCs following 18 days 
culture, with 25 % and 23 % more cells, respectively. 
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4.1.3 Colony Formation Frequency  
Quantitative analysis of the number of colonies present in each 35 mm
2
 culture dish 
indicated that BMDC cultures contained significantly (P<0.05) more colonies than ADC 
and DPDC cultures, 2-fold and 1.5-fold respectively (see figure 4.1.3).  ADC cultures 
contained comparatively few colonies with 1.3-fold fewer than present in DPDC cultures.  
Observation of all three cultures using phase contrast microscopy indicated that colonies 
present within ADC cultures were generally much larger than those present within BMDC 
and DPDC cultures with each colony having an approximately 3-fold higher cell number 
(see figure 4.1.3c).  These data demonstrated a correlation between the relatively low 
colony frequency within adipose cultures and the comparatively high numbers of cells 
obtained after 6 days culture (see section 4.1.2). 
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Figure 4.1.3 (a) Photomicrographs displaying Toluidine blue-stained colonies formed 
within passage 2 ADC, BMDC and DPDC cultures with accompanying quantification of 
colony number per 35 mm
2
 (b) and number of cells per colony (c).  colonies were defined 
as clusters of ≥ 50 cells and counted manually under a phase contrast microscope (see 
section 2.5.1) (Mean ± SD, n=3, * = P<0.05). 
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4.2 Comparative Analysis of the Expression of MSC Markers 
4.2.1 FACS Profiling for CD29/CD90 Positive Populations 
FACS was used to identify the proportion of cells positive for mesenchymal stem cell 
markers within freshly isolated, passage 1 and passage 2 ADC, BMDC and DPDC 
populations.  CD29, CD90 and CD29/CD90 positivity was analysed within a defined 
region of cells that was established to avoid the selection of false positives resulting as a 
consequence of cell clumping or cell death (see appendix 8).  CD29 and CD90 surface 
antigens were chosen based on guidelines presented by the ISCT, and the prevalence of 
these markers within MSC populations has been consistently demonstrated (Dominici et 
al, 2006; Mafi et al, 2011).  Freshly isolated ADC populations were 91 % positive for 
CD29, 57 % positive for CD90 and 51 % positive for CD29/CD90 (see figure 4.2.1a).  
When cultured in basal growth medium at passage 1 the population of CD29, CD90 and 
CD29/CD90 positive cells within the total ADC population increased by 6 %, 12 % and 13 
%, respectively (see figure 4.2.1b).  Further expansion at passage 2 resulted in no increase 
in presence of CD29 positive cells but did increase the numbers of CD90 and CD29/CD90 
positive cells detected by a further 13 % and 11 %, respectively (see figure 4.2.1c).  
Freshly isolated ADCs displayed significantly (P<0.05) increased numbers of CD29, 
CD90, and CD29/CD90 positive cells when compared with freshly isolated BMDCs (see 
figure 4.2.1a).  However, the proportion of CD29 positive cells within BMDC populations 
increased by 33 % following initial subculture to levels that were 8 % higher than ADC 
populations (see figure 4.2.1b).  No data were obtained for newly isolated DPDCs as these 
cells were not isolated in sufficient quantities required for FACS analysis.  Expression of 
CD29 at passages 1 and 2 showed no variation between ADC, BMDC and DPDC 
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populations with each displaying between 95-99 % positivity.  Expression of CD90 and 
CD29/CD90 in DPDC populations at passage 1 was 10 % and 8 % higher than the 
expression of these markers in BMDC populations and significantly (P<0.05) higher than 
their expression in ADC populations.  The profile of these markers remained stable for 
BMDC cultures between passage 1 and 2, with only minor fluctuations in expression, 
while CD90 and CD29/CD90 expression increased for passage 2 DPDC cultures by 4 % 
and 4.5 %, respectively.  These data demonstrated that tissue culture polystyrene selection 
was able to increase the proportion of cells expressing MSC-associated markers in ADC, 
BMDC and DPDC populations and provide similar numbers of CD29, CD90 and 
CD29/CD90 positive cells in all three populations. 
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Figure 4.2.1 Graphical representation of FACS profiles displaying the percentage of 
CD29, CD90 and CD29/CD90 positive cells in freshly isolated ADC and BMDC cultures 
(a), and passage 1 (b) and 2 (c) ADC, BMDC and DPDC cultures.  Y-axis represents the 
total number of positive cells located within a defined area.  The area was selected to avoid 
the inclusion of dead or clumped cells (see appendix 8) (Mean ± SD, n=5, * = P<0.05).  
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4.2.2 sqRT-PCR Analysis for the Expression of Mesenchymal Stem Cell Markers 
Data presented in section 4.2.1 demonstrated that ADC, BMDC and DPDC cultures 
contained high proportions of cells that express MSC-associated markers and that these 
positive populations could be expanded in vitro.  Gene expression analyses from gel 
images depicted in Appendix 1 were used to provide a semi-quantitative measure of the 
expression of pluripotent and multipotent markers associated with MSCs over the course 
of 5 passages (Riekstina et al, 2009; Mafi et al, 2011; Tsai et al, 2012).  Freshly isolated 
ADCs, BMDCs and DPDCs expressed pluripotent markers and continued to express these 
markers throughout passages 1- 4 (see figure 4.2.2a).  Gene expression was most variable 
for freshly isolated cells from all sources but became less variable following in vitro 
culture.  Primary DPDC populations demonstrated a significantly (P<0.05) lower 
expression of Nanog and Klf4 than ADC and BMDC populations, and a significantly 
lower expression of SOX-2 and C-myc than BMDC and ADC populations, respectively.  
This analysis indicated that cells isolated from all three tissues expressed stem cell markers 
associated with pluripotency and the expression of these markers was maintained as 
passage number increased.   
CD34 expression was limited to freshly isolated ADC cultures and was not detected in 
BMDC and DPDC cultures (see figure 4.2.2b).  There was also a significantly (P<0.05) 
higher expression level of CD29 and CD105 in primary ADC cultures when compared 
with BMDC and DPDC cultures.  The levels of expression of these two markers declined 
when ADCs passage number increased, but the markers continued to be detected over the 
five passages analysed.  At passage 2, the expression of multipotent markers became less 
variable for all three cultures, with similar trends observed for CD44, CD90, CD73 and 
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CD105 expression between the three cell types.  Cells derived from ADC, BMDC and 
DPDC cultures expressed common MSC markers associated with multipotency, but the 
relative expression of these markers at each passage differed depending on the tissue from 
which they were sourced.   
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4.3 Multilineage Differentiation  
4.3.1 The Influence of Dexamethasone on the Differentiation of ADCs towards a 
Mineralising Cell Phenotype  
Dexamethasone is a glucocorticoid typically supplemented into osteogenic medium at 
varying concentrations as reported throughout the literature (Hoemann et al, 2009; 
Kyllonen et al, 2013).  The effect of dexamethasone on mineralisation within ADC 
cultures was assessed by culturing them in the presence of osteogenic medium containing 
10
-7
, 10
-8
 and 10
-9
 M concentrations of dexamethasone. Images obtained using phase 
contrast microscopy demonstrated that dexamethasone had a dose-dependent effect on 
mineralisation within ADC cultures, with increasing concentrations of dexamethasone 
inhibiting the formation of mineralised nodules (see figure 4.3.1a). ADCs grown in the 
absence of dexamethasone displayed a cobblestone-like arrangement of cells that were 
densely packed (see figure 4.3.1I).  Cultures lacking dexamethasone also lacked 
observable alizarin red staining (ARS).  ADCs grown in the presence of 10
-8
 and 10
-9 
M 
dexamethasone exhibited a similar morphology and the formation of mineralised foci (see 
figure 4.3.1II and III).  However, significant (P<0.05) differences were observed relating 
to the size and frequency of foci within the two cultures, with 10
-9
 M dexamethasone 
promoting a visible and quantifiable increase in nodule diameter and concentration of ARS 
present in these cultures (see figure 4.3.1III and b).
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Figure 4.3.1 (a) Representative phase contrast photomicrographs demonstrating the 
influence of dexamethasone concentration on the mineralising capacity of ADC cultures.  
Cells were exposed to osteogenic medium supplemented with 10
-7
, 10
-8
, 10
-9
 M 
dexamethasone for a period of 21 days, stained and compared with osteogenic cultures 
lacking dexamethasone (0 M).  Total ARS was then quantified (b) (Mean ± SD, n=5, * = 
P<0.05). 
 
4.3.2 Osteogenic Induction 
Phase contrast microscopy and ARS quantification were used to examine the capacity of 
ADC, BMDC and DPDC cultures to differentiate towards a mineralising cell phenotype 
(see figure 4.3.2).  All three cell populations responded to osteogenic induction by forming 
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mineralised matrix with characteristic nodules that stained with ARS (see figure 4.3.2a).  
However, cells isolated from these three tissues displayed different patterns of 
mineralisation.  ADCs exhibited the lowest level of mineralisation with fewer ARS 
nodules, which measured approximately ≤ 100 µm in diameter (see figure 4.3.2aII).  ARS 
nodules in BMDC cultures were observed at a higher frequency than in ADC and DPDC 
cultures and typically had diameters exceeding 100 µm (see figures 4.3.2aI and aII).  
Microscopic examination showed that DPDC cultures demonstrated a unique pattern of 
mineralisation, lacking defined nodules that were visibly present in the ADC and BMDC 
cultures (see figure 4.3.2aI and aII).  Staining in DPDC cultures resembled a sheet that 
covered the majority of the cell culture with no defined nodules associated with the in vitro 
mineralisation.  Quantification of ARS within each culture after 7, 14 and 21 days 
demonstrated that DPDC cultures bound significantly (P<0.05) more ARS than ADC or 
BMDC cultures at each time point (see figure 4.3.2b).  Mineralised foci were observed in 
BMDC populations following 14 days exposure to osteogenic medium, while ADC 
populations required ~21 days for mineralised nodule formation to occur.  Following 14 
and 21 days exposure to osteogenic medium, DPSC and BMDC populations showed 
significantly (P<0.05) greater ARS than ADC populations (as normalised for total number 
of cells; Figure 4.3.2b).  For analysis of the relative expression of genes associated with 
osteogenic differentiation in ADC, BMDC and DPDC cultures see section 7.4. 
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Figure 4.3.2 (a) Representative Phase contrast photomicrographs of alizarin red stained 
(ARS) ADC, BMDC and DPDC cultures following exposure to osteogenic (I and II) or 
growth medium (III) for a period of 21 days.  (b) Accompanying ARS quantification 
normalised by the total number of cells (Mean ± SD, n=5, * = P<0.05).  Scale bars in 
images represent 100 µm. 
111 
 
4.3.3 Quantification of the Total Inorganic Content of Osteogenic Cultures 
The proportion of inorganic material present in ADC and BMDC cultures after 21 days 
exposure to osteogenic medium represented only 1.91 % and 2.14 % of the respective total 
weights (see figure 4.3.3).  However, for DPDC cultures the proportion of inorganic 
material was significantly higher, representing 45.74 % of the total culture weight (23-fold 
higher than ADC and BMDC cultures).  These data correlated with previous findings 
(Section 4.3.1) indicating that DPDC cultures were capable of producing more mineral 
than ADC and BMDC when exposed to osteogenic culture medium, with almost half of 
the weight of the final culture being represented by inorganic content.   
 
Figure 4.3.3 Quantification of the total area represented by inorganic material in 
osteogenic cultures.  ADC, BMDC and DPDC cultures were exposed to osteogenic 
medium for 21 days, after which the medium was aspirated and the inorganic phase turned 
to ash by heating at 600 ºC for a period of 15 minutes (see section 2.8.3).  Cultures were 
weighed before and after incubation at 600 °C and the initial and final weighs used to 
calculate the percentage mineral content (Mean ± SD, n=20). 
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4.4 Adipogenic Induction 
Cells were cultured in adipogenic medium for a period of 21 days, after which each culture 
was stained with oil red O (ORO) to visualise intracellular lipid droplets.  Images obtained 
using phase contrast microscopy demonstrated the appearance of rounded cells containing 
large vacuoles that stained red after the addition of ORO (see figure 4.4a).   ORO staining 
differed between the three cell populations, with ADC cultures binding significantly         
(P<0.05) more ORO stain than BMDC or DPDC cultures following 7, 14 and 21 days 
exposure to adipogenic medium (see figure 4.4b).  BMDC cultures bound significantly 
(P<0.05) more ORO stain than DPDC cultures after both 14 and 21 days culture.  DPDC 
cultures demonstrated no increase in ORO uptake until day 21 with numbers of ORO 
positive cells remaining relatively low.  Cells derived from all three tissues were able to 
form adipocyte-like cells after exposure to adipogenic medium.  However, the relative 
adipogenic capacity of cells derived from the three tissues was markedly different, with 
ADCs displaying significantly (P<0.05) more ORO positive inclusions than BMDC and 
DPDC cultures. 
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Figure 4.4 (a) Representative phase contrast photomicrographs of passage 2 ADC, BMDC 
and DPDC cultures exposed to adipogenic medium for a period of 21 days before (I) and 
after (II) ORO staining, or growth medium (III).  (b) Accompanying ORO quantification 
normalised by the total number of cells (Mean ± SD, n=5, * = P<0.05).  Scale bars 
represent 100 µm. 
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4.4.1 sqRT-PCR Analysis for the Expression of Genes Associated with Adipogenesis 
Gene expression analysis indicated that ADCs, BMDCs and DPDCs demonstrated 
expression for the three adipogenic markers, LPL, aP2 and PPARγ (see figure 4.4.1) (Hu 
et al, 1995; Ding et al, 1999).  ADC and BMDC cultures that had been exposed to 
adipogenic medium typically displayed highest expression of adipocytic markers after 7 
days culture, with expression of LPL, PPARγ and aP2 all significantly (P<0.05) increased 
when compared with DPDC cultures.  After 14 days exposure, the expression of all three 
adipocytic markers decreased for ADC and BMDC cultures, while remaining relatively 
constant in DPDC cultures.  Following 21 days adipogenic culture levels of LPL 
expression within DPDC cultures declined and the expression of PPARγ and aP2 dropped 
to a basal level.  ADC and BMDC cultures demonstrated slight decreases in the expression 
of all three markers after 21 days exposure to the adipogenic stimulus, but maintained 
levels significantly (P<0.05) higher than those observed for DPDC cultures at this time 
point. Cells derived from all three tissues expressed markers associated with adipogenesis 
but the relative expression levels of these markers were typically lower for DPDC cultures 
over the course of 21 days.   
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Figure 4.4.1  Graphical representation of the expression of adipogenic genes for passage 2 
ADC, BMDC and DPDC cultures exposed to adipogenic medium for periods of 7, 14 and 
21 days.  Data were normalised against GAPDH and the normalised densitometric values 
of PCR products represented graphically. (Mean ± SD, n=3, * = P<0.05).  For 
corresponding PCR gel images see appendix 2. 
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5.0 THE INFLUENCE OF FACS ON THE VIABILITY, MULTI-
DIFFERENTIATION POTENTIAL AND GENE EXPRESSION PROFILES 
OF MSC-LIKE CELLS 
 
Fluorescence activated cell sorting (FACS) represents a routinely applied method for the 
profiling and isolation of MSC-like cell populations from heterogeneous tissue isolates.   
However, the benefits of FACS over simple polystyrene adherence for the selection of 
multipotent cells, together with the influence of FACS on cell viability, are not well 
documented.  Moreover, the commercial availability of antibodies raised against rodent 
MSC markers is limited.  The work presented in this section utilised FACS for the 
antibody-based selection of cells displaying MSC-identifying surface antigens in order to 
evaluate if cell selection could provide a more stem-like population than simple adherence 
and expansion on tissue culture polystyrene (Huang et al, 2009; Mafi et al, 2011). 
5.1 The Effect of FACS on Cell Viability 
5.1.1 Viability of Cells Selected Using FACS  
FACS utilises hydrodynamic and extensional forces for the selection of cells based on the 
presence of specific surface markers (Herbertson and Aubin, 1997; Zaitoun et al, 2010).  
The influence of FACS on cell viability was assessed by performing Trypan blue cells 
counts.  Results were compared with two control groups: no primary antibody controls that 
were not labelled with antibody but passed through the FACS system, and no sort controls 
that were neither conjugated with antibody nor passed through the FACS system.  Results 
indicated that CD29, CD90, CD29/CD90, and no primary antibody control populations 
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demonstrated no significant differences in viability following FACS (see figure 5.1.1).  
However, when sorted populations were compared with unsorted populations that had 
been treated identically (excluding FACS selection) and had undergone the same period of 
time out of culture, viability was found to be decreased. Both unsorted ADC and DPDC 
populations contained significantly (P<0.05) more viable cells than any of the 
corresponding FACS selected populations.  Sorted populations showed a reduction in the 
number of viable cells in BMDC cultures, with more viable cells present in unsorted 
populations than CD90 and CD29/CD90 positive populations and significantly (P <0.05) 
more viable cells than CD29 selected populations and the no primary controls.  This 
indicated that the process of cell selection significantly reduced the viability of ADC, 
BMDC and DPDC populations. 
 
Figure 5.1.1 Viability of passage 2 cells derived from adipose (AD), bone marrow (BM) 
and dental pulp (DP) tissues following FACS.  The viability of CD29, CD90 and 
CD29/CD90 sorted populations, unsorted populations and no primary controls was 
assessed using the Trypan blue exclusion assay.  Unsorted populations underwent identical 
pre-FACS treatment to sorted cells. (Mean ± SD, n=5, * = P<0.05). 
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5.1.2 The Influence of Time Out of Standard Culture Conditions on Cell Viability 
FACS requires cells to be maintained in suspension (FACS buffer, see section 2.2.1) 
during pre-selection labelling and during cell selection.  ADCs, BMDCs and DPDCs were 
maintained in suspension at approximately 4 ºC for a period of 4.5 hours with Trypan blue 
cell counts performed every 30 minutes to assess how time spent in suspension influenced 
their viability.   All three cell types displayed >90 % viability when removed from normal 
culture conditions for 60 minutes or less (see figure 5.1.2).  ADCs maintained viable cell 
counts of >90 % over the total 270 minute incubation, while BMDCs and DPDCs 
maintained >90 % viability for up to 150 minutes in suspension.  The number of viable 
cells present in both BMDC and DPDC cultures continued to decline at a similar rate 
following 150 minutes in suspension, with decreases of 14 % and 9 %, respectively.  
Following 270 minutes in suspension, BMDCs displayed the greatest decrease in viable 
cell numbers with a 23 % decrease.  DPDC cultures displayed a 16 % reduction in the 
number of viable cells, whereas ADC cultures experienced only an 8 % reduction in 
viability.  Since the time taken for FACS did not exceed 3 hours these results indicated that 
time spent in suspension could not solely account for the reduction in cell viability 
following selection (see section 5.1.1). 
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Figure 5.1.2 Graphical representation of the decline in percentage viability of ADCs, 
BMDCs and DPDCs maintained in suspension (FACS buffer: PBS + 1 % FCS) over a 
period of 270 minutes at approximately 4 ºC.  (Mean ± SD, n=5, * = p<0.05). 
 
5.2 The Influence of FACS on Cell Differentiation Potential 
5.2.1 Differentiation towards a Mineralising Cell Phenotype 
Sorting cells for CD29, CD90 or CD29/CD90 significantly reduced their ability to undergo 
differentiation towards a mineralising cell phenotype.  Whether populations were used 
directly after FACS (direct) or expanded and then differentiated (indirect) (see section 
2.2.1) also appeared to influence the size and number of mineralised foci formed (Figure 
5.2.1a and b).  Direct seeding of cells following FACS yielded more nodules when 
compared with indirectly seeded cells; although this increase was not significant (see 
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figure 5.2.1a and 5.2.1b).  The diameter of ARS nodules for cells assayed directly after 
FACS and no primary control cultures was ≥100 µm, while cells expanded following 
FACS and then assayed exhibited decreased nodule sizes (<50 μm for ADC cultures and 
<100 μm for BMDC cultures).  Nodules formed by unsorted cell cultures typically had a 
larger diameter (≥150 μm) and more intense ARS.  Quantification of ARS confirmed the 
comparatively low levels of mineral deposited in CD29, CD90, or CD29/CD90 positive 
cultures (see figure 5.2.1c and d).  Controls that had not been selected with primary 
antibody contained significantly (P<0.05) higher concentrations of ARS when compared 
with CD29, CD90, and CD29/CD90 sorted populations.  Unsorted populations that 
underwent identical treatment to all sorted cell populations (excluding FACS analysis) 
exhibited a greater ARS, with significantly (P<0.05) more stain bound when compared 
with all sorted population and the no primary controls.   
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5.2.2 Adipogenic Differentiation 
Phase contrast images obtained following 21 days exposure to adipogenic medium 
demonstrated that sorting cultures for CD29, CD90 or CD29/CD90 significantly reduced 
the area of intracellular lipid formed in each cell, as assessed by ORO staining (see figure 
5.2.2). Direct and indirect seeding following FACS selection also appeared to have an 
influence on the capacity of cultures to form lipid filled adipocytes-like cells.  Following 
the trend observed for osteogenic differentiation, no primary controls demonstrated a 
higher level of ORO staining (see figure 5.2.2).  ORO quantification further indicated that 
cells not subjected to FACS selection displayed a significantly (P<0.05) increased ORO 
staining following 21 days culture when compared with cells subjected to all other sorting 
criteria.  These results together with those obtained for osteogenic differentiation (see 
section 5.2.1) indicated that FACS reduced the differentiation potential of ADCs and 
BMDCs. 
 
 
 
 
 
 
 
122 
 
 
Figure 5.2.1 Representative phase contrast photomicrographs displaying FACS sorted and 
unsorted passage 2 ADC (a) and BMDC (b) cultures that were exposed to osteogenic 
medium and stained with ARS.  Sorted populations were either directly assayed (I) in 
osteogenic medium or expanded (indirectly) in basal culture medium (II) to increase cell 
numbers and then assayed.  ARS was quantified from both ADC (c) and BMDC (d) 
cultures and normalised by the total cell number (Mean ±SD, n=3, * = p<0.05).  Scale bars 
in images represent 100 μm. 
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Figure 5.2.2 Representative phase contrast photomicrographs displaying FACS sorted and 
unsorted passage 2 ADC (a) and BMDC (b) cultures that were exposed to adipogenic 
medium and stained with ORO.  Sorted populations were either directly assayed (I) in 
adipogenic medium or expanded in basal culture medium (II) to increase cell numbers and 
then assayed.  ORO was quantified from both ADC (c) and BMDC (d) cultures and 
normalised by the total cell number. (Mean ±SD, n=3, * = p<0.05).  Scale bars represent 
100 μm. 
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5.3 FACS Analysis of CD29/CD90 Expression Following Post-FACS Culture 
Following FACS selection, CD29, CD90 and CD29/CD90 positive populations were 
cultured in growth medium until confluent. After reaching confluence, these cells were 
FACS profiled to determine the influence of post-FACS expansion on the surface marker 
expression of each population (See section 2.2.1). ADC populations sorted using CD29 
displayed a 3.4 % decline in the number of CD29 positive cells following post-FACS 
culture, while BMDC populations displayed a significant (P<0.05) 40.1 % decline (see 
figure 5.3).  Post-FACS culture caused a significant (P<0.05) 17.8 % increase in the 
number of CD90 positive cells present within the ADC population, while only a 3.3 % 
increase was observed for the post-FACS cultured BMDC population.  Similar proportions 
of CD29/CD90 positive cells were displayed in post-FACS cultured ADC and BMDC 
populations, with both showing significant (P<0.05) increases of 23.6 % and 22.9 %, 
respectively.  These results indicated that CD90 sorted populations expanded following 
post-FACS culture, whilst CD29 only populations decreased. 
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Figure 5.3 Graphical representation of the percentage change in the number of CD29, 
CD90 and CD29/CD90 positive cells in ADC and BMDC populations before and after 
post-FACS expansion.  All cells were sorted, expanded in culture until confluent and then 
re-analysed to determine if expansion following FACS had an influence on the 
immunophenotype.  (Mean ± SD, n=3, * = p<0.05). 
 
5.4 The Expression of MSC Markers in FACS Cultures 
5.4.1 sqRT-PCR Analysis of Stem Cell Markers 
sqRT-PCR was used to evaluate the effects of expanding CD29, CD90 and CD29/CD90 
populations on the expression of stem cell marker genes.  FACS generally had a negative 
influence on the expression of pluripotent markers within ADC cultures, but had limited 
effects on the expression of these genes in BMDC cultures.  The expression levels of 
Lin28, Nanog, Sox-2 and Klf4 in ADC populations were all significantly reduced 
following FACS when compared with unsorted populations (see figure 5.4.1aI).  FACS 
had less of an effect on the expression of pluripotent markers in BMDC populations with 
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only a reduction in the expression of Sox-2 detected following CD29 selection (see figure 
5.4.1bI).   
The expression of multipotent markers within ADC and BMDC populations was 
influenced by FACS selection.  Levels of CD29, CD44 and CD90 were significantly 
(P<0.05) higher following the dual selection of CD29/CD90 positive cells from ADC 
populations (see figure 5.4.1aII).  However, the expression of CD73 and CD105 was not 
influenced by FACS selection.  In contrast with data obtained for ADC cultures FACS had 
no detectable influence on the expression of CD29, CD44 or CD90 in BMDC cultures, and 
levels of CD73 and CD105 remained lower than in the unsorted BMDC population (see 
figure 5.4.1bII).  These results demonstrated that CD29, CD90 and CD29/CD90 positive 
populations within ADC and BMDC cultures exhibited different gene expression profiles 
to unsorted populations.   
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6.0 THE EFFECTS OF CRYO-STORAGE ON CELLS DERIVED FROM 
ADIPOSE, BONE MARROW AND DENTAL PULP TISSUES 
A reduction in the osteogenic capacity of MSCs following liquid nitrogen storage has been 
previously demonstrated, as well as interspecies differences in the overall viability of 
stored cells (Ock and Rho, 2011; Naaldijk et al, 2012).  However, information regarding 
the viability of cryo-preserved MSC populations derived from different tissues remains 
limited.  Furthermore, it has been demonstrated that postnatal stem cells continue to 
express MSC markers following cryopreservation, however, information concerning the 
relative levels of these markers compared with freshly isolated controls is lacking (Perry et 
al, 2008).  Therefore, the work in this chapter evaluates the effects of liquid nitrogen 
storage on the morphologies, FACS and PCR profiles, and viabilities of ADCs, BMDCs 
and DPDCs. 
6.1 The Influence of Cryo-Storage on Cell Phenotype 
6.1.1 The Influence of Cryo-Storage on Cell Morphology 
Passage 2 ADC, BMDC and DPDC cultures that had been preserved for a period of 14 
days using cryo-storage were thawed and grown until confluent (see section 2.1.6).  
Reseeded cells were observed using phase contrast microscopy and appeared 
morphologically similar to freshly isolated controls with both displaying a fibroblast-like 
appearance with thin processes extending from the cell bodies (see figure 6.1.1).  The time 
taken for ADCs, BMDCs or DPDCs to reach confluence was also unaffected by cryo-
storage with all cells becoming approximately 80 % confluent after 8 days in culture. 
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Figure 6.1.1 Representative phase contrast photomicrographs comparing the morphologies 
of freshly isolated (a) cyro-preserved (b) ADC, BMDC and DPDC cultures established at 
passage 2.  Cyro-preserved cells were seeded in FCS containing 10 % DMSO and 
maintained in liquid nitrogen for a period of 14 days.  Scale bars on unmagnified images 
represent 100 µm. 
6.1.2 The Influence of Cryo-Storage on Cell Viability 
To determine if cryo-stored cells could be used for FACS analysis (see section 5) the 
capacity of these cells to survive time in suspension was analysed.  To evaluate the effects 
of cryo-storage on the viability passage 2 ADCs, BMDCs and DPDCs these cells were 
cryo-stored for a period of 14 days, thawed, grown to confluence and placed in a FACS 
buffer (see section 2.2.1) suspension for a total duration of 270 minutes. Cell viability 
counts were performed every 30 minutes and are displayed in figure 6.1.2.  The viability of 
ADCs was least variable with only a 6 % decrease in the number of viable cells over the 
total 270 minute duration (see figure 6.1.2).  DPDC cultures displayed >90 % viability 
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when maintained in suspension for 60 minutes.  The total decline in the number of viable 
cells in DPDC cultures was 27 % over the entire 270 minute duration.  The total number of 
viable cells present within BMDC cultures after 30 minutes in suspension was 37 % lower 
than for ADC cultures and 34% lower than for DPDC cultures.  The total number of viable 
cells present within BMDC cultures further declined with increasing time in suspension, 
with significantly (P<0.05) fewer viable cells at all time intervals than were present in 
ADC and DPDC populations.  After 270 minutes in suspension, BMDC cultures were 
significantly (P<0.05) less viable than respective ADC and DPDC populations indicating 
that MSC-like cells derived from different anatomical locations had different survival rates 
following cryo-storage.  These results demonstrated that a reduction in the number of 
viable cells could partially account for the selective pressures applied by cryo-storage 
documented in section 6.2, particularly for BMDCs. 
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Figure 6.1.2 Measure of the number of viable cells found in ADC, BMDC and DPDC 
suspensions following 2 weeks in cryo-storage.  Passage 2 ADC, BMDC and DPDC 
populations were placed in FACS buffer (PBS supplemented with 1 % FBS) and 
maintained out of culture for a period of 270 minutes in order to mimic the FACS 
procedure (Mean ± SD, n=5, * = P<0.05). 
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6.2 The Influence of Cryo-Storage on the Expression of MSC Markers 
6.2.1 The Influence of Cryo-Storage on the CD29/CD90 FACS Profile 
To evaluate if cryo-storage had an effect on the expression of cell surface markers, liquid 
nitrogen (LN) stored and freshly isolated Passage 2 adipose (ADLN), bone marrow 
(BMLN) and dental pulp (DPLN) cultures were FACS profiled for the expression of 
CD29, CD90, and CD29/CD90.  The relative expression levels of CD29 between stored 
and freshly isolated cells from all three tissues remained similar with liquid nitrogen 
storage having no significant difference on the level of CD29 expression (see figure 6.2.1).  
Significant (P<0.05) increases were observed in expression of CD90 for both ADLN and 
BMLN cultures. The relative percentage of cells expressing CD29/CD90 was also found to 
be significantly (P<0.05) increased for ADLN, BMLN and DPLN populations.   
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Figure 6.2.1 Comparison of the levels of CD29, CD90 and CD29/CD90 expression in 
cryo-stored (a) adipose (ADLN), (b) bone marrow (BMLN) and (c) dental pulp (DPLN) 
cultures with freshly isolated populations established at passage 2.  Y-axis represents the 
percentage of positive cells within a manually defined area that was selected to exclude 
dead/clumped cells (see appendix 8) (Mean ± SD, n=5, * = P<0.05).   
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6.2.2 sqRT-PCR Analysis of the Effect of Cryo- Storage on the Expression of Stem 
Cell Markers Genes 
Semi-quantitative RT-PCR was used to assess the effects of cryo-storage on the expression 
of stem cell marker genes.  LN storage promoted significant (P<0.05) increases in the 
expression of the pluripotent markers Klf4, Lin28 and Nanog in ADC and DPDC cultures 
(see figure 6.2.2a).  Cryo-storage had no detectable influence on the expression of Klf4 or 
Lin28 in BMDC populations when compared with freshly isolated cultures, but caused a 
decrease in the expression of Nanog.  Cryo-storage also resulted in a significantly (P<0.05) 
higher level of c-Myc expression detected within the BMDC population (see figure 
6.2.2a). 
Cryo-storage led to cell-specific increases in the expression of several MSC markers.  Cell 
selection through liquid nitrogen storage significantly (P<0.05) up-regulated the 
expression of CD73, CD90, and CD105 in ADC cultures, although it had no influence on 
CD44 or CD29 expression (see figure 6.2.2b).  Unlike ADC cultures, both BMDC and 
DPDC cultures demonstrated a significantly (P<0.05) higher expression of CD44 
following cryo-storage.  BMDC cultures also demonstrated higher levels of CD105 in 
response to cryo-storage, while CD73 expression was significantly (P<0.05) higher in 
cryo-stored DPDC cultures.  CD29 expression remained unaltered following liquid 
nitrogen storage in ADC, BMDC and DPDC cultures.  These results demonstrated that 
cryo-storage resulted in an increase in the expression of stem cell markers that may be 
related to a selective reduction in the total number of viable cells (see section 6.1.2) 
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7.0 CHARACTERISATION OF DENTINE MATRIX COMPONENTS (DMCs) 
AND THEIR EFFECTS ON ODONTOGENIC DIFFERENTIATION 
The organic dentine matrix is predominantly composed of type-I collagen, which 
represents 20 % of the total weight of this tissue (Goldberg et al, 2011).   The remaining 
non-collagenous component is made up of non-collagenous proteins (NCPs), 
glycosaminoglycans (GAGs) and proteoglycans (PGs) (Butler, 1998).  Dentine matrix 
components (DMCs) represent a heterogeneous mixture of NCPs with putative roles in 
tertiary dentine formation (Smith et al, 2012). These bioactive molecules may be released 
through the action of bacterial acids or physical trauma and have been implicated in the 
coordination of differentiation of dental pulp stem cells towards odontoblast-like cells (Liu 
et al, 2005).  The addition of DMCs to MSC cultures has also been shown to promote 
odontoblast-like differentiation in vitro and in vivo (Liu et al, 2005; Lei et al, 2013).  
However, use of DMCs for the induction of adipose-derived stem cells remains 
unexplored.  
The studies in this chapter sought to characterise EDTA-extracted DMC components (see 
section 7.1), define the most effective DMC concentration for the differentiation of ADCs, 
BMDCs and DPDCs towards a mineralising cell type (see section 7.2) and subsequently to 
provide a comprehensive and comparative evaluation of the effects of DMC-
supplementation on odontogenic differentiation in these cultures (see sections 7.3 and 7.4). 
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7.1 DMC Characterisation 
7.1.1 Analysis of DMC Extraction Profile 
The pH and spectrophotometric absorbance values of EDTA-soluble dentine extracts were 
measured daily during a 14 day extraction period to monitor changes in the pH of the 
extraction conditions and provide a measure of the dissolution of EDTA-soluble DMCs 
(see figure 7.1.1). The percentage yield of DMCs extracted from dentine powder using 
EDTA-solubilisation was 3.06 % and the total NCP and GAG content measured using 
Bradford (Bradford, 1976) and Farndale (Farndale et al, 1986) assays was found to 
represent 2.5 and 2.4 mg per gram of dentine, respectively (see appendix 9).  Daily 
measurements of the absorbance values of EDTA-soluble extracts began to decrease after 
the first 24 hours of extraction indicating that the dissolution of proteins from the dentine 
matrix began immediately (Figure 7.1.1a).  Absorbance values continued to decrease over 
the course of the 14 day extraction period but began to stabilise around day 12.  The pH of 
the extraction varied only by a pH of 0.5 over the course of 14 days.  The pH approached 
neutrality as the concentration of extracted proteins decreased and reached neutrality at 
day 14 (Figure 7.1.1b).  These results were in agreement with data previously reported 
(Smith and Leaver, 1979; Tomson et al, 2007; Graham et al, 2007). 
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Figure 7.1.1 Characterisation of EDTA-soluble fractions over a 14 day extraction period.  
(a) Absorbance and (b) pH measurments were recorded daily to provide an indication of 
the dissolution of DMCs by EDTA and provide measure of changes in extraction 
conditions respectively (Mean +/- SD, n=3). 
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7.2 Examining the Effect of DMC Concentration  
Previous studies have shown that DMCs can influence various aspects of the 
mineralisation process, including mineral crystal growth and orientation, and can promote 
the differentiation of stem and progenitor cells towards an odontogenic phenotype 
(Boskey, 1991; Begue-Kirn et al, 1992; Almushayt et al, 2006; Deque et al, 2006; Wu et 
al, 2008; Lei et al, 2013).  To evaluate the inductive capacity of DMCs, three 
concentrations were tested for the induction of ADCs, BMDCs and DPDCs towards a 
mineralising cell phenotype. 
 
7.2.1 The Influence of DMC Concentration on Cell Morphology  
ADC, BMDC and DPDC cultures were exposed to growth medium containing 10 % (v/v) 
FBS supplemented with 0, 0.1, 1 or 10 µg/mL DMCs.  Images obtained using phase 
contrast microscopy demonstrated no observable effects on cellular morphologies between 
cultures supplemented with DMCs at the concentrations tested with all cells exhibiting 
typical fibroblastic appearance and the presence of thin processes emanating from the cell 
bodies (see figure 7.2.1).   
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Figure 7.2.1 Representative phase contrast photomicrographs displaying the influence of 
dentine matrix components (DMCs) on the appearance of ADC, BMDC and DPDC 
cultures established at passage 2.  DMCs were added to culture medium (α-MEM + 10 % 
FBS) at concentrations of 0, 0.1, 1 and 10 µg/mL and grown for a period of 14 days.  
Images were collected at day 14 to provide a representation of cell morphology (n=3).  
Scale bars represent 100 µm. 
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7.2.2 The Influence of DMC Concentration on Mineralisation in MSC Cultures 
7.2.2.1 Adipose-Derived Cultures 
Cells supplemented with 1 and 10 µg/mL DMCs generated more developed areas of 
mineralisation after 14 days culture (see figure 7.2.2.1a).  All cultures exposed to 
osteogenic medium generated mineralised foci of varying sizes (40 µm – 150 µm) after 21 
days incubation.  Cultures grown in the presence of 1 µg/mL DMCs displayed the most 
advanced nodular arrangements (see figure 7.2.2.1a), with a darker appearance and a more 
intense alizarin red staining (ARS). ARS quantification indicated that cultures 
supplemented with 1 µg/mL DMCs stained more intensely with ARS than any other group, 
and significantly (<0.05) more than cultures treated with 0.1 µg/mL DMCs (see figure 
7.2.2.1b).  ADCs cultured in osteogenic medium supplemented with 0.1 and 10 µg/mL 
DMCs demonstrated less ARS than un-supplemented cultures (see section 2.6.1.1 for 
medium composition).  This indicated that DMCs had the capacity to influence 
differentiation and mineralisation in ADC cultures. 
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7.2.2.2 Bone Marrow-Derived Cultures 
Observable differences in cellular morphology were evident after 7 days culture in DMC-
supplemented BMDC cultures (see figure 7.2.2.2a).  Small extracellular nodules were 
observed within a densely packed network of cells in the BMDC cultures supplemented 
with 1 or 10 µg/mL DMCs (see figure 7.2.2.2a).  No nodules were present at this stage for 
cultures supplemented with 0 or 0.1 µg/mL DMCs (see figure 7.2.2.2a).  After 14 days 
incubation, DMC-supplemented cultures displayed well developed nodular arrangements 
with increased diameters (> 100 µm) when compared with those cultured in untreated 
osteogenic medium (≤ 100 µm).  Following 21 days exposure to DMC-supplemented 
osteogenic medium, mineralised nodules appeared darker with diameters exceeding 100 
µm.  Quantification of ARS indicated that significantly (P<0.05) more mineral was present 
in DMC-supplemented cultures at all concentrations when compared with the osteogenic 
medium controls (see figure 7.2.2.2b).  The most effective concentration was 1 µg/mL (see 
figure 7.2.2.2b).   
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7.2.2.3 Dental Pulp-Derived Cultures 
In DPDC cultures the appearance of dark mineralising areas became evident following 7 
days culture in osteogenic medium supplemented with 1 µg/mL DMCs (see figure 
7.2.2.3a).  Following 14 days exposure to osteogenic medium, the deposition of mineral 
within all DMC-supplemented cultures significantly (P<0.05) increased, as indicated by 
phase contrast microscopy images and ARS quantification (see figures 7.2.2.3a and b).  
Cultures supplemented with 1 μg/mL DMCs demonstrated more intense ARS than cultures 
treated with 10 µg/mL DMCs or osteogenic controls (see figure 7.2.2.3b).  The addition of 
0.1 and 1 µg/mL DMCs to osteogenic medium led to a significantly (P<0.05) increased 
deposition of mineral (see figure 7.2.2.3b). 
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7.2.3 The Effect of DMC Concentration on the Expression of Markers Associated 
with Mineralisation and Dentinogenesis: Developing an Optimal Concentration for 
the Induction of Odontogenic Differentiation 
Semi-quantitative RT-PCR was used to examine the influence of DMC concentration on 
the expression of genes associated with the formation of a mineralised extracellular matrix 
(ECM) and differentiation towards an odontogenic phenotype. The expression of three 
genes associated with dentinogenic differentiation, DSPP, DMP1 and Nestin, were 
significantly (P<0.05) increased in ADC cultures supplemented with 1 µg/mL DMCs (see 
figure 7.2.3a).  BMDC cultures also displayed a significant (P<0.05) increase in the 
expression of DSPP when treated with 1 µg/mL DMCs, whereas no concentration of 
DMCs had caused a relative increase in the expression of dentinogenic genes in DPDC 
cultures (see figure 7.2.3a).  Gene expression of type-Iα1 collagen (Col1α1) was increased 
in ADC cultures following supplementation with 10 µg/mL DMCs, although this was not 
significant.  The concentration of DMCs added to BMDC or DPDC cultures appeared to 
have minimal influence on Col1α1 and OP expression (see figure 7.2.3b).  The expression 
of ON also appeared to not be affected by DMC-supplementation in ADC, BMDC or 
DPDC cultures (see figure 7.2.3b). These results indicated that DMC concentration had a 
significant influence on the expression of odontogenic markers within ADC and BMDC 
cultures, but had minimal effect on DPDC cultures.  Moreover, no relationship was found 
between DMC concentration and the expression of common genes associated with the 
formation of a mineralised ECM (i.e. Col1α1, OP and ON) (see figure 7.2.3b). 
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7.3 Effect of DMCs on Odontogenic Differentiation 
Based on comparative analyses of DMC concentrations conducted in section 7.2, a 
concentration of 1 μg/mL DMCs was selected and added to osteogenic medium as a 
putative dentinogenic supplement.   
7.3.1 The Influence of DMCs on Cell Growth 
The influence of 1 μg/mL DMCs on ADC, BMDC and DPDC cell numbers was compared 
in osteogenic and basal growth (α-MEM + 10 % (v/v) FBS) media over a period of 18 
days (see figure 7.3.1).  Cell numbers began to decline in DMC-supplemented cultures 
relative to basal growth medium cultures after 3 days and remained comparatively 
decreased until day 18.  Following 18 days culture, the addition of DMCs to basal growth 
medium resulted in a 5 %, 10 % and 5 % reduction in the number of cells present in ADC, 
BMDC and DPDC cultures, respectively (Figure 7.3.1Ia, Ib and Ic).  
ADCs, BMDCs and DPDCs cultured in osteogenic medium supplemented with 1 µg/mL 
DMCs displayed only minor decreases in cell numbers following 6 (ADCs) and 9 days 
(BMDCs and DPDCs) culture (Figure 7.3.1IIa, IIb and IIc). At day 15, cell numbers 
plateaued within un-supplemented osteogenic cultures, causing DMC-supplemented ADC, 
BMDC and DPDC populations to reach similar cell numbers, with only 0.2 %, 6% and 0.9 
% fewer cells, respectively.  
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Figure 7.3.1 Growth curves displaying the influence of DMCs on cell growth in ADC (a), 
BMDC (b) and DPDC (c) cultures exposed to basal growth medium (I) or osteogenic 
medium (II) (Mean ± SD, n=5). 
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7.3.2 The Influence of DMCs on Colony Formation 
Since the addition of DMCs resulted in only minor effects on cell growth (see section 
7.3.1), the effects of these dentine proteins on colony formation were assessed.  Passage 2 
cells were cultured in the presence of basic growth medium containing 10 % (v/v) FBS or 
supplemented with 1 µg/mL DMCs.  Colonies were defined as clusters of ≥ 50 Toluidine 
blue-positive cells (see figure 7.3.2a).  Minor increases in colony numbers were recorded 
for all three populations with DMC-treated ADC, BMDC and DPDC cultures displaying 
increases of 17 %, 14 % and 3 %, respectively (see figure 7.3.2b).  The average number of 
cells per colony was not affected by the addition of DMCs to ADC, BMDC or DPDC 
cultures (see figure 7.3.2c). 
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Figure 7.3.2 (a) Representative images displaying Toluidine blue-stained colonies within 
ADC, BMDC and DPDC cultures exposed to DMC-supplemented and un-supplemented 
basal growth medium.  Accompanying quantification of the number of colonies present per 
35 mm
2
 (b) and the average number of cells per colony (c) (Mean ± SD, n=5). 
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7.3.3 The Influence of DMCs on Cellular Metabolic Activity  
To determine whether the supplementation of DMCs in cultures resulted in an up-
regulation in the metabolic activity per cell, MTT analysis and accompanying cell counts 
were performed over a period of 18 days for cells cultured in basal growth medium (see 
figure 7.3.3a) and osteogenic medium (see figure 7.3.3b).  Metabolic activity per cell was 
significantly (P<0.05) increased after 3 days culture in DMC-supplemented BMDC 
populations and following 6 days culture for DMC-treated ADC and DPDC populations.  
The metabolic activity per cell in DPDC cultures varied from day 9 to day 18 with 
significant (P<0.05) increases on days 12, 15 and 18 relative to un-supplemented basal 
growth medium controls.  Both ADC and BMDC cultures maintained a significantly 
(P<0.05) increased metabolic activity per cell throughout days 9-18 when compared with 
untreated controls.  The addition of DMCs caused an up-regulation in MTT staining for all 
three cell types.  However, this effect was more consistent for ADC and BMDC cultures 
over the course of the 18 day culture period.  The addition of DMCs to osteogenic medium 
resulted in no significant (P<0.05) up-regulation in metabolic activity per cell in ADC, 
BMDC or DPDC cultures, with the exception of day 6 and 9 ADC and DPDC cultures, 
respectively.  BMDC cultures demonstrated no increase in metabolic activity at any of the 
time points analysed.   
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Figure 7.3.3 MTT analysis of metabolic activity per cell for passage 2 ADC, BMDC and 
DPDC cultures grown in basal growth medium (a) or osteogenic medium (b) in the 
presence or absence of DMCs.  Cell counts were performed at 3 day intervals and used to 
normalise metabolic activity by cell number (Mean ± SD, n=5 * = P<0.05 and indicates 
significance between treated and untreated cultures at a specific day). 
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7.3.4 The Influence of 1 µg/mL DMCs on Mineralisation 
ADC, BMDC and DPDC cultures were exposed to DMC-supplemented and un-
supplemented osteogenic and basal growth media for a period of 21 days, and subjected to 
ARS, which was quantified per cell.  The addition of DMCs to basal growth medium did 
not promote mineralisation (see figure 7.3.4a).  Quantification of ARS per cell indicated 
that the amount of mineral secreted by BMDC and DPDC cultures was significantly 
(P<0.05) increased following DMC-treatment (see figure 7.3.4b). DMC-supplemented 
BMDC cultures contained characteristic darkly staining nodules (see figure 7.3.4a).  
However, these nodules were superimposed on a more prevalent sheet-like mineral deposit 
similar to DPDC cultures (see figure 7.3.4a).  The relative concentration of ARS between 
BMDC and DPDC cultures exposed to osteogenic medium was also significantly (P<0.05) 
decreased by 21 % following DMC-supplementation. ADCs exposed to DMC-treated 
osteogenic medium appeared morphologically similar to untreated cultures with no 
quantitative influence on ARS (see figure 7.3.4b).  DPDC cultures exposed to DMC-
supplemented osteogenic medium were visually similar to those exposed to un-
supplemented osteogenic medium (see figure 7.2.4a).  However, quantification of ARS 
demonstrated a significant (P<0.05) 22% increase in staining for DMC-treated DPDC 
cultures (see figure 7.2.4b).  These results demonstrated that the addition of 1 μg/mL 
DMCs to osteogenic medium resulted in a significant (P<0.05) increase in the quantity of 
mineral deposited in both BMDC and DPDC cultures. 
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Figure 7.3.4 (a) Representative images displaying the effects of 1 µg/mL DMCs on the 
ARS of mineral deposits in ADC, BMDC and DPDC cultures exposed to un-supplemented 
osteogenic medium, DMC-supplemented osteogenic medium, DMC-supplemented growth 
medium (GM), or un-supplemented growth medium for a period of 21 days ARS was 
eluted, quantified and normalised by cell number (b) (Mean ± SD, n=5, * = P<0.05). 
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7.3.5 Analysis of Mineral using Scanning Electron Microscopy  
Secondary electron and backscatter electron imaging were used to provide a more detailed 
examination of the effects of DMCs on the deposition of mineral within ADC, BMDC and 
DPDC cultures (see also sections 7.3.4, 7.3.6 and 7.3.7).  After 21 days exposure, each 
culture was fixed and subsequently examined using a high vacuum scanning electron 
microscope to provide detailed morphological analysis of any mineral present.  
Mineralised foci formed within DMC-supplemented ADC cultures were in general larger 
than those formed by culture in un-supplemented osteogenic medium with average 
diameters of ~30 µm, approximately two thirds larger than foci formed in un-
supplemented osteogenic cultures (see figure 7.3.5a).  Foci formed within BMDC cultures 
were typically much larger than those present in ADC cultures with average diameters of 
approximately 80 µm for un-supplemented osteogenic cultures and 200 µm for DMC-
supplemented osteogenic cultures (see figure 7.3.5b).  Morphological differences in 
mineral deposited in DMC-supplemented and un-supplemented osteogenic cultures were 
also apparent.  Mineral deposited in un-supplemented DPDC cultures formed a sheet that 
covered the underlying cells, while mineral deposited by DMC-supplemented DPDC 
cultures was less uniform with a large number of matrix-free areas (see figure 7.3.5c).  
Images obtained using backscattered electron imaging indicated the presence of high 
atomic number elements that confirmed the presence of mineral within these cultures.  
EDX and calcium/phosphate micro-determination assays (see appendix 10) further 
confirmed the presence of calcium and phosphate and demonstrated that these elements 
were present with an atomic percentage ratio of 1.25 (Ca/P).  This ratio is indicative of an 
intermediate phase in the formation of β-tricalcium phosphate (β-TCP) within mineralising 
systems (Dorozhkin, 2010; Zhao et al, 2011). 
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Figure 7.3.5 Secondary electron (SE) and backscatter electron (BSE) micrographs 
displaying the influence of DMCs on the secretion of mineral in DMC-supplemented 
osteogenic, un-supplemented osteogenic and control media on ADC, BMDC and DPDC 
cultures.  All cultures were grown for a period of 21 days and analysed using secondary 
electron (SE) and backscatter electron (BSE) detection.  (n=5). 
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7.3.6 Analysis of Mineral Deposited in DMC-Supplemented and Un-supplemented 
Cultures 
7.3.6.1 Micro-Computed Tomography (MicroCT) Analysis of Mineralised Cell 
Cultures 
MicroCT data were obtained for ADC, BMDC and DPDC cultures that had been grown in 
DMC-supplemented osteogenic medium, un-supplemented osteogenic medium or basal 
growth medium for a period of 21 days.  These data were represented as two-dimensional 
surface plots of whole culture dishes (see figure 7.3.6.1a) with accompanying mineral 
quantification (7.3.6.1b).  Surface analysis indicated an increase in the volume of mineral 
present in all cultures exposed to osteogenic and DMC-supplemented osteogenic medium 
when compared with corresponding basal growth medium controls (see figure 7.3.6.1a).  
Quantification based on the construction of a calibration curve using di-potassium 
phosphate (K2HPO4) phantoms indicated that the addition of DMCs promoted an increase 
in the volume of mineral deposited in both ADC and BMDC cultures, with this increase 
proving significant (P<0.05) for BMDC cultures (see figure 7.3.6.1b).  The increase in 
mineral content found in the ADC cultures indicated that minor differences in the 
quantification of mineral could be detected using MicroCT analyses that were not 
detectable using ARS analysis (see section 7.3.4).  However, only a minor increase in 
mineral deposition was found in DPDC cultures following exposure to DMC-
supplemented osteogenic medium (Figure 7.3.6.1b). Quantification of mineral using a di-
potassium phosphate phantom demonstrated some small differences in the total mineral 
content of ADC and DPDC cultures when compared with ARS quantification, possibly 
caused by the semi-quantitative nature of ARS (see section 7.3.4). These results 
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demonstrated that ADC and BMDC cultures may respond to differentiation promoting 
factors present within the DMCs by up-regulating the secretion of mineralised matrix and 
that MicroCT may provide a more sensitive method for the quantification of this mineral.  
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7.3.6.2 MicroCT Analysis of Mineral Density 
The density of the mineral phase present in dentine and bone is important for providing the 
structural integrity required for optimum function, with lower densities related to dentinal 
caries, periodontal disease, osteoporosis and bone fractures (Kinney et al, 1994; Tezal et 
al, 2000).  Previous studies have grouped mineral into low (200-400 mg/cm
3
), medium 
(400-800 mg/cm
3) and high (≥ 800 mg/cm3) density categories representing trabecular-
subcortical bone, porous cortical bone and dense cortical bone respectively (Roldan et al, 
2001).  MicroCT analysis of the volumetric density of mineral secreted by ADC, BMDC 
and DPDC cultures demonstrated that mineral deposited following 21 days exposure to 
osteogenic medium was of a low density (0-250 mg/cm
3
), particularly for BMDC cultures, 
with volumetric densities of ≥ 250 mg/cm3 representing only 3.5 % of the total mineralised 
tissue (see figure 7.3.6.2).  Although ADC cultures secreted a lower overall volume of 
mineral than BMDC cultures, a larger proportion of the mineral secreted was of a higher 
volumetric density than that secreted by BMDC cultures, with 50 % representing mineral 
of ≥ 250 mg/cm3.  DPDC cultures contained the highest volume of mineral after exposure 
to un-supplemented osteogenic medium with significantly (P<0.05) more mineral present 
than for ADC and BMDC cultures, 25 % and 20 % respectively.  A large proportion of the 
mineral produced by DPDC cultures was of a low volumetric density, with 86 % of the 
mineral ≤ 250 mg/cm3.  High density bone has been reported to have a volumetric density 
of ≥ 800 mg/cm3, representative of human cortical bone (Roldan et al, 2001).  Cultures 
exposed to osteogenic medium demonstrated only a low volume of mineral with such a 
high volumetric density, with BMDC and DPDC cultures containing only 1 % and 1.8 % 
mineral ≥ 800 mg/cm3 respectively. A comparison of mineral densities for cultures 
exposed to osteogenic medium demonstrated that ADC populations displayed the largest 
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volume of high density mineral, with mineral ≥ 750 mg/cm3 representing 16 %.  Addition 
of DMCs to osteogenic culture medium promoted an increase in the volume of mineral 
secreted by ADC, a significant (P<0.05) increase in the volume of mineral secreted in 
BMDC cultures.  Exposure to DMC-supplemented osteogenic medium only resulted in a 
2.4 % increase in the volume of mineral secreted by DPDC cultures.  The mineral 
produced by MDC-supplemented DPDC cultures was of a low density (< 250 mg/cm
3
), 
with the volume of higher density mineral (> 250 mg/cm
3
) decreased by 1.2 %.  ADC 
cultures demonstrated a significant (P<0.05) 40.3 % increase in mineral volume, while 
BMDC cultures more than doubled the volume of mineral present with an increase of 62.6 
%.  The increased volume of mineral secreted by DMC-supplemented ADC cultures was 
typically of a low density (< 250 mg/cm
3
), with only a 4.5 % increase in mineral                
> 250 mg/cm
3
.  However, DMC-supplemented BMDC cultures demonstrated a significant 
(P<0.05) increase in the total volume of higher density mineral with a 98.7 % increase in 
the presence of mineral with a density > 250 mg/cm
3
, with 14.8 % representing densities 
comparable with cortical bone (≥ 750 mg/cm3).  Mineral secreted by ADC, BMDC and 
DPDC cultures under osteogenic conditions was not uniform, but comprised of several 
different densities.  Mineral secreted by BMDCs cultured in un-supplemented osteogenic 
medium was predominantly of a lower density than that secreted by un-supplemented 
ADC and DPDC cultures.  The addition of DMCs to osteogenic medium increased the 
volume of mineral found in all three cultures, with an accompanying increase in mineral 
density for BMDC cultures.  These results indicated that the application of DMCs to 
osteogenic culture medium could be used to increase the quantity and density of mineral 
deposited in ADC and BMDC cultures.   
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Figure 7.3.6.2 MicroCT analysis of the density of mineral secreted by cultures grown in 
the presence and absence of DMCs.  Passage 2 ADC, BMDC and DPDC cultures were 
exposed to DMC-supplemented osteogenic medium for a period of 21 days and compared 
with un-supplemented osteogenic controls.  Mineral density was determined through the 
use of graded di-potassium phosphate phantoms of known densities ranging from 0-1500 
mg/cm
3
 (Mean, n=5). 
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7.3.6.3 Analysis of Mineral Using FTIR Spectroscopy 
The combined inorganic mineralised phase derived from ADC, BMDC and DPDC cultures 
exposed to DMC-supplemented osteogenic medium was analysed using Fourier transform 
infrared (FTIR) spectroscopy and compared with known dentine and hydroxyapatite (HA) 
standards (see section 2.8.5).  Mineralised ADC, BMDC and DPDC cultures and dentine 
standards were burned at 600 °C for a period of 15 minutes to remove water (vaporised at 
110 °C) and organic components (vaporised at 600 °C) and analysed within a spectral 
range of 590-2000 cm
-1
 (Holager, 1970; Lim and Liboff, 1972).  Data indicated that the 
inorganic phase of osteogenic cultures shared a number of common functional groups with 
both dentine and HA standards (see figure 7.3.6.3).  The presence of characteristic dentinal 
peaks representing amides within the spectral window of 1200-1700 cm
-1
 indicated 
detectable levels of collagen and matrix proteins even after heating at 600 °C for both 
sample and dentine standard (Sato et al, 2013).  A corresponding band was also observed 
for test sample, dentine and HA standards within the 900-1200 cm
-1
 spectral range 
(Paschalis et al, 1996; Wang et al, 2009).  This band represented the inorganic component 
of dentine and contained peaks indicating the presence of V1 symmetric and V3 anti-
symmetric phosphate components present within dentinal apatite, typically seen at around 
960 and 1040 cm
-1
, respectively (Raynaud, et al, 2002).  Further peaks representing 
phosphates were observed between test sample and dentine and HA standards at 605 cm
-1
, 
as well as a typical carbonate peak situated at 870-880 cm
-1
 (Leventouri et al, 2009; 
Yoshihara et al, 2011).  These data indicated that the inorganic phase secreted in response 
to culture in DMC-supplemented osteogenic medium shared a number of common peaks 
with dentine and its major inorganic constituent, HA.   
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Figure 7.3.6.3 FTIR spectra of the combined inorganic component of ADC, BMDC and 
DPDC cultures.  All three cultures were combined and heated at 600 °C to remove any 
organic material and compared with hydroxyapatite and dentine standards.  (n=20). 
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7.4 The Influence of DMCs on the Expression of Genes Associated with 
Mineralisation and Odontogenesis 
FTIR spectroscopy demonstrated similarities between the mineral phase of DMC-
supplemented ADC, BMDC and DPDC cultures and physiological dentine (see section 
7.3.6.3).  However, dentine and bone are structurally and compositionally similar tissues 
and further evaluation of the relative expression of genes associated with osteoblast and 
odontoblast differentiation is commonly used to differentiate between these tissues 
(Hwang et al, 2008; Fujisawa et al, 1993). Therefore, semi-quantitative RT-PCR was used 
to provide a comparative indication of the effects of 1 μg/mL DMCs on the expression of 
genes related to osteogenic and odontogenic differentiation (for corresponding PCR gel 
images see appendix 7). 
7.4.1 Early Markers of Differentiation 
Cbfa1 and Osterix are commonly defined as markers of early stage mineralisation 
associated with osteogenic and odontogenic differentiation (Gronthos et al, 2003).  Semi-
quantitative RT-PCR analysis indicated that the addition of DMCs affected the gene 
expression levels of early mineralisation markers in a time and tissue-dependent manner 
(see figure 7.4.1).  When cultures were assessed after 24 hours incubation, both DMC-
supplemented ADC and BMDC populations displayed a significant (P<0.05) increase in 
the expression of Cbfa1 relative to both osteogenic medium and basal growth medium 
controls (see figure 7.4.1).  BMDC cultures also demonstrated a significant (P<0.05) 
increase in the expression of Osterix relative to both osteogenic medium and basal growth 
medium controls after 24 hours culture.  However, the expression of both Cbfa1 and 
Osterix was relatively low for DMC-supplemented DPDCs at day 1 when compared with 
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osteogenic medium controls.  Following 7 days culture in DMC-supplemented osteogenic 
medium, there was a reduction in the relative expression of Cbfa1 in both ADC and 
BMDC cultures with a corresponding increase in Cbfa1 expression by basal growth 
medium controls.  Levels of Osterix expression were higher for ADC and DPDC 
populations cultured in osteogenic medium at day 7 when compared with DMC-
supplemented cultures, while DMC-treated BMDC cultures demonstrated a significantly 
(P<0.05) increased expression relative to osteogenic controls.  Following 14 days culture, 
the relative Cbfa1 expression profiles for ADC and BMDC cultures returned to levels 
similar to those observed at day 1, while expression increased for DPDC populations 
exposed to osteogenic medium.  Osterix expression remained relatively constant for 
BMDC cultures between days 7 and 14, while expression levels in osteogenic ADC and 
DPDC cultures decreased relative to DMC-supplemented cultures.  These results indicated 
that both culture in DMC-supplemented and un-supplemented osteogenic medium resulted 
in an increase in the expression of early differentiation genes, but that DMC-
supplementation altered the timing of these events in a cell-specific manner. 
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Figure 7.4.1 Representative influence of DMCs on the relative expression levels of early 
markers of mineralisation, Cbfa1 and Osterix.  Passage 2 ADC, BMDC and DPDC 
cultures were exposed to DMC-supplemented and un-supplemented osteogenic media for 
periods of 1, 7, 14 and 21 days.  PCR band intensities obtained for each gene were 
normalised against GAPDH and the normalised densitometric values of PCR products 
represented graphically.  (Mean ± SD, n=3, * = P<0.05).  
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7.4.2 Differentiation Markers 
Alkaline phosphatase (ALP), collagen type 1 (Col1) and osteonectin (ON) represent three 
markers commonly used to provide an indication of differentiation towards a mineralising 
cell phenotype (Gronthos et al, 2000).  Data indicated that the addition of DMCs 
influenced the expression of all three markers, but that the effect was time and tissue-
dependent (see figure 7.4.2).  At day 1, the addition of DMCs had no significant (P<0.05) 
influence on the expression of Col1 in ADC or BMDC cultures, but promoted a significant 
(P<0.05) increase in Col1 expression for DPDC cultures. ADC, BMDC and DPDC 
exposed to DMC-supplemented osteogenic medium displayed a significant (P<0.05) 
reduction in the expression of ALP at day 1.  The addition of DMCs appeared to have no 
discernible influence on ON expression at day 1 when compared with osteogenic controls. 
Following 7 days in culture, expression of Col1 increased for DMC-supplemented ADC 
cultures, while no significant (P<0.05) differences between DMC-supplemented and un-
supplemented osteogenic cultures were observed.  The expression of ON significantly 
(P<0.05) declined in both osteogenic and DMC-treated ADC and DPDC cultures relative 
to the basal growth medium controls at this time point.  However, BMDC cultures 
demonstrated no decrease in ON expression at day 7 when compared with corresponding 
basal growth medium controls.  Levels of ALP expression decreased for both ADC and 
DPDC populations following 7 days culture in osteogenic medium relative to DMC-
treated cultures, while the expression profiles for BMDC cultures remained relatively 
constant.  Col1 expression decreased to levels comparable with basal growth medium 
controls after 14 days culture, while ON and ALP expression profiles remained relatively 
constant for all cell populations. However, increases were observed for ON expression 
within DPDC osteogenic controls, and ALP expression within BMDC osteogenic controls.  
172 
 
No ALP expression was detected for any of the cultures following 21 days culture, while 
ON expression decreased significantly for ADCs and BMDCs cultured in up-
supplemented osteogenic medium.  These results indicated that the DMCs altered the 
temporal expression of markers associated with differentiation towards a mineralised cell 
phenotype and that the effects of DMCs are dependent on the tissue from which the 
multipotent cells are derived. 
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7.4.3 Osteogenic Markers 
Bone sialoprotein (BSP) and osteopontin (OP) represent two markers frequently used to 
identify osteogenic differentiation (Butler, 1991).  These markers are reported as being up-
regulated during osteogenic differentiation whilst down-regulated during odontogenic 
differentiation (Fujisawa et al, 1993; Qin et al, 2001).  Semi quantitative RT-PCR analysis 
demonstrated OP expression was significantly (P<0.05) down-regulated for ADC and 
DPDC cultures treated with DMCs at day 1 when compared with corresponding un-treated 
osteogenic cultures (see figure 7.4.3).  This trend was also apparent for DPDC cultures at 
day 7, but was reduced after 14 days when expression of this marker was reduced.  DMC-
treated BMDC cultures displayed a significantly increased OP expression when compared 
with the osteogenic control at this time point.  However, OP expression by DMC-treated 
BMDC cultures was significantly (P<0.05) lower than the osteogenic control at days 7, 14 
and 21.  The addition of DMCs to ADC cultures promoted significantly (P<0.05) higher 
OP expression at days 7 and 14 when compared with the osteogenic controls, which 
decreased at day 21.  The expression of BSP followed a similar trend for BMDC and 
DPDC cultures at day 1, while expression in ADC cultures was reduced.  At day 7 BSP 
expressions were reduced for all cultures, but increased at day 14 for osteogenic BMDC 
and DPDC cultures when compared with DMC-treated cultures and the basal growth 
medium controls.  BSP expression was reduced for all ADC treatments over the entire 14 
day culture period.  These results demonstrated that the addition of DMCs caused 
significant reductions in the expression of genes related to osteogenic differentiation. 
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Figure 7.4.3 Representative influence of DMCs on the expression of markers associated 
with osteogenic differentiation, BSP and OP.  Passage 2 ADC, BMDC and DPDC cultures 
were exposed to DMC-supplemented and un-supplemented osteogenic medium for periods 
of 1, 7, 14 and 21 days.  Intensities were normalised against GAPDH and and the 
normalised densitometric values of PCR products represented graphically.  (Mean ± SD, 
n=3, * = P<0.05). 
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7.4.4 Odontogenic Markers 
Dentine matrix protein 1 (DMP1), dentine sialophosphoprotein (DSPP) and Nestin 
represent three markers more commonly used to identify odontogenic differentiation 
(Narayanan et al, 2006; Li et al, 2011). These markers are expressed during osteogenic and 
odontogenic differentiation, but the relative levels are reportedly greater for cultures 
undergoing odontogenic induction (Zhao et al, 2007; Hwang et al, 2008).  Semi-
quantitative RT-PCR analysis demonstrated that DSPP and Nestin shared a common 
expression profile for all cell types (see figure 7.4.4).  Expression of these two markers by 
ADC and DPDC cultures was significantly (P<0.05) reduced when compared with 
osteogenic controls at days 7 and 14, but significantly (P<0.05) increased at day 21 for 
ADCs. In comparison, DMC-treated BMDC cultures demonstrated a significantly 
increased expression for both of these genes at days 14 and 21 when compared with 
BMDCs cultured in un-supplemented osteogenic medium.  Expression levels of DMP1 
was relatively similar for DMC-treated and untreated osteogenic cultures at day 1 for ADC 
and BMDC populations, while expression was significantly (P<0.05) increased for un-
supplemented osteogenic BMDC cultures.  At day 7, ADC and DPDC cultures displayed a 
similar trend with increased DMP1 expression in un-supplemented osteogenic cultures.  
DMP1 expression decreased for all cultures at days 14 and 21, although levels of 
expression were significantly (P<0.05) higher for DMC-treated ADC and BMDC cultures 
when compared with osteogenic and growth medium controls.  The addition of DMCs 
altered the temporal expression of markers strongly associated with odontogenic 
differentiation and caused the most consistent increases (P <0.05) in the expression of 
these genes in BMDC cultures.  These results together with those described in section 
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7.4.3 demonstrated the addition of DMCs promoted relative increases in the expression of 
odontogenic genes with corresponding decreases in the expression of osteogenic genes. 
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9.0 DISCUSSION 
 
Adipose tissue can be isolated in large volumes and contains a source of post-natal stem 
cells that can be abundantly harvested in a relatively painless manner.  Additionally, the 
proportion of MSCs present in adipose tissue (~10 %) is greater than within more 
commonly used stem cell sources such as bone marrow (0.001-0.1 %) (Aust et al, 2004; 
Oedayrajsingh-Varma et al, 2006; Fraser et al, 2007; Zhu et al, 2012).  Adipose-derived 
stem cells (ADSCs) are routinely used throughout many areas of tissue engineering 
research and their popularity is continuously growing.  However, there is much debate 
concerning the properties of ADSCs when compared with other commonly used MSCs 
such as bone marrow stem cells (BMSCs), with studies reporting variations in the MSC 
marker profile and differentiation capacity of these cells (Gronthos et al, 2000; De Ugarte 
et al, 2003; Mafi et al, 2011).  Variations in MSC profiles are primarily thought to arise 
due to non-standardised isolation protocols, donor-mismatched comparisons between 
ADSCs and other MSCs, and a lack of data relating to the consistency of MSC 
characteristics between species.  The use of these cells for regenerative dental research 
also remains relatively unexplored with only a small number of studies investigating the 
dentinogenic potential of these multipotent cells (Wu et al, 2008; Jing et al, 2008; Ferro et 
al, 2011; Tobita et al, 2013).   
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9.1 Adipose-Derived Cell (ADC) Isolation 
Previous studies have shown that a population of multipotent stem cells reside in the 
stromal vascular fraction of adipose tissue (Zuk et al, 2001).  These adipose-derived cells 
(ADCs) can be readily isolated in large numbers and represent a highly proliferative cell 
type that have been utilised for tissue engineering applications.  The original method 
employed for the dissociation of ADCs was introduced in the mid 1960s and required 
digestion with type I collagenase followed by centrifugal isolation of the stromal vascular 
fraction (SVF) (Rodbell, 1966; Rodbell and Jones, 1966; Bourin et al, 2013).  This 
procedure has since been modified, but still requires a lengthy extraction process averaging 
several hours with no commonly defined period of enzymatic digestion (Zuk et al, 2001).  
Typical digestion periods used for the isolation of ADCs vary between 30 and 90 minutes 
depending on the study, while type I collagenase generally remains the most frequently 
used enzyme for the release of ADCs (Gimble and Guilak, 2003; Eom et al, 2011; Yu et 
al, 2010).  Furthermore, most studies evaluating the release of ADCs from adipose tissue 
are conducted using human or mouse adipose tissue (Safford et al, 2002; Aust et al, 2004; 
Fraser et al, 2007).  Therefore, comparative analysis of digestive enzymes and incubation 
times for the release of rat-derived ADCs are required.  One of the objectives of the 
present study was to compare several methods of ADC isolation to establish the most 
optimal and reproducible protocol for the isolation of ADCs from rat inguinal adipose 
tissue.  The present study found that 30 minute digestion using 1 g/L type I collagenase 
was most effective for the dissociation of ADCs; releasing approximately 1.8 million cells 
per gram of adipose tissue (see section 3.1).  This is in agreement with the method 
presented by Zuk et al. (2001) for the dissociation of ADCs from human adipose tissue.  
Moreover, the protocol used in the present study uses a shorter digestion period than many 
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employed throughout the literature and is able to yield equivalent numbers of colony-
forming cells (Yoshimura et al, 2007; Kingham et al, 2007; Wang et al, 2012).  Varying 
cell harvesting protocols employing a range of digestive enzymes and incubation periods 
are generally thought to be partly responsible for discrepancies within the literature 
concerning the expression of MSC-associated markers, as well as contributing to 
conflicting information regarding the multi-lineage differentiation potential of ADCs 
(Oedayrajsingh-Varma et al, 2006; Baptista et al, 2009; Strioga et al, 2012; Priva et al, 
2012).  Therefore, it is important that protocols are optimised for dissociation of ADCs in 
different species and standardised to reduce the amount of variation in MSC profiling and 
tissue engineering research. 
 
9.2 Expansion of Tissue Culture Polystyrene Adherent Cells Derived from Adipose, 
Bone Marrow and Dental Pulp Tissues 
Previous studies have shown that mesenchymal stem cells can be isolated from virtually 
every tissue in the body (da Silva Meirelles et al, 2006; Hoogduijin et al, 2011; De Miguel 
et al, 2012).  These cells are defined by their adherence to tissue culture polystyrene 
(TCP), their colony-forming capacities, the expression of a defined profile of surface 
markers, such as CD73, CD90 and CD105, and the potential to differentiate towards 
osteogenic, adipogenic and chondrogenic lineages (Dominici et al, 2006).  However, thus 
far no experimental studies have been conducted to directly compare the "stem-like" 
properties of adipose (ADCs), bone marrow (BMDCs) or dental pulp-derived cells 
(DPDCs) (Huang et al, 2009; Peng et al, 2009).  In this study, ADCs, BMDCs and DPDCs 
isolated from 6 week old male rats were compared using cells at the same passage number 
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to eliminate any discrepancies relating to donor-specific variation and alterations in MSC 
characteristics due to differential expansion (Siddappa et al, 2007; Alves et al, 2012).  
Minor differences were observed between the morphologies of cells derived from each 
tissue (see section 4.1.1).  All cells displayed characteristic fibroblast “stromal” cell 
morphology, but ADCs appeared to possess slightly smaller cell bodies with thinner 
processes, as reported in previous studies (Monaco et al, 2009; Hematti, 2012).  Colonies 
formed within ADC cultures were larger than those formed within BMDC and DPDC 
cultures, although their frequency was comparatively low (see section 4.1.3).  A relatively 
low number of colonies containing higher numbers of cells within ADC cultures have 
previously been reported (Rider et al, 2008; Tawonsawatruk et al, 2012; Al-Nbaheen et al, 
2013). Variations in the number of colony forming cells present in ADC, BMDC and 
DPDC cultures may be due to differences in composition of these tissues, since dental pulp 
and adipose tissues represent more fibrous environments than the bone marrow (Gronthos 
et al, 2000; Al-Nbaheen et al, 2013).   
Comparison of growth kinetics of ADC and BMDC populations established at passage 1 
and 2 indicated that these two cell types shared similar growth rates (see section 4.1.2).  
Comparison of the growth kinetics of ADCs and BMDCs within the literature is 
conflicting with some studies claiming that BMDCs display a slightly elevated growth rate 
when compared with ADCs, while other studies report no discernible differences (Kisiel et 
al, 2012; Tawonsawatruk et al, 2012).  Differences in the growth kinetics of DPDC and 
ADC cultures are likely due to the varying methods employed for dissociation of these 
cells from the surrounding tissue, with different studies using collagenase I, dispase, 
trypsin or even a mixture of these enzymes for the isolation of DPDCs from the pulp 
(Huang et al, 2008; Alge et al, 2010; Smith et al, 2012).  DPDC populations demonstrated 
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an initial lag phase not present in ADC or BMDC populations and as a consequence, 
demonstrated significantly lower cell numbers following an identical period of cell culture 
(see section 4.1.2).  Conflicting data have been reported regarding the presence of a lag 
phase in DPDC cultures (Gronthos et al, 2000; Eslaminejad et al, 2010; Alge et al, 2010).  
This may in part be due to the method of isolation, the concentration of FBS added to the 
culture medium or the cell seeding density used for the analysis of DPDC growth kinetics 
(Eslaminejad et al, 2010).  A previous study has proposed that this lag phase may represent 
a beneficial period of adaptation during which these cells readjust to the new culture 
conditions and may be characterised by the presence of small agranular cells called 
recycling stem cells, which give rise to larger proliferating cells during the log phase of 
cell growth (Ferro et al, 2012).  It has been further demonstrated that the exponential 
growth phase is lengthened if preceded by an initial lag phase, potentially due to the higher 
availability of nutrients per cell (Neuhuber et al, 2008).  Therefore, these results indicated 
that although the number of cells isolated from adipose, bone marrow and dental pulp 
differed, each cell type represents a potential source of multipotent cells for dental tissue 
engineering. 
 
9.3 Mesenchymal Stem Cell Marker Profiles 
The International Society for Cellular Therapy (ISCT) defined CD73, CD90 and CD105 as 
the three key cell surface markers required for MSC characterisation (Dominici et al, 
2006).  Other markers cited include CD29 and CD44 (Maurer, 2011), whilst  a recent 
review reported that the five most commonly used markers for MSC selection were 
CD105, CD90, CD44, CD73 and CD29 (in descending order) (Mafi et al, 2011).  In the 
184 
 
present study, the effect of in vitro expansion on the MSC-associated marker profiles of 
rat-derived ADCs, BMDCs and DPDCs was evaluated using FACS and sqRT-PCR gene 
expression analysis.  The work presented here is novel since studies focussing on the 
profiling of several anatomically distinct rat-derived MSCs do not exist since the majority 
of studies are devoted to human and mouse cell lines (Zangi et al, 2006; Harting et al, 
2008).  The present investigation found that both pluripotent and multipotent markers were 
expressed in primary cell populations and continued to be expressed until passage 4, but 
that the relative levels of expression were not consistent between populations isolated from 
different tissues, particularly for primary and passage 1 cultures (see section 4.2.2).  The 
level of expression of these markers became more stable with successive sub-culture 
indicating that the MSC population had expanded and become more homogeneous.  This 
correlated with previous evidence indicating that expression of MSC-associated genes 
increased and became more stable with adherence to tissue culture polystyrene (TCP) and 
in vitro expansion until passage 5 (Mitchell et al, 2006).  
Analysis of MSC-associated cell surface markers using fluorescence activated cell sorting 
(FACS) and sqRT-PCR demonstrated the presence of MSC markers such as CD29, CD44, 
CD73, CD90 and CD105 in ADC, BMDC and DPDC cultures (see section 4.2).  
Quantification of cell surface markers using FACS indicated primary ADC cultures 
displayed a 26 % higher level of CD29 and CD90 expression when compared with primary 
BMDC cultures, while passage 1 and 2 ADC, BMDC and DPDC populations all 
demonstrated > 90 % CD29 positivity and ≥ 70 % CD90 positivity, which is consistent 
with other reports in the literature (see section 4.2.1) (Mitchell et al, 2006; Zhu et al, 
2008).   A 26 % higher expression of CD29 and CD90 in primary ADCs could be related 
to the heterogeneity of primary adipose populations, since these markers are present on 
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MSCs as well as lymphocytes, fibroblasts, activated endothelial cells and differentiating 
neuronal cells that are reduced following in vitro expansion on TCP (Seymour et al, 1997; 
Pruszak et al, 2009; Kisselback et al, 2009; Mafi et al, 2011).  In fact, reports have 
indicated that a largely homogeneous population of MSCs exists in BMDC cultures 
obtained from rat after just three passages (Harting et al, 2008).   
One of the main issues faced when attempting to define MSCs within newly isolated 
tissues is that stromal progenitors within primary isolates are likely to exist at various 
stages of differentiation, thereby influencing the expression of surface markers, renewal 
capacity and multi-lineage potential (Niemela et al, 2008; Lin et al, 2010).  This may 
provide some rationale for the divergence in the expression of MSC-associated genes 
displayed by primary ADC, BMDC and DPDC populations in the present study (see 
section 4.2.2).  Relative differences in the expression of MSC-associated markers in 
primary cultures can also be explained by the relative differences in stem/progenitor cell 
content or the comparative cellular heterogeneity of each tissue, with the proportion of 
mesenchymal stem cells found in different tissues typically representing between       
0.001-10 % of the entire cell population, with bone marrow tissue shown to contain the 
lowest proportion of MSCs (0.001-0.1 %) (Pittenger et al, 1999; Bourin et al, 2013).  The 
different proportions of stem cells and various other tissue-dependent cell types is likely to 
influence the relative expression levels of single genes used for the profiling of stem cell 
populations.  This is particularly applicable to primary cultures, but may even account for 
the comparatively low CD90 positive fraction in FACS analysed passage 1 and 2 BMDC 
cultures when compared with ADC and DPDC cultures (see section 4.2.1) (Halfon et al, 
2011).  A second reason for the divergence in MSC marker expression is that the 
characterisation of MSCs has primarily been conducted using stem cells derived from 
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humans or mice with comparatively few studies focussing on rat stem cells (Pittenger et al, 
1999; Jiang et al, 2002; Harting et al, 2008).  This means that the majority of research 
relies on the comparability of features such as stem cell markers and multi-differentiation 
capacities common to human and murine MSCs and then attempts to apply them to MSCs 
derived from rats (Harting et al, 2008).  Previous research has indicated that such 
assumptions may not be entirely accurate with BMDCs derived from rats demonstrating a 
much faster selection of predominantly pure MSCs on TCP (by passage 3) than BMDCs 
derived from mice (over 10 passages required) (Harting et al, 2008).   
Genes such as Sox2, Nanog, Klf4, Lin28 and C-myc function in the maintenance of 
embryonic stem cell self-renewal and regulate the expression of loci involved in 
pluripotency and differentiation (Kashyap et al, 2009; Varlakhanova et al, 2010; Shyh-
Chang, 2013).  Recent evidence has indicated that these stem cell maintenance factors may 
play a very similar role within the adult-derived stem cell population (Greco et al, 2007;                
Saulnier et al, 2011; Tsai et al, 2012; Seo et al, 2013).  The transfection of combinations of 
these factors has been shown to induce pluripotency in unipotent cell types, such as 
fibroblasts, and has also been shown to increase the proliferation and differentiation 
potentials of MSCs (Go et al, 2008; Kashvap et al, 2009; Chambers and Tomlinson, 2009).  
Semi-quantitative RT-PCR analysis of the expression of MSC-associated genes presented 
in this study demonstrated the presence of such markers within ADC, BMDC and DPDC 
populations, with the expression of Sox-2, Nanog, Klf4 and C-myc varying most between 
ADCs, BMDCs and DPDCs in primary and passage 1 cultures (see section 4.2.2a).  
Differences in the expression of pluripotent markers within primary populations may be 
explained by the fact that the combination of markers expressed by MSCs derived from 
different anatomical locations is not universal.  In fact, the presence and absence of certain 
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pluripotent markers may provide an indication of functional and compositional tissue-
specific differences that are maintained during early cell culture but lost as populations 
become more homogeneous following adherence and expansion on TCP (Riekstina et al, 
2009).  This proposal is based on the fact that the present study identified differences in the 
expression of markers of pluripotency between primary MSC cultures isolated from 
different tissue sources, with Sox-2, Nanog and Klf4 expression not detected in primary 
DPDC cultures but detected in primary ADC and BMDC cultures (see section 4.2.2a).  
The lack of Nestin and SOX-2 expression in primary DPDC cultures has been previously 
documented and may be related to differences in the embryological derivation of the three 
MSCs, with both ADCs and BMDCs being of mesodermal origin and DPDCs being of 
ecto-mesenchymal origin (Lengler et al, 2005; Greco et al, 2007; Riekstina et al, 2009). 
The presence of CD34 on ADCs remains a controversial topic within the literature (Yu et 
al, 2010; Lin et al, 2010; Mafi et al, 2011).  The present study detected CD34 positivity 
among primary ADC populations, which became reduced to un-detectable levels following 
culture on TCP at passage 1 (see section 4.2.2b).  Various hypotheses have been put 
forward to explain the ambiguous nature of CD34 expression within ADC populations, 
with some reports indicating that CD34 positive members of the stromal vascular fraction 
(SVF) represent a distinct group of cells that also express other MSC-defining markers, 
such as CD73, CD90 and CD105 (Zvaifler et al, 2000).  Interestingly, the presence of 
CD34 has been previously demonstrated within Stro-1 positive dental pulp stem cell 
isolates and may indicate the presence of a pericytic fraction with a multipotent capacity or 
the association of stem cells with a perivascular niche (Shi and Gronthos, 2003; Laino et 
al, 2006; Stokowski et al, 2007; Martens et al, 2012).  The present study indicated that the 
expression of CD34 was limited to primary ADC isolates and would support previous 
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studies demonstrating that CD34 positivity is present only in freshly isolated adipose 
digests after which expression of this marker decreased rapidly (Mitchell et al, 2006; 
Maumus et al, 2011).   
The results presented in this study indicated that even though the expression of MSC 
markers differed between primary populations of ADCs, BMDCs and DPDCs, once 
established in culture at passage 2-4 the levels of these markers reached similar levels.  
Therefore, ADCs represent an accessible and rapidly proliferating population of cells that 
have an expression profile common with MSC-like cells isolated from the dental pulp and 
bone marrow. 
 
9.4 Differentiation Capacity of ADCs, BMDCs and DPDCs 
The reported ability of ADCs, BMDCs and DPDCs to differentiate towards different 
lineages commonly varies within the literature (Im et al, 2005; Rosenbaum et al, 2008; 
Pachon-Pena et al, 2011; Shafiee et al, 2011).  This study only compared the 
differentiation of MSCs towards osteogenic and adipogenic lineages since a standardised 
protocol for the differentiation of ADCs towards a chondrogenic phenotype does not exist.  
Data presented in section 4.3 demonstrated that even though all three cell types were 
capable of bi-lineal differentiation, the relative capacity for adipo- and osteogenic 
differentiation differed considerably between these cells.  These findings are in agreement 
with other published work indicating that ADCs have a low osteogenic potential as 
compared with BMDCs or DPDCs, while DPDCs, have a reduced adipogenic potential 
when compared with ADCs (Gronthos et al, 2000; De Ugarte et al, 2003; Kern et al, 2006; 
Izadpanah et al, 2006; Liu et al, 2007; Zaminy et al, 2008; Hayashi et al, 2008; Pachon et 
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al, 2011).  These differences were confirmed at the RNA level, with DPDC cultures 
displaying comparatively low levels of lipoprotein lipase (LPL), peroxisome proliferator-
activated receptor γ (PPARγ) and adipocyte protein 2 (aP2) when compared with ADC and 
BMDC cultures (see section 4.4.1).   
The appearance of mineral in different MSC cultures varies considerably; with some 
groups claiming that BMDCs are able to form a continuous osteogenic sheet of small 
mineralised nodules, while others indicate this is a characteristic of DPSCs (Yu et al, 
2007; Monaco et al, 2009).  The present study indicated that mineral present in DPDC 
cultures had a different appearance to that found in ADC and DPDC cultures.  The mineral 
present in DPDC cultures lacked defined nodules typically observed in mineralising cell 
cultures and instead formed a sheet of mineral that covered the entire culture dish (see 
sections 4.3.2, 7.3.4 and 7.3.5) (Gronthos et al, 2000; Monaco et al, 2009; Balic et al, 
2009).  Comparison of the total amount of mineral present in these cultures using alizarin 
red staining (ARS) confirmed that DPDC cultures mineralised at a faster rate than ADC 
and BMDC cultures with significantly more mineral present after 7, 14 and 21 days culture 
in osteogenic medium (see section 4.3.2).  Evaluation of the density of the mineral present 
in all three cultures using micro-computed tomography indicated that it was predominantly 
≤ 250 mg/cm3 (see section 7.3.6.2), while dissociation of the organic and inorganic phases 
revealed that almost half of the weight of DPDC cultures was represented by inorganic 
material, while this only represented approximately 2 % of ADC and BMDC cultures (see 
section 4.3.3).  Previous studies using microarrays to analyse the differential expression of 
genes between MSCs on a genome-wide level have shown differences in the expression of 
ECM components, cell adhesion molecules, and growth and transcription factors (Yamada 
et al, 2006).  It is likely that such variations in the level of growth and transcription factors 
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within the developing extracellular matrix could lead to differences in the pattern of 
mineralisation observed in the present study (Sapir-Koren and Livshits, 2011). 
Differences in the capacity of ADCs, BMDCs and DPDCs to differentiate towards osteo- 
and adipogenic lineages may also be explained by the relative proportions of MSCs 
residing within each tissue.  For instance, several authors have suggested that in spite of 
morphological and immunophenotypic similarities, ADCs may represent a heterogeneous 
population of cells containing a relatively small proportion of multipotent cells capable of 
osteogenic differentiation (Im et al, 2005; Mochizuki et al, 2006; Yoshimura et al, 2007).  
There is evidence to suggest that although ADSCs and BMDCs express an array of 
common genes allowing differentiation towards early stage osteoblasts or adipocytes, 
various late-stage differentiation factors are required for the onset of maturation, with these 
late stage factors potentially influenced by MSC origin (Lin et al, 2005; Liu et al, 2007).  
This hypothesis was supported by the identification of late stage factors that have been 
associated with osteogenic and adipogenic lineage commitment that include osteomodulin 
(OMD), apolipoprotein (APOD), adiponectin (ACDC) and fatty acid binding-protein 5 
(FABP5), which have been shown to be differentially expressed by ADCs and BMDCs 
(Liu et al, 2007).  Furthermore, there is evidence to suggest that it is likely that progenitors 
localised within tissues are likely not to exist as a single multipotent population but as an 
uncharacterised mixture of pluripotent, tripotent, bipotent, and unipotent progenitor cells 
of varying proportions (Pittenger et al, 1999; Zuk et al, 2002; Guilak et al, 2006).  
Therefore, the comparatively low osteogenic capacity of ADCs may be due to the fact that 
the ratio of true multipotent cells capable of osteogenic differentiation in ADC cultures 
may be relatively low when compared with unipotent adipogenic progenitors, while in 
BMSC and DPSC populations the proportion of mineralising progenitors may be higher 
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(Liu et al, 2007).  In fact, a study investigating BMDC clonal expansion revealed that only 
one third of the cells present were capable of trilineage differentiation, with approximately 
70% demonstrating osteo- and chondrogenic potential (bipotent), and nearly all displaying 
osteogenic potential (Murgalia et al, 2000).   
The osteogenic potential of ADCs can also be significantly influenced by culture 
conditions (concentration/use of dexamethasone), the species from which the ADCs are 
isolated, the harvesting technique employed, whether cells are cultured in vitro or in vivo 
and whether the cells were cultivated in a 2D or 3D (tissue engineering scaffold) 
environment (Gronthos et al, 2001; Cowan et al, 2004; Gabbay et al, 2006; Wan et al, 
2006; Mitchell et al, 2006; Touomura et al, 2007).  Currently, there is no consensus 
regarding induction factors required for the osteogenic differentiation of ADCs with 
investigators typically using osteogenic medium originally formulated for use with 
BMSCs, not knowing whether this medium is best suited to promote ADC differentiation 
(Kyllonen et al, 2013).  For instance, dexamethasone is routinely added to osteogenic 
medium at concentrations of 10
-7 
M (Gronthos et al, 1994; Zhang et al, 2006).  The 
addition of dexamethasone at concentrations of 10
-7
 and 10
-8
 has been shown to lead to a 
reduction in alkaline phosphatase (ALP) activity, the expression of genes associated with 
mineralisation such as osteopontin or osteocalcin (OC), or the induction of adipogenesis in 
ADC cultures (de Girolamo et al, 2007; Hoemann et al, 2009; Mostafa et al, 2012).  
Examination of the influence of dexamethasone on mineralisation in ADC cultures in the 
present study demonstrated that 10
-9
 M doses of dexamethasone were optimal for 
promoting mineralisation in ADC cultures (see section 4.3.1).  Recent evidence has 
indicated that the osteogenic differentiation of these cells may be further improved by 
culturing ADCs in a xeno-free medium or a medium containing human serum rather than 
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standard culture medium containing FBS (Kyllonen et al, 2013).  This recent study has 
also demonstrated that differentiation of ADCs to a mineralising cell phenotype may also 
be enhanced by increasing the ratio of ascorbic acid to β-glycerophosphate (Kyllonen et al, 
2013).  
Elemental analysis of the inorganic phase present in mineralising cell cultures following 
exposure to osteogenic medium demonstrated a calcium to phosphate ratio of 1.25 
indicative of an amorphous (immature) calcium phosphate (ACP) (see section 7.3.5) (Zhao 
et al, 2011)  The majority of inorganic matter within hard tissue is composed of a non-
stoichiometric calcium deficient - biological – apatite, with calcium to phosphate ratios for 
bone and dentine representing 1.71 and 1.61, respectively (Dorozhkin and Epple, 2002).  
The formation of calcium-based biomineral is thought to progress from the formation of 
stable prenucleation clusters, which aggregate to form an amorphous precursor (Termine 
and Posner, 1966).  Therefore, the presence of amorphous calcium phosphate (ACP) 
characterises a transient stage in a kinetically driven process leading to the formation of 
octacalcium phosphate, and finally crystallised hydroxyapatite (HA) (Skrtic et al, 1996; 
Penn and Banfield, 1999; Takano et al, 2000; Banfield et al, 2000; Zhao et al, 2011).  
Thus, it can be postulated that the presence of ACP-like inorganic matter may represent an 
early, transitory phase in mineralisation that can be correlated with the early stages of bone 
and tooth mineralisation during which ACP functions as an important intermediate phase 
(Bodier-Houlle et al, 2000; Tsuji et al, 2008).   
Data collected in this study demonstrated that ADCs, BMDCs and DPDCs demonstrated a 
bi-lineal differentiation potential.  Together with the adherence of these cells to TCP and 
their expression of MSC markers these results indicated that the cells isolated in this study 
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could be characterised as MSC-like.  However, the comparatively limited capacity of 
ADCs to differentiate to a mineral-secreting cell type casts some doubts on the suitability 
of this cells type for dental tissue engineering. 
 
9.5 The Effects of Cryo-Storage on ADCs, BMDCs and DPDCs 
In order to determine whether the data presented in this study could be obtained using both 
cryo-preserved and freshly isolated cells the influence of cryo-storage on MSC viability 
and marker expression needed to be determined.  Furthermore, the ability of MSCs to 
survive long term storage and maintain their phenotype upon revival is critical if they are 
to be banked and used for future therapeutic purposes.  The majority of published cryo-
preservation protocols rely on the use of dimethyl sulfoxide (DMSO), to prevent the 
formation of intra and extra-cellular crystals during the freezing process (Thirumala et al, 
2009; Chin et al, 2010).  However, recent studies have confirmed that the survival and 
number of colonies formed by MSCs is significantly decreased following cryopreservation 
and that the severity of this decline is inversely proportional to DMSO content (Ock and 
Rho, 2011).  The present study indicated cryo-storage with 10 % DMSO had no 
observable influence on the morphology of ADCs, BMDCs or DPDCs following culture 
(see section 6.1.1), while the effects of cryo-storage on viability were found to be cell-type 
specific, with the average number of viable cells following expansion in culture being      
94 % for ADCs, 89 % for DPDCs and 60 % for BMDCs (see section 6.1.2).  Intriguingly, 
recent high magnification cell surface analysis of cryo-stored and un-stored ADCs has 
revealed changes in cell shape from broad and flat to a more stellate morphology following 
cryo-preservation, which could not be detected by low magnification phase contrast 
194 
 
imaging used in the present study (James et al, 2011).  The reduction in cellular viability 
following cyro-storage may be explained by cell damage occurring due to hyperosmotic 
stress, differences in the concentrations of intracellular salts, membrane alterations or the 
toxic effects of DMSO (Lovelock, 1954; Meryman, 2007).  Previous studies have also 
noted that although DMSO acts as a hydroxyl-free radical scavenger, damage can still 
occur due to the action of oxygen radicals formed during the freeze-thaw process (Kruuv 
and Glofcheski, 1993; Limaye, 1997).   
The influence of cryo-storage on the expression of MSC-associated markers was also 
evaluated using sqRT-PCR gene expression analysis and FACS profiling.  These analyses 
showed higher levels of expression of MSC-associated markers CD73, CD90 and CD105 
for ADC cultures, CD44 and CD105 for BMDC cultures, and CD73 and CD44 for DPDC 
cultures following cryo-storage (see section 6.2).  Genes associated with cell maintenance 
and pluripotency such as Klf4, Lin28 and Nanog were also increased following cryo-
storage of ADC and DPDC cultures (see section 6.4).  Loss of viability coupled with an 
increase in the expression of MSC-associated markers indicated that cryo-storage may 
reduce the viability of certain non-MSCs and consequently cause a proportional increase in 
the number of cells expressing MSC markers within these heterogeneous populations.  The 
fact that no increase in the expression of pluripotent markers in BMDC cultures was 
detected following cryo-storage, together with the comparatively large reduction in BMDC 
viability may indicate that the population of stem cells present within bone marrow isolates 
decreased following cryo-storage.  These results suggest that MSCs present within the 
bone marrow may be more susceptible to hyperosmotic damage resulting from cryo-
preservation.  Increases in the expression of transcription factors first identified with the 
maintenance of multi-potency and cell renewal in embryonic stem cells, such as Nanog, 
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Lin28, C-myc and Klf4 indicate that cryo-storage may have an effect on the relative 
"stemness" of heterogeneous MSC-containing cultures.     
The effect of cryo-storage on cell viability and MSC marker expression led to the sole use 
of freshly isolated cells in the present study.  This choice aimed to minimise variation in 
MSC characteristics and provide an accurate and reproducible evaluation of the 
odontogenic capacity of MSCs. 
 
9.6 The Influence of the Fluorescence-Activated Cell Sorting (FACS) Procedure on 
Cell Viability, Differentiation and Immunophenotype 
This study was designed to determine if selecting cells for markers associated with MSCs 
had an influence on their viability and multi-differentiation capacity.  It has been 
postulated that MSCs must be sorted from heterogeneous populations since the 
heterogeneity of a culture may compromise the proliferation and/or differentiation 
potential of the MSCs contained (Lennon et al, 2000; Schrepfer et al, 2007; Rada et al, 
2011).  As nutrient limitation and the action of endogenous enzymes are known to have a 
detrimental effect on cells when kept outside of normal culture conditions, the present 
experiments were carried out at 4 ºC to limit reductions in cell viability, and sorted into 
polypropylene collection tubes containing a high percentage FBS medium to ensure 
maximum cell recovery (Laiho and Penttila, 1981; McNally and Brockbank, 1992).  
Section 5.2 presented results demonstrating the osteogenic and adipogenic differentiation 
of ADC, BMDC and DPDC cultures following FACS on the basis of MSC-associated 
markers CD29 and CD90.  The findings indicated that selecting for MSC markers 
significantly reduced the osteogenic and adipogenic capacity of TCP adherent cells. 
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Moreover, the FACS procedure was also shown to significantly reduce the viability of 
these cells (see section 5.1.1).  These data are consistent with previous reports suggesting 
that hydrodynamic and extensional forces encountered by cells during FACS have a 
negative influence on cell viability, osteogenic differentiation, as well as on gene 
expression and a variety of signalling pathways (Herbertson and Aubin, 1997; Alenghat 
and Ingber, 2002; Mollet et al, 2008; Zaitoun et al, 2010).   
FACS preparation and analysis required maintenance of cells in suspension for up to 3 
hours.  Therefore, time spent out of culture was assessed over a 5 hour period mimicking 
the conditions experienced when preparing for FACS (see section 2.2).  Data indicated that 
ADCs could survive for long periods out of culture with a minimal loss of cell viability 
(<10 % after 5 hours out of culture), while DPDCs (~16 %), and particularly BMDCs (~23 
%) underwent greater reductions (see section 5.1.2).  These data demonstrated differences 
in the ability of MSC-like cells isolated from different tissues to survive prolonged periods 
out of culture, indicating that ADCs may represent a more robust cell type than other MSC 
sources (Wu et al, 2013).  The comparative robustness of ADCs was also corroborated by 
a relatively high level of viability following FACS and cryo-storage, also documented in 
the present study (see sections 5.1.1 and 6.1.2), as well as the documented ability of these 
cells to maintain their phenotype with age and increasing time spent in culture (Wu et al, 
2013).  However, since the entire FACS procedure consistently took no longer than 3 
hours, loss of viability due to time out of culture could not solely account for the decline 
experienced following sorting.  The ability of ADCs to survive out of culture for longer 
periods than either DPDCs or BMSCs was also interesting given that this tissue has 
recently been shown to contain a population of multi-lineage differentiating stress-
enduring (Muse) cells that are able to endure extreme stresses such as hypoxia, serum 
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deprivation, long term exposure to proteolytic enzymes such as collagenase, and low 
temperatures (Heneidi et al, 2013; Kuroda et al, 2013).  Similar cells with the ability to 
survive extreme stress within bone marrow and dental pulp tissues have not yet been 
described. However, measuring the percentage of viable cells present following FACS 
gave no indication as to whether the remaining population were capable of differentiation 
or rather comprised of a population of pre-apoptotic or senescent cells (Tomlinson et al, 
2013). Therefore, the capacity of sorted cells to undergo differentiation towards osteogenic 
and adipogenic lineages was assessed. 
The differentiation capacity of cells selected using FACS was compared with no primary 
controls and unsorted populations to determine whether sorting for characteristic MSC 
markers had a positive influence on the differentiation capacity of these cells.  Previous 
studies have suggested that CD90 can be used as a selective agent to increase the 
osteogenic capacity of heterogeneous ADC populations (Chung et al, 2013).  However, in 
this example, the CD90 positive cell population was removed directly from the SVF with 
no prior selection on TCP.  Interestingly, data obtained in the present investigation 
indicating that any enhanced osteogenic capacity resulting from CD90 selection becomes 
lost following the in vitro expansion of these cells (see section 5.2.1).  A previous study 
has demonstrated that independent sorting for CD29 and CD90 positivity resulted in an 
up-regulation in some MSC-associated genes and altered the differentiation capacity of 
these cells (Rada et al, 2011).  However, these results were obtained using adipose tissue 
derived from female donors and sorted using immunomagnetic beads within the first 24 
hours of isolation.  Immunomagnetic sorting is unable to provide the purity of selection 
associated with FACS but this technique may provide a more delicate method for the 
selection of immuno-positive cell populations due to the reduced hydrodynamic forces 
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involved in this method (de Wynter et al, 1995; Dainiak et al, 2007; Pruszak et al, 2007; 
Zhu et al, 2013). 
Since reportedly 0.001-10 % of primary populations are represented by MSCs, the 
selection of cells based on the presence of MSC markers often results in the recovery of a 
very small proportion of the original population (Pittenger et al, 1999; Zuk, 2010; Bourin 
et al, 2013).  This study indicated that the proportion of CD90 and CD29/CD90 positive 
cells was increased following the in vitro culture of FACS selected populations, but the 
proportion of CD29 positive cells was decreased (see section 5.3).  This may be related to 
the reduction in cell viability as a consequence of FACS (see section 5.1.1).  Interestingly, 
corresponding significant increases were observed in Klf4 gene expression within CD29 
positive fractions (see section 5.4.1a).  Klf4, as well as having a role in the self-renewal 
and differentiation capacities of stem cells, has been associated with inflammation and the 
differentiation of monocytes.  Therefore the high level of Klf4 expression within CD29 
positive populations may result as a consequence of cell damage following FACS 
(Feinberg et al, 2005; Alder et al, 2008).  Alternatively, since CD29 is known to be 
important for the adhesion and migration of MSCs, it could be postulated that the impact 
of labelling and the shearing forces imparted during FACS may cause damage to this cell 
surface integrin and limit the ability of sorted cells to adhere and proliferate in culture 
(Konakahara et al, 2004).  This capacity appears to be at least in part restored by the 
presence of CD90, potentially due to its role as cell-cell and cell-matrix adhesion protein 
(see section 5.3) (Rege and Hagood, 2006; Kisselbach et al, 2009).   
To assess how selecting for cells based on the presence of MSC surface markers CD29 and 
CD90 affected the expression of other defined MSC markers ADC, BMDC and DPDC 
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gene expression was compared before and after FACS.  The results demonstrated tissue-
specific changes in the levels of various pluripotent markers in FACS selected ADC and 
BMDC populations (see section 5.4.1).  Sorted ADC populations typically displayed a 
reduction in the expression of pluripotent genes associated with cell renewal and 
maintenance, while CD29/CD90 sorted populations displayed increases in certain 
multipotent markers such as CD44, CD29 and CD90 (see section 5.4.1a).  BMDC 
populations demonstrated a very different profile of pluripotent gene expression following 
FACS with only minor decreases observed in the expression of the pluripotent marker 
SOX-2 and multipotent marker CD105 (see section 5.4.1b).  Changes in gene expression 
have been shown to result from nuclear distortions resulting from the application of 
pressure to cells, with stem cells being particularly susceptible due to the presence of large 
nuclei and relatively little cytoplasm (Dahl et al, 2008; Karaoz et al, 2009; Bray et al, 
2010).  Previous studies have shown such stimulation can influence the expression of 
various pluripotent genes such as Nanog and SOX-2 through rearrangement of the actin 
cytoskeleton (Teramura et al, 2012; Horiuchi et al, 2012).  Therefore, it could be 
hypothesised that the hydrodynamic shearing forces encountered during FACS may cause 
distortions in nuclear shape and that these changes may be associated with alterations in 
the gene expression profiles of ADCs and BMDCs.  It was also evident that TCP adherent 
ADCs and BMDCs did not respond to forces experienced during FACS in an identical 
manner with ADCs displaying a greater number of significant reductions in the expression 
of pluripotent and multipotent genes following selection (see section 5.4.1).   
This study suggested that FACS selection for CD29 and CD90 MSC markers negatively 
affected the viability of ADCs, BMDCs and DPDCs and did not improve the 
osteogenic/adipogenic potential of these cells.  This effect may be due to cell disruption by 
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hydrodynamic forces encountered during the FACS procedure or the fact that the markers 
used did not select for clones with osteogenic/adipogenic potential.  This informed the 
choice to carry out all subsequent experiments using TCP adherence alone for the selection 
of multipotent cell types for odontogenic differentiation. 
 
9.7 Odontogenic Differentiation  
Various local and systemic factors, such as TGF-β, BMP-2, FGF-2, platelet-derived 
growth factor (PDGF) and insulin-like growth factor (IGF) are associated with early 
odontoblast and osteoblast lineage commitment (Canalis et al, 1993; Canalis, 1993; 
Centrella et al, 1994).  Many of these factors have been documented within EDTA-
extracted dentine fractions and their ability to promote the differentiation of multipotent 
cells towards an odontoblast-like phenotype has been reported (Begue-Kirn et al, 1992; 
Martin et al, 1998; Hao et al, 2004).  The present study found that the supplementation of 
DMCs at a concentration of 1 µg/mg  promoted the most significant increase in mineral 
deposition, as well as in the expression of odontogenic genes (see sections 7.2.2 and 7.2.3) 
for ADC and BMDC cultures, while DPDC cultures demonstrated limited response to any 
of the DMC concentrations studied. Previous studies have demonstrated that DPDCs can 
be induced to differentiate towards an odontogenic cell type through exposure to growth 
media containing dexamethasone, by supplementing media with EDTA-extracted DMCs, 
or through transfection with vectors expressing proteins common to the dentine matrix, 
such as BMP-2 or FGF-2 (Tziafas et al, 1995; Smith et al, 2001; Alliot-Licht et al, 2005; 
Liu et al, 2005; Lopez-Cazaux et al, 2006; Prescott et al, 2008; Galler et al, 2011).  
However, other in vitro studies have indicated that the addition of total EDTA-extracted 
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DMCs only had a limited influence on the differentiation capacity of odontoblast 
precursors, with the addition of DMCs only able to promote odontoblast-like 
differentiation when combined with TGF-β1 or BMP-2, or when purified for the active 
TGF-β1 fragment using heparin or DEAE-celluose chromatography (Begue-Kirn et al, 
1992; Liu et al, 2005).  This may be related to the dental pulp niche, with the presence of 
factors in the pulp resembling those present within the dentine matrix (Garcia et al, 2003). 
The present study may also highlight differences in the capacity of DPSCs isolated from 
rodent incisors to respond to inductive dentine components, potentially due to the 
continuous growth of these teeth (Ohshima et al, 2005). 
The addition of DMCs has been shown to reduce cell growth and promote the deposition 
of mineral in MSC cultures (Smith and Leaver, 1981; Goldberg and Smith, 2004; Wu et al, 
2008; Ma et al, 2008).  DMCs may act as a differentiation-inducing agent, whilst down-
regulating proliferation and promoting entry to the G0/G1 phase of the cell cycle (Zhu and 
Skoultchi, 2001; Wu et al, 2008).  This inverse relationship between cell growth and 
differentiation was corroborated in the present study by quantitative analyses 
demonstrating that culture with DMC stimulated in vitro minearalisation while causing a 
reduction in overall cell growth (see sections 7.3.4 and 7.3.1).  Analysis of the mineral 
deposited by ADC and BMDC cultures indicated that mineralised nodules formed 
following exposure to DMCs were larger and more developed than those formed after 
osteogenic culture (see sections 7.3.4 and 7.3.5).  The addition of DMCs to DPDC cultures 
also altered the appearance of mineral, causing the formation of a continuous mineralised 
sheet over the culture dish (see sections 7.3.4 and 7.3.5).  Results documented in section 
7.4 demonstrated that the expression of DMP1 and Cbfa1 within ADC and BMDC cultures 
was increased by the addition of DMCs, with corresponding increases in the volume and 
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density of mineral present in these cultures (see section 7.3.6.2).  Interestingly, DMP1 and 
Cbfa1 gene expression was not increased within DMC-supplemented DPDC cultures, nor 
was the density of the mineral formed in these cultures increased (see sections 7.4 and 
7.3.6.2) potentially highlighting an association between Cbfa1 and DMP1 previously 
reported by Fen et al. (2002) in the developing skeleton.  Analysis of the composition of 
mineral present in all three cultures using FTIR spectroscopy indicated that it displayed 
many similarities with non-stoichiometric apatite’s that make up physiological bone and 
dentine, with the presence of characteristic phosphate (960, 1024 and 1095 cm
-1
) carbonate 
(872 cm
-
1) and amide (1550 and 1640-1650 cm
-1
) peaks (Lazarev et al, 1984; Rey et al, 
1989; Rey et al, 1991; Gadaleta et al, 1996; Boskey, 2007).   
It has been hypothesised that levels of DSPP and DMP1 in comparison with BSP and OP 
may provide an indication as to whether the mineralising matrix formed in the presence of 
various inductive factors is bone or dentine-like (Fujisawa et al, 1993; Zhao et al, 2007; 
Hwang et al, 2008).  This hypothesis is based on the fact that the expression of DMP1 and 
DSPP is significantly higher within dentine, while BSP and OP expression is higher in 
bone (Fujisawa et al, 1993).  Gene expression analysis using sqRT-PCR demonstrated that 
BSP and OP levels were higher for BMDCs and DPDCs cultured in un-supplemented 
osteogenic medium (see section 7.4.3), while the addition of DMCs to ADC and BMDC 
cultures increased the expression of genes associated with odontogenesis, DSPP and 
DMP1 (see section 7.4.4).  Both DSPP and DMP1 have been described as key markers of 
odontoblast-like differentiation and over-expression of the DSPP gene within ADC and 
BMDC cultures, and the DMP1 gene within embryonic stem cell cultures, has previously 
been shown to induce differentiation towards an odontoblast-like cell type, as 
characterised by the expression of characteristic markers of early- and late-stage 
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odontogenesis (Narayanan et al, 2001; Goldberg and Smith, 2004; Almushayt et al, 2006; 
Zhu et al, 2008).  Such increases in the expression of odontogenic genes together with 
accompanying reductions in the expression of osteogenic genes indicated that the addition 
of 1 μg/mL DMCs to osteogenic culture medium promoted a more odontogenic pattern of 
differentiation, particularly for BMDC cultures.   
Expression of OP, a well characterised regulator of mineralisation, is known to be reliant 
on the presence of alkaline phosphatase (ALP), with OP acting to regulate levels of 
phosphate homeostasis during the post-proliferative phases of osteo- and odonto-genesis 
(Owen et al, 1990; Beck et al, 2000; Beck and Knecht, 2003).  In the present study, levels 
of ALP gene expression within DMC-treated cultures were consistently lower than those 
cultured in un-supplemented osteogenic medium (see section 7.4.2).  Both the expression 
of OP and ALP have been shown to be influenced by the the concentration of 
dexamethasone added to osteogenic medium, (Leboy et al, 1991; Beresford et al, 1994; 
Rickard et al, 1994).  Different concentrations of dexamethasone can have a major 
influence on the level and timing of ALP gene expression, as well as influencing levels of 
other stage-specific osteogenic markers such as osteocalcin (OC), bone sialoprotein (BSP) 
and osteonectin (ON) (Kim et al, 1999; Jorgensen et al, 2004).  The expression of ON, a 
non-collagenous protein shown to have a role in the regulation of collagen deposition 
within the ECM and the remodelling of mineralised tissues, was reduced following 
exposure to osteogenic medium and increased through the addition of DMCs (see section 
7.4.2) (Gundberg et al, 1984; Boskey et al, 2003; Kawasaki et al, 2006; Martinek et al, 
2007; Delany and Hankenson, 2009).  Previous evidence indicates that the addition of 
TGF-β superfamily members, such as TGF-β1, a common dentine matrix protein, or 
members of the BMP family such as BMP-2 or 4 have been shown to increase the 
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expression of ON but repress the activity of ALP (Nakashima et al, 1990, 1994; Shiba et 
al, 2001).  Therefore, it could be proposed that the presence of these TGF-β superfamily 
members within the DMC fraction may be responsible for the related changes in 
expression of both ALP and ON observed in this study.   
Finally, the effect of DMCs on the expression of genes involved in the regulation of 
epithelial-mesenchymal interactions during tooth morphogenesis and the terminal 
differentiation of odontoblasts were investigated (Hirata et al, 2009).  Semi-quantitative 
RT-PCR analysis indicated that DMC-supplementation of osteogenic medium caused a 
significant increase in the expression of Cbfa1 and Osterix in ADC and BMDC cultures 
(see section 7.4.1) (Komori et al, 1997; Ducy et al, 1997; Disouza et al, 1999).  However, 
the addition of DMCs had only a negligible effect on DPDC cultures with expression of 
these genes reduced when compared with the osteogenic controls. Previous studies have 
demonstrated that the forced expression of Cbfa1 in non-osteoblast cells promoted the 
expression of key osteoblast/odontoblast-specific markers, while the introduction of Cbfa1 
antisense DNA resulted in the supression of DSPP and DMP1 gene expression (Ducy et al, 
1997; Otto et al, 1997; Komori et al, 1997; Chen et al, 2009; Kobayashi et al, 2006). It has 
also been demonstrated that by supplementing osteogenic medium with 10 µg/mL DMCs 
in the absence of dexamethasone, the expression of both Cbfa1 and DSPP were increased, 
perhaps indicating that the addition of dexamethasone to DPDC cultures may have limited 
the odontogenic differentiation of these cells (Liu et al, 2005).  These findings, together 
with a correlation between the late-stage expression of Cbfa1 and corresponding increases 
in DMP1 and DSPP found in the present study, suggest that odontogenic differentiation 
can be induced by the addition of DMCs.  However, the capacity of DMC-
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supplementation to induce the mineralisation and the expression of dentinogenic genes in 
MSCs isolated from different tissues was was not equal.  
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10.0 CONCLUSIONS 
For MSCs to be used for regenerative medicine they need to represent an abundant cell 
type that can be isolated using minimally invasive procedures, and differentiate towards 
multiple lineages in a reproducible manner (Gimble, 2002).  Based on these criteria, ADCs 
could potentially provide a valuable source of MSCs since they can be isolated in large 
quantities under local anaesthesia, causing the patient relatively minimal discomfort (Zuk 
et al, 2001).  However, at present the comparative characterisation of ADCs with other 
commonly used MSCs, such as BMDCs and DPDCS remains relatively unexplored.  
There also remains a lack of published research comparing the benefits of cell selection 
methods, such as FACS, with simple adherence to tissue culture polystyrene for the 
expansion of stem cell populations.  Furthermore, if ADCs and other MSCs are to be 
clinically and commercially advantageous, the relative MSC marker profile of these cells 
before and after cryo-storage needs to be examined.  Finally, the use of ADCs for 
regenerative dentistry is as yet relatively unexplored with the majority of research 
focussing on the use of dental and bone marrow stem cells.  Therefore, the work conducted 
in this study aimed to develop an optimal methodology for the isolation of ADCs from 
adipose tissue, evaluate the influence of cell selection and cryo-storage on MSC phenotype 
and compare the relative "stemness" and odontogenic potential of ADCs with BMSCs and 
DPDCs. 
This study compared the relative effectiveness of type I collagenase digestion for the 
release of ADCs with other digestive enzymes such as trypsin, Accutase and a 
combination of type I collagenase/trypsin.  The results confirmed that incubating adipose 
tissue with type-I collagenase for a period of 30 minutes at 37 ºC was the most effective 
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approach for the isolation of ADCs.  These ADCs demonstrated increased CFU-F 
formation and proliferation when compared with ADCs obtained using all other enzymes 
and digestion periods.  These data highlighted the need for a consistent method of ADC 
dissociation and demonstrated that collagenase digestion should be limited to 30 minutes 
for the release of the most highly proliferative ADCs. 
This study next compared the MSC marker profile and differentiation capacity of ADCs 
with BMDCs and DPDCs.  All three cells types expressed similar levels of MSC markers 
up to passage 4 and demonstrated a bi-lineal differentiation potential.  However, this study 
indicated for the first time using rat-derived donor-matched MSCs that using a standard 
osteogenic protocol, ADCs had a limited capacity for osteogenic differentiation when 
compared with BMDCs and DPDCs.  Moreover, the patterns of mineralisation between 
these three cell types differed with DPDCs depositing a mineralised layer throughout the 
culture while ADCs and BMDCs deposited mineral in a discrete nodular arrangement.  
These data may reflect the lasting effect of stem cell niche on the differentiation capacity 
of its MSCs, possibly resulting from epigenetic modifications such as DNA methylation 
and histone modifications (Teven et al, 2011).  This study further highlights the need for a 
comprehensive evaluation of rat-derived MSCs in order to determine any species-specific 
differences in the marker profiles and differentiation capacities of these cells. 
Cryo-storage is a commonly used method for the long term preservation of MSCs.  
Therefore, the influence of cryo-storage on MSC viability and the expression of stem cell 
markers needed to be evaluated.  This study demonstrated for the first time that cryo-
storage had a cell-specific effect on viability, with BMDCs demonstrating a greater 
decrease in viability compared with ADCs and DPDCs.  Furthermore, cryo-storage also 
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caused a significant increase in the expression of MSC markers when compared with 
freshly isolated cells.  These results suggest that ADCs and DPDCs represent a more 
robust cell type than BMDCs and that cryo-storage might provide a means of increasing 
the proportion of MSCs in a heterogeneous population. 
The establishment of homogeneous MSC populations often relies on the FACS selection 
of cells presenting defined stem cells markers, such as CD29, CD73, CD90 or CD105 
(Dominici et al, 2006).  Previous studies have shown that FACS can have a negative 
influence on cell viability due to the high shearing and hydrodynamic forces experienced 
by the cells during selection (Mollet et al, 2008).  This study presented novel data 
demonstrating that the selection of CD29/CD90 positive cells from heterogeneous adipose, 
bone marrow and dental pulp isolates using FACS significantly reduced the viability and 
ability of these cells to differentiate towards osteogenic and adipogenic lineages.  
Moreover, cells that were not antibody labelled, but were FACS processed, also 
demonstrated reductions in viability and differentiation.  This indicated that the FACS 
procedure was responsible for these negative effects, rather than the selection criteria.  
This study indicated that FACS represents a relatively harsh method of selecting MSCs 
that is not as effective as simple adherence to tissue culture polystyrene for the selection of 
bi-potent cells.  It’s plausible that a more “gentle” cell sorting procedure such as MACS 
may be better suited for the selection of MSCs. 
This study demonstrated that the addition of DMCs as a putative dentinogenic supplement 
promoted an increase in the mineralisation of ADC, BMDC and DPDC cultures.  Data also 
indicated that the addition of DMCs significantly increased the density of mineral present 
in BMDC cultures.  Furthermore, DMC-supplementation resulted in the increased 
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expression of the dentinogenic genes, DMP1 and DSPP, in ADC and BMDC cultures.  
These novel results demonstrated that DMCs could be used to promote dentinogenic 
differentiation of non-dental MSCs.   
Ultimately, the data compiled in this thesis have shown that although ADCs represent a 
convenient source of MSCs, the potential of these cells to produce mineral and 
differentiate to an odontogenic cell type remains limited when compared with DPDCs and 
BMDCs.  However, due to the relative abundance of ADCs throughout the body, their 
comparative ease of isolation and the increasing number of liposuction surgeries carried 
out each year, it is important to further optimise the potential of these cells for regenerative 
mineralised tissue research. 
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11.0 FUTURE WORK 
 
The work presented in this study has provided a detailed account of the similarities and 
differences between rat-derived MSCs isolated from different tissue sources and the 
potential of these cells for dental tissue engineering.  This study has demonstrated that 
ADCs can be isolated in relatively large numbers, proliferate at a similar rate to BMDCs 
and express key markers associated with odontogenic differentiation following 
supplementation with DMCs.  Data presented in this study have demonstrated the negative 
effects of FACS on cell viability and differentiation.  Furthermore, the study has also 
highlighted that ADCs possess a comparatively limited potential to form a mineral-
secreting cell type when compared with BMDCs, and particularly DPDCs, and that the 
need to develop an optimal culture medium that improves the odontogenic potential of 
these cells is paramount if they are to be used for regenerative dentistry.   
Different types of culture serum (e.g. human or xeno-free serum) could be used in the 
composition of mineralising medium to determine if these improve the differentiation of 
ADCs towards a mineral-secreting cell type.  Recently, the application of human or xeno-
free serum to mineralising culture medium has been shown to increase the capacity of 
ADCs to differentiate towards a mineralising cell type (Kyllonen et al, 2013).  The 
application of growth factors may also be appropriate, since the addition of members of the 
BMP family has been shown to improve the mineralising potential of MSC cultures (Luu 
et al, 2007).  
It would be beneficial to further evaluate the differentiation potential of tissue isolates 
sorted using other available MSC markers, such as CD73 and CD105, to better understand 
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the effects of cell sorting on the differentiation potential of these cells.  Different methods 
of cell sorting (e.g. MACS) could also be explored for their ability to isolate viable and 
multipotent cell populations.  However, this approach is dependent and potentially limited 
by the commercial availability of antibodies that react with MSC antigens in the rat 
species. 
In the present study the capacity of ADCs to differentiate towards a mineral-secreting cell 
type was comparatively limited when compared with BMDCs and DPDCs.  Previous 
studies have indicated that the differentiation capacity of ADCs is increased when cultured 
in three-dimensions (Shen et al, 2013).  This approach could be used to assess the effect on 
the mineralisation potential of ADCs and their capacity to differentiate towards an 
odontoblast-like cell.   
Finally, the heterogeneous population of proteins extracted using EDTA solubilisation 
could be fractionated using techniques such as affinity chromatography to identify the 
constituents which may contribute to the odontogenic differentiation process.  Such a study 
could provide better understanding as to how DMC constituents contribute to the 
signalling mechanisms involved in the odontogenic differentiation of ADCs.  
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APPENDIX 1 
 
Gel images corresponding to Figure 4.2.2 
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APPENDIX 2 
Gel images corresponding to Figure 4.4.1 
LPL 
 
 
PPARγ 
 
 
aP2 
 
1, 2 and 3 corresponds to weeks 1, 2 and 3 
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APPENDIX 3 
 
Gel images corresponding to Figure 6.2.2 
 
 
1 = ADC 
2 = Cryo-Stored ADC 
3 = BMDC 
4 = Cryo-Stored BMDC 
5 = DPDC 
6 = Cyro-Stored DPDC 
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APPENDIX 4 
 
Gel images corresponding to Figure 5.4.1a 
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APPENDIX 5 
 
Gel images corresponding to Figure 5.4.1b 
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APPENDIX 6 
 
Gel image corresponding to Figure 7.2.3a 
 
 
Gel image corresponding to Figure 7.2.3b 
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APPENDIX 7 
  
Gel images corresponding to Figure 7.4 
Cbfa1 (Figure 7.4.1a) 
 
 
Osterix (Figure 7.4.1b) 
 
 
COL1 (Figure 7.4.2a) 
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ON (Figure 7.4.2b) 
 
 
ALP (Figure 7.4.2c) 
 
 
BSP (Figure 7.4.3a) 
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OP (Figure 7.4.3b) 
 
 
Nestin (Figure 7.4.4a) 
 
 
DSPP (Figure 7.4.4b) 
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DMP1 (Figure 7.4.4c) 
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APPENDIX 8 
 
FACS images corresponding to Figures 4.2.1 and 6.2.1 
 
 
AD = Adipose 
BM = Bone Marrow 
DP = Dental Pulp 
LN = Liquid Nitrogen 
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APPENDIX 9 
 
Dentine analyses corresponding to figure 7.1.1 
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APPENDIX 10 
 
EDS and calcium/phosphate micro-determination analyses corresponding to figure 
7.3.5 
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Table 2.7.5  DNA sequences, annealing temperatures, and cycle numbers for primers used 
in the RT-PCR reaction.  All primers were designed using Primer Blast software 
(http://ncbi.nlm.nih.gov/tools/primer-blast/) and manufactured by Invitrogen, UK. 
 
 
 
 
 
 
 
 
 
 
 
